<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="letter" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Microbiome</journal-id><journal-id journal-id-type="iso-abbrev">Microbiome</journal-id><journal-title-group><journal-title>Microbiome</journal-title></journal-title-group><issn pub-type="epub">2049-2618</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40410872</article-id><article-id pub-id-type="pmc">PMC12100821</article-id><article-id pub-id-type="publisher-id">2119</article-id><article-id pub-id-type="doi">10.1186/s40168-025-02119-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Comment</subject></subj-group></article-categories><title-group><article-title>Metaproteomics in the One Health framework for unraveling microbial effectors in microbiomes</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Heyer</surname><given-names>Robert</given-names></name><address><email>robert.heyer@ISAS.de</email><email>robert.heyer@uni-bielefeld.de</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wolf</surname><given-names>Maximilian</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Benndorf</surname><given-names>Dirk</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Uzzau</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Seifert</surname><given-names>Jana</given-names></name><xref ref-type="aff" rid="Aff7">7</xref><xref ref-type="aff" rid="Aff8">8</xref></contrib><contrib contrib-type="author"><name><surname>Grenga</surname><given-names>Lucia</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Pabst</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Schmitt</surname><given-names>Heike</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Mesuere</surname><given-names>Bart</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Van Den Bossche</surname><given-names>Tim</given-names></name><xref ref-type="aff" rid="Aff13">13</xref><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><name><surname>Haange</surname><given-names>Sven-Bastiaan</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Jehmlich</surname><given-names>Nico</given-names></name><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0688-034X</contrib-id><name><surname>Di Luca</surname><given-names>Mariagrazia</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4962-4714</contrib-id><name><surname>Ferrer</surname><given-names>Manuel</given-names></name><xref ref-type="aff" rid="Aff17">17</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5447-3554</contrib-id><name><surname>Serrano-Villar</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="Aff18">18</xref></contrib><contrib contrib-type="author"><name><surname>Armengaud</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><name><surname>Bode</surname><given-names>Helge B.</given-names></name><xref ref-type="aff" rid="Aff19">19</xref><xref ref-type="aff" rid="Aff20">20</xref><xref ref-type="aff" rid="Aff21">21</xref></contrib><contrib contrib-type="author"><name><surname>Hellwig</surname><given-names>Patrick</given-names></name><xref ref-type="aff" rid="Aff3">3</xref><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>Masselot</surname><given-names>Catherine Robbe</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>L&#x000e9;onard</surname><given-names>Renaud</given-names></name><xref ref-type="aff" rid="Aff23">23</xref></contrib><contrib contrib-type="author"><name><surname>Wilmes</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff24">24</xref><xref ref-type="aff" rid="Aff25">25</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02jhqqg57</institution-id><institution-id institution-id-type="GRID">grid.419243.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0492 9407</institution-id><institution>Multidimensional Omics Analyses Group, Leibniz-Institut f&#x000fc;r Analytische Wissenschaften &#x02013; ISAS &#x02013; e.V., </institution></institution-wrap>Bunsen-Kirchhoff-Stra&#x000df;e 11, 44139 Dortmund, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02hpadn98</institution-id><institution-id institution-id-type="GRID">grid.7491.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0944 9128</institution-id><institution>Multidimensional Omics Analyses Group, Faculty of Technology, </institution><institution>Bielefeld University, </institution></institution-wrap>Universit&#x000e4;tsstra&#x000df;e 25, 33615 Bielefeld, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00ggpsq73</institution-id><institution-id institution-id-type="GRID">grid.5807.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 1018 4307</institution-id><institution>Bioprocess Engineering, Otto-Von-Guericke University Magdeburg, </institution></institution-wrap>Universit&#x000e4;tsplatz 2, 39106 Magdeburg, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/030h7k016</institution-id><institution-id institution-id-type="GRID">grid.419517.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0491 802X</institution-id><institution>Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems Magdeburg, </institution></institution-wrap>Sandtorstra&#x000df;e 1, 39106 Magdeburg, Germany </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0076zct58</institution-id><institution-id institution-id-type="GRID">grid.427932.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 0692 3664</institution-id><institution> Applied Biosciences and Process Engineering, </institution><institution>Anhalt University of Applied Sciences, </institution></institution-wrap>K&#x000f6;then, Germany </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01bnjbv91</institution-id><institution-id institution-id-type="GRID">grid.11450.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 9138</institution-id><institution>Department of Biomedical Sciences, </institution><institution>University of Sassari, </institution></institution-wrap>07100 Sassari, Italy </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b1c9541</institution-id><institution-id institution-id-type="GRID">grid.9464.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2290 1502</institution-id><institution>Institute of Animal Science, </institution><institution>University of Hohenheim, </institution></institution-wrap>Emil-Wolff-Str, Stuttgart, Germany </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b1c9541</institution-id><institution-id institution-id-type="GRID">grid.9464.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2290 1502</institution-id><institution>HoLMiR - Hohenheim Center for Livestock Microbiome Research, University of Hohenheim, </institution></institution-wrap>Leonore-Blosser-Reisen Weg, Stuttgart, Germany </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03xjwb503</institution-id><institution-id institution-id-type="GRID">grid.460789.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 4910 6535</institution-id><institution>D&#x000e9;partement M&#x000e9;dicaments Et Technologies Pour La Sant&#x000e9; (DMTS), </institution><institution>Universit&#x000e9; Paris-Saclay, CEA, INRAE, SPI, </institution></institution-wrap>Bagnols-Sur-C&#x000e8;ze, France </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02e2c7k09</institution-id><institution-id institution-id-type="GRID">grid.5292.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2097 4740</institution-id><institution>Department of Biotechnology, </institution><institution>Delft University of Technology, </institution></institution-wrap>Delft, The Netherlands </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01cesdt21</institution-id><institution-id institution-id-type="GRID">grid.31147.30</institution-id><institution-id institution-id-type="ISNI">0000 0001 2208 0118</institution-id><institution>Institute for Infectious Disease Control, </institution><institution>National Institute for Public Health and the Environment (RIVM), </institution></institution-wrap>Bilthoven, The Netherlands </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cv9y106</institution-id><institution-id institution-id-type="GRID">grid.5342.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2069 7798</institution-id><institution>Department of Applied Mathematics, Computer Science and Statistics, </institution><institution>Ghent University, </institution></institution-wrap>9000 Ghent, Belgium </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04hbttm44</institution-id><institution-id institution-id-type="GRID">grid.511525.7</institution-id><institution>VIB - UGent Center for Medical Biotechnology, VIB, </institution></institution-wrap>9052 Ghent, Belgium </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cv9y106</institution-id><institution-id institution-id-type="GRID">grid.5342.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2069 7798</institution-id><institution>Department of Biomolecular Medicine, Faculty of Medicine and Health Sciences, </institution><institution>Ghent University, </institution></institution-wrap>9052 Ghent, Belgium </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/000h6jb29</institution-id><institution-id institution-id-type="GRID">grid.7492.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0492 3830</institution-id><institution>Department of Molecular Toxicology, </institution><institution>Helmholtz-Centre for Environmental Research - UFZ GmbH, </institution></institution-wrap>Permoserstrasse 15, 04318 Leipzig, Germany </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03ad39j10</institution-id><institution-id institution-id-type="GRID">grid.5395.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3729</institution-id><institution>Department of Biology, </institution><institution>University of Pisa, </institution></institution-wrap>56127 Pisa, Italy </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/004swtw80</institution-id><institution-id institution-id-type="GRID">grid.418900.4</institution-id><institution-id institution-id-type="ISNI">0000 0004 1804 3922</institution-id><institution>Instituto de Catalisis y Petroleoquimica (ICP), CSIC, </institution></institution-wrap>28049 Madrid, Spain </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/050eq1942</institution-id><institution-id institution-id-type="GRID">grid.411347.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 9248 5770</institution-id><institution>Department of Infectious Diseases, </institution><institution>Hospital Universitario Ramon y Cajal, Instituto de Investigaci&#x000f3;n Sanitaria Ram&#x000f3;n y Cajal (IRYCIS), CIBER de Enfermedades Infecciosas, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05r7n9c40</institution-id><institution-id institution-id-type="GRID">grid.419554.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0491 8361</institution-id><institution>Department of Natural Products in Organismic Interactions, Max-Planck-Institut for Terrestrial Microbiology, </institution></institution-wrap>Karl-Von-Frisch-Str. 10, 35043 Marburg, Germany </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rdrb571</institution-id><institution-id institution-id-type="GRID">grid.10253.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9756</institution-id><institution>Center for Synthetic Microbiology (SYNMIKRO), </institution><institution>Phillips University Marburg, </institution></institution-wrap>35043 Marburg, Germany </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01rdrb571</institution-id><institution-id institution-id-type="GRID">grid.10253.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9756</institution-id><institution>Department of Chemistry, </institution><institution>Phillips University Marburg, </institution></institution-wrap>35043 Marburg, Germany </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/030h7k016</institution-id><institution-id institution-id-type="GRID">grid.419517.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0491 802X</institution-id><institution>Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, </institution></institution-wrap>Sandtorstra&#x000df;e 1, 39106 Magdeburg, Germany </aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kzqn938</institution-id><institution-id institution-id-type="GRID">grid.503422.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2242 6780</institution-id><institution>Universit&#x000e9; de Lille, CNRS, UMR, </institution></institution-wrap>8576 - UGSF Lille, France </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/036x5ad56</institution-id><institution-id institution-id-type="GRID">grid.16008.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2295 9843</institution-id><institution>Luxembourg Centre for Systems Biomedicine, </institution><institution>University of Luxembourg, </institution></institution-wrap>L-4362 Esch-Sur-Alzette, Luxembourg </aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/036x5ad56</institution-id><institution-id institution-id-type="GRID">grid.16008.3f</institution-id><institution-id institution-id-type="ISNI">0000 0001 2295 9843</institution-id><institution>Department of Life Sciences and Medicine, </institution><institution>University of Luxembourg, </institution></institution-wrap>L-4362 Esch-Sur-Alzette, Luxembourg </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>13</volume><elocation-id>134</elocation-id><history><date date-type="received"><day>9</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">One Health seeks to integrate and balance the health of humans, animals, and environmental systems, which are intricately linked through microbiomes. These microbial communities exchange microbes and genes, influencing not only human and animal health but also key environmental, agricultural, and biotechnological processes. Preventing the emergence of pathogens as well as monitoring and controlling the composition of microbiomes through microbial effectors including virulence factors, toxins, antibiotics, non-ribosomal peptides, and viruses holds transformative potential. However, the mechanisms by which these microbial effectors shape microbiomes and their broader functional consequences for host and ecosystem health remain poorly understood. Metaproteomics offers a novel methodological framework as it provides insights into microbial dynamics by quantifying microbial biomass composition, metabolic functions, and detecting effectors like viruses, antimicrobial resistance proteins, and non-ribosomal peptides. Here, we highlight the potential of metaproteomics in elucidating microbial effectors and their impact on microbiomes and discuss their potential for modulating microbiomes to foster desired functions.</p><sec><title>Graphical Abstract</title><p id="Par2">Word Cloud showing the abundance of keywords in combination with the &#x0201c;Microbiome&#x0201d; in PubMed NCBI. As abundance values, the rounded logarithm with the base of 2 hits were used and submitted to <ext-link ext-link-type="uri" xlink:href="https://wordart.com/create">https://wordart.com/create</ext-link>. For microbiome, the number without any combination was used for calculation. The word cloud displays different aspects of microbiome research: (i.) sources of microbiomes (green), (ii.) interactions (purple), (iii.) involved taxa (red), (iv.) applied experimental approaches (blue), and (vi.) societal effects and recent or future applications (gray).</p><p id="Par3">
<graphic position="anchor" xlink:href="40168_2025_2119_Figa_HTML" id="MO1"/></p><p id="Par6000">
<media xlink:href="40168_2025_2119_MOESM1_ESM.mp4" id="MOESM1"><caption><p>Video Abstract</p></caption></media></p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s40168-025-02119-5.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd> Microbiome
</kwd><kwd><bold>Microbial community</bold></kwd><kwd><bold>Metaproteomics</bold></kwd><kwd> Bacteriophages
</kwd><kwd>Microbial effectors</kwd></kwd-group><funding-group><award-group><funding-source><institution>R&#x000e9;gion Occitanie (DeepMicro grant)</institution></funding-source><award-id>ANR-20-CE34-0012</award-id><award-id>ANR-20-CE34-0012</award-id><principal-award-recipient><name><surname>Grenga</surname><given-names>Lucia</given-names></name><name><surname>Armengaud</surname><given-names>Jean</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001665</institution-id><institution>Agence Nationale de la Recherche</institution></institution-wrap></funding-source><award-id>ANR-24-INBS-0015</award-id><award-id>ANR-24-INBS-0015</award-id><principal-award-recipient><name><surname>Grenga</surname><given-names>Lucia</given-names></name><name><surname>Armengaud</surname><given-names>Jean</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Research Foundation Flanders (FWO)</institution></funding-source><award-id>1286824N</award-id><principal-award-recipient><name><surname>Van Den Bossche</surname><given-names>Tim</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100011033</institution-id><institution>Agencia Estatal de Investigaci&#x000f3;n</institution></institution-wrap></funding-source><award-id>MICIU/AEI/10.13039/501100011033</award-id><principal-award-recipient><name><surname>Ferrer</surname><given-names>Manuel</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>NextGenerationEU/PRTR</institution></funding-source><award-id>PID2023-153370OB-I00</award-id><principal-award-recipient><name><surname>Ferrer</surname><given-names>Manuel</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>CSIC (COCREA program)</institution></funding-source><award-id>INMUNOBIOTA</award-id><principal-award-recipient><name><surname>Ferrer</surname><given-names>Manuel</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par30">The One Health framework is based on the deep interconnection among human health, animals, and agricultural and environmental ecosystems. These interactions are evident in examples such as zoonotic diseases and the emerging spread of antibiotic resistance. A key factor linking human and animal health with environmental, agricultural, and biotechnological systems is their microbiome. The exchange of cellular organisms, viruses, plasmids, transposons, and genes between different microbiomes leads to (i.) alterations in microbiome composition and function within recipient systems, (ii.) the introduction of pathogenic species and genes, and (iii.) the transfer of antibiotic resistance genes. In relation to the latter, in 2019 alone, deaths related to antimicrobial resistance (AMR) were estimated at 4.71 million worldwide, including 1.14 million deaths attributable to bacterial AMR [<xref ref-type="bibr" rid="CR1">1</xref>]. Conversely, controlling microbiome composition holds transformative potential for healthcare and biotechnological applications. Identifying microbial effectors, such as virulence factors, toxins, antibiotics, non-ribosomal peptides (NRP)s, and viruses across diverse environments, is crucial for precisely managing microbial communities [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par31">While microbiome-based effectors hold significant potential for future applications, a deeper understanding of the mechanisms by which these effectors influence microbiomes and broader functional impacts remains essential.</p><p id="Par32">Metaproteomics provides a powerful toolbox to identify and monitor microbial effectors [<xref ref-type="bibr" rid="CR4">4</xref>]. It has already proven valuable across diverse applications, including characterizing the impact of antibiotic therapy on human gut microbiomes [<xref ref-type="bibr" rid="CR5">5</xref>], assessing antibiotic resistance in animals [<xref ref-type="bibr" rid="CR6">6</xref>] and their manure [<xref ref-type="bibr" rid="CR7">7</xref>], evaluating the impact of mycotoxins on animal gut microbiomes [<xref ref-type="bibr" rid="CR8">8</xref>], exploring alternative genes encoded in human gut bacteriophages (phages) [<xref ref-type="bibr" rid="CR9">9</xref>], characterizing the human gut virome [<xref ref-type="bibr" rid="CR10">10</xref>], and identifying phage populations within anaerobic digesters [<xref ref-type="bibr" rid="CR11">11</xref>].</p><p id="Par33">Recent advancements in high-resolution mass spectrometers and overall progress in metaproteomics have significantly improved the sensitivity and specificity of microbial effector identification. Further refinements in the metaproteomic workflow hold great promise for advancing our understanding of microbial effectors and their impact on microbiomes.</p><p id="Par34">In this opinion piece, we discuss how metaproteomics provides insights into the occurrence of microbial effectors and how these influence microbiomes. We focus on seven key challenges: (i.) detecting and quantification of low-abundant microbial effectors, (ii.) identification of non-canonical peptides and proteins (e.g., NRPs), (iii.) using search databases for microbial effectors, (iv.) taxonomic and functional annotation of microbial effectors, (v.) mapping of microbial effectors to their hosts and targets, and (vi.) identification strategies to explore their interactions. To address these questions, we will first introduce the microbial effectors, then outline the metaproteomics workflow and the required adaptations for microbial effector analysis, before focusing on their application in microbiomes within the framework of One Health.</p></sec><sec id="Sec2"><title>Microbial effectors</title><p id="Par35">Microbial effectors encompass a diverse range of biomolecules that microorganisms utilize to compete with other species or modify their environment (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>, see also Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref> for a comprehensive overview of databases for microbial effectors). For instance, microorganisms produce virulence factors to infect hosts, evade immune defenses, and cause disease. Among these, toxins are exceptionally potent, as their highly specific enzymatic activities allow them to damage host cells and disrupt biological processes even in trace amounts. In addition, many microbial species synthesize antibiotics to inhibit the growth of competing species or eliminate them entirely. Furthermore, nearly all living organisms produce antimicrobial peptides (AMP) as a defense mechanism against bacteria, viruses, fungi, and even tumor cells. These AMPs can be classified into ribosomal peptides and NRPs. Another class of microbial effectors is viruses and phages, which function as mobile, self-replicating genetic elements. The unique advantage of metaproteomics is its ability to confirm the actual presence of these microbial effectors and elucidate the involvement of specific protein machinery in their synthesis. Additionally, metaproteomics data correlate well with the actual functional microbial activity and identify host proteins present in the sample, providing valuable insights into host responses. For a selected example of the application of metaproteomics to microbial effector research, please refer to Table&#x000a0;<xref rid="Tab3" ref-type="table">3</xref>.<fig id="Fig1"><label>Fig.&#x000a0;1</label><caption><p>Overview of the role of microbial effectors in microbiomes and their interaction with the hosts</p></caption><graphic xlink:href="40168_2025_2119_Fig1_HTML" id="MO2"/></fig><table-wrap id="Tab1"><label>Table&#x000a0;1</label><caption><p>Overview of microbial effectors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Microbial effector</th><th align="left">Definition</th><th align="left">Structure</th><th align="left">Producer</th><th align="left">Target</th><th align="left">Resistance</th></tr></thead><tbody><tr><td align="left">Virulence factor</td><td align="left">Molecules or structures that enable pathogens to infect hosts, evade immune defenses, or cause disease</td><td align="left">Enzymes, toxins, adhesins</td><td align="left">Bacteria, Archaea, Fungi, Viruses</td><td align="left">Hosts including animals and plants</td><td align="left">Usually slow, but fast adaptation by immune system</td></tr><tr><td align="left">Toxins</td><td align="left">Substances produced by organisms to damage host cells, disrupt biological functions, or cause toxicity</td><td align="left">Complex metabolites (may contain amino acids)</td><td align="left">Bacteria, Archaea, Fungi, Viruses</td><td align="left">Hosts including animals and plants</td><td align="left">Usually slow, but fast adaptation by immune system</td></tr><tr><td align="left">Antimicrobial peptide</td><td align="left">Short peptides produced to defend against bacteria, viruses fungi and tumor cells</td><td align="left">Canonical amino acids</td><td align="left">All species</td><td align="left">broad range against bacteria, virus, fungi or parasites</td><td align="left">Rare</td></tr><tr><td align="left">Non-ribosomal peptide</td><td align="left">Peptides synthesized by non-ribosomal peptide synthetase (NRPS) enzymes, not ribosomes</td><td align="left">Peptide secondary metabolites</td><td align="left">Bacteria, Archaea, Fungi</td><td align="left">broad range against bacteria, virus, fungi or parasites</td><td align="left">Rare</td></tr><tr><td align="left">Antibiotics</td><td align="left">Chemical compounds that specifically inhibit bacterial growth or kill bacteria</td><td align="left">Diverse small molecules (may contain amino acids)</td><td align="left">Bacteria, Archaea, Fungi</td><td align="left">Target microbial structures</td><td align="left">Frequent</td></tr><tr><td align="left">Viruses</td><td align="left">Infectious agents consisting of nucleic acids</td><td align="left">Nucleic acids (DNA/RNA) and proteins; sometimes lipids</td><td align="left">Self-reproducing in hosts</td><td align="left">All domains</td><td align="left">Usually slow, but fast adaptation by immune system</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table&#x000a0;2</label><caption><p>Overview of databases and tools for microbial effectors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="2">Microbial effector</th><th align="left">Name</th><th align="left">Description</th><th align="left">Source</th></tr></thead><tbody><tr><td align="left" rowspan="3">Virulence factors</td><td align="left">Database</td><td align="left">VFDB</td><td align="left">- Virulence factors of bacterial pathogens</td><td align="left">[<xref ref-type="bibr" rid="CR12">12</xref>]</td></tr><tr><td align="left" rowspan="2">Tool</td><td align="left">PATHOFact</td><td align="left">- Prediction of AMR genes, virulence factors, toxins, and BGCs</td><td align="left">[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td align="left">MetaVF</td><td align="left">- Identification of pathobiont-carried VFGs at the species level</td><td align="left">[<xref ref-type="bibr" rid="CR14">14</xref>]</td></tr><tr><td align="left" rowspan="3">Toxins</td><td align="left" rowspan="2">Database</td><td align="left">Toxinome</td><td align="left">- Bacterial protein toxin</td><td align="left">[<xref ref-type="bibr" rid="CR15">15</xref>]</td></tr><tr><td align="left">TADB</td><td align="left">- Bacterial types I to VIII toxin-antitoxin loci</td><td align="left">[<xref ref-type="bibr" rid="CR16">16</xref>]</td></tr><tr><td align="left">Tool</td><td align="left">PathoFact</td><td align="left">- Prediction of AMR genes, virulence factors, toxins and BGCs</td><td align="left">[<xref ref-type="bibr" rid="CR13">13</xref>]</td></tr><tr><td align="left" rowspan="7">Antimicrobials</td><td align="left" rowspan="5">Database</td><td align="left">AntibioticDB</td><td align="left">- Antibacterial compounds (incl. discontinued agents and drugs under pre-clinical development or in clinical trials)</td><td align="left">[<xref ref-type="bibr" rid="CR17">17</xref>]</td></tr><tr><td align="left">DrugBank</td><td align="left">- Drugs, drug targets, and related pharmaceutical information</td><td align="left">[<xref ref-type="bibr" rid="CR18">18</xref>]</td></tr><tr><td align="left">PubChem</td><td align="left">- Chemical information on e.g., small molecules, siRNA, miRNA, lipids or carbohydrates</td><td align="left">[<xref ref-type="bibr" rid="CR19">19</xref>]</td></tr><tr><td align="left">ChEMBL</td><td align="left">- Bioactive molecules with drug-like properties</td><td align="left">[<xref ref-type="bibr" rid="CR20">20</xref>]</td></tr><tr><td align="left">CARD</td><td align="left">- Antibiotic resistance ontologies with curated AMR gene sequences and resistance-conferring mutations</td><td align="left">[<xref ref-type="bibr" rid="CR21">21</xref>]</td></tr><tr><td align="left" rowspan="2">Tool</td><td align="left">antiSMASH</td><td align="left">- Detecting and characterizing biosynthetic gene clusters (BGCs)</td><td align="left">[<xref ref-type="bibr" rid="CR22">22</xref>]</td></tr><tr><td align="left">ResFinder</td><td align="left">- Identification of AMR genes in NGS-data</td><td align="left">[<xref ref-type="bibr" rid="CR23">23</xref>]</td></tr><tr><td align="left" rowspan="13">Antimicrobial/non-ribosomal peptides</td><td align="left" rowspan="4">Database</td><td align="left">CAMP<sub>R4</sub>
</td><td align="left">- Natural and synthetic AMPs</td><td align="left">[<xref ref-type="bibr" rid="CR24">24</xref>]</td></tr><tr><td align="left">dbAMP</td><td align="left">- Annotations on AMPs (incl. sequence information, functional activity data, or physicochemical properties)</td><td align="left">[<xref ref-type="bibr" rid="CR25">25</xref>]</td></tr><tr><td align="left">DBAASP</td><td align="left">- Sequences, chemical modifications, structures, bioactivities and toxicities of AMPs</td><td align="left">[<xref ref-type="bibr" rid="CR26">26</xref>]</td></tr><tr><td align="left">DRAMP</td><td align="left">- Antimicrobial, antifungal, antiviral, anticancer, antitumor, antiprotozoal, and insecticidal peptides</td><td align="left">[<xref ref-type="bibr" rid="CR27">27</xref>]</td></tr><tr><td align="left" rowspan="9">Tool</td><td align="left">Macrel</td><td align="left">- Prediction of AMP sequences from genomes and metagenomes</td><td align="left">[<xref ref-type="bibr" rid="CR28">28</xref>]</td></tr><tr><td align="left">SPEQ</td><td align="left">- Identification of high-quality, not identified LC&#x02013;MS spectra</td><td align="left">[<xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td align="left">Ensemble-AMPPred</td><td align="left">- AMP prediction and recognition from sequence data</td><td align="left">[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td align="left">Deep-AmPEP30</td><td align="left">- Prediction of short-length (&#x02264;&#x02009;30 aa) AMP</td><td align="left">[<xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td align="left">SBSPKSv3</td><td align="left">- Prediction of macrocyclized structures of non-ribosomal peptide synthetase and polyketide synthase</td><td align="left">[<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td align="left">NRPminer</td><td align="left">- NRP discovery from (meta)genomic and mass spectrometry datasets</td><td align="left">[<xref ref-type="bibr" rid="CR33">33</xref>]</td></tr><tr><td align="left">BiG-MEx</td><td align="left">- Identification of BGC protein domains and assessment of diversity and novelty</td><td align="left">[<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td align="left">BiG-SCAPE</td><td align="left">- Analysis of sequence similarity networks of biosynthetic gene clusters and gene cluster families</td><td align="left">[<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td align="left">NaPDos</td><td align="left">- Assessment of secondary metabolite biosynthetic gene diversity and novelty of in organisms and environments</td><td align="left">[<xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td align="left" rowspan="10">Bacteriophages/Archeophages</td><td align="left" rowspan="5">Database</td><td align="left">PhageDive</td><td align="left">- Experimental data (e.g., host range) and metadata (e.g., geographical origin) on bacteriophages</td><td align="left">[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td align="left">Gut Phage Database (GPD)</td><td align="left">- Non-redundant viral genomes obtained by mining human gut metagenomes and reference genomes of cultured gut bacteria</td><td align="left">[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td align="left">
<italic>M</italic>icrobe <italic>V</italic>ersus <italic>P</italic>hage (MVP)
</td><td align="left">- Phage&#x02013;microbe interactions</td><td align="left">[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td align="left">PhagesDB</td><td align="left">- Interactive website for discovery, characterization, and genomics of viruses that infect Actinobacteria</td><td align="left">[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td align="left">PhaLP</td><td align="left">- Phage lytic proteins</td><td align="left">[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td align="left" rowspan="5">Tool</td><td align="left">phageAI</td><td align="left">- Lifecycle prediction tasks based on bacteriophage nucleotide sequences</td><td align="left">[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td align="left">What the Phage</td><td align="left">- Identification and analysis of phage sequences</td><td align="left">[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td align="left">PHASTEST</td><td align="left">- Identification, interactive visualization, and annotation of prophage sequences within bacterial genomes or plasmids</td><td align="left">[<xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td align="left">PEPGM</td><td align="left">- Taxonomic inference of viral proteome samples</td><td align="left">[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td align="left">VirHostMatcher</td><td align="left">- Prediction of virus-prokaryote interactions</td><td align="left">[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr></tbody></table></table-wrap><table-wrap id="Tab3"><label>Table&#x000a0;3</label><caption><p>Examples for the usage of microbial effectors</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Microbial effector</th><th align="left">Use case description</th><th align="left">Source</th></tr></thead><tbody><tr><td align="left">Virulence factors (VF)</td><td align="left">- Identification of virulence factors in body fluids (e.g., sputum) and at marine plastic surfaces</td><td align="left">[<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]</td></tr><tr><td align="left" rowspan="2">Toxins</td><td align="left">- Assessment of metabolic changes of the gut microbiome in response to toxins</td><td align="left">[<xref ref-type="bibr" rid="CR8">8</xref>]</td></tr><tr><td align="left">- Verification of the expression of protein toxins and proteins involved in their biosynthesis and secretion</td><td align="left">[<xref ref-type="bibr" rid="CR49">49</xref>]</td></tr><tr><td align="left">Antimicrobials</td><td align="left">- Revelation of complex cellular/metabolic responses included in antimicrobial-resistance (e.g., increased production of outer membrane proteins)</td><td align="left">[<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td align="left">Bacteriophages/Archeophages</td><td align="left">- Assessment of host-phage interactions (over time), e.g., via the host immune response</td><td align="left">[<xref ref-type="bibr" rid="CR52">52</xref>, <xref ref-type="bibr" rid="CR53">53</xref>]</td></tr></tbody></table></table-wrap></p><sec id="Sec3"><title>Virulence factors</title><p id="Par36">Virulence factors support microorganisms in host infection and disease [<xref ref-type="bibr" rid="CR54">54</xref>]. Many of these factors are either secreted, membrane-associated, or cytosolic proteins including toxins, adhesins, invasins, proteases, and hemolysins. Other proteins are involved in biosynthesis and secretion systems for non-protein virulence factors (i.e., capsules and endotoxins) [<xref ref-type="bibr" rid="CR55">55</xref>]. Genes encoding virulence factors can be transmitted between or within species, facilitating the selection of pathogens of enhanced virulence and driving the emergence of new diseases [<xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par37">The transfer of DNA and thereby virulence factors is either accomplished by transduction through phages, conjugation through pili, or by uptake of naked, extracellular DNA [<xref ref-type="bibr" rid="CR57">57</xref>]. In particular, environmental microbiomes such as those in wastewater treatment plants are reservoirs for clinically relevant virulence genes and are important drivers for the exchange and transmission of genes [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. Therefore, monitoring the presence of virulence factors in high-risk environments is a key task of the One Health framework. While metagenomics and qPCR can identify the presence of virulence genes [<xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR61">61</xref>], these approaches may underestimate the presence of pseudogenes and cannot reveal the actual synthesis and secretion of virulence factors [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. On the contrary, proteomics and metaproteomics methods are more suitable for exploring protein synthesis and secretion according to environmental stimuli.</p></sec><sec id="Sec4"><title>Toxins</title><p id="Par38">Toxins are a subclass of virulence factors comprising diverse bioactive compounds, including proteins [<xref ref-type="bibr" rid="CR64">64</xref>]. They can be classified based on their biological effect on the target organism and on whether they are released to target cells (exotoxins) or cell-associated (endotoxins) [<xref ref-type="bibr" rid="CR65">65</xref>]. Protein toxins are active at very low concentrations, posing severe or even life-threatening risks to human and animal health. They can either act on the cell surface, by interfering with signal transduction, damaging the membrane, or intracellularly, where they induce cell death, cytoskeleton alteration, or blockade of exocytosis [<xref ref-type="bibr" rid="CR66">66</xref>].</p><p id="Par39">Toxins readily transfer between environments. For instance, toxins produced by cyanobacteria in an aquatic environment can accumulate in fish or seafood [<xref ref-type="bibr" rid="CR67">67</xref>]. Mycotoxins in contaminated feed can impact the intestinal microbiome and cause hormonal changes in pigs [<xref ref-type="bibr" rid="CR8">8</xref>] and can accumulate in chicken tissue [<xref ref-type="bibr" rid="CR68">68</xref>], which are then consumed by humans and animals, impacting their health. Additionally, soil-derived toxins can be mobilized by water, spreading across ecosystems.</p><p id="Par40">Notably, xenobiotics derived from microbial toxins are currently being explored for their use in cancer treatment [<xref ref-type="bibr" rid="CR69">69</xref>]. Therefore, identifying toxin-producing microorganisms and detecting toxins in complex matrices (environmental samples or body fluids) is crucial for the One Health framework. Recently established databases containing information about microbial toxins and antitoxins [<xref ref-type="bibr" rid="CR15">15</xref>], and tools for predicting toxin genes in (meta-) genomic data [<xref ref-type="bibr" rid="CR61">61</xref>], will enable the in-depth exploration of these microbial effectors.</p></sec><sec id="Sec5"><title>Antimicrobials</title><p id="Par41">Antimicrobials are capable of killing or inhibiting the growth of bacteria (antibiotics), viruses (antivirals), or fungi (antimycotics). The resistance of bacteria against antimicrobials represents a significant public health concern [<xref ref-type="bibr" rid="CR1">1</xref>]. Antibiotics are generally classified by their molecular targets, such as the bacterial cell wall, cell membrane, essential bacterial enzymes, or protein synthesis. Several databases are available for more detailed information on antimicrobials, including AntibioticDB [<xref ref-type="bibr" rid="CR17">17</xref>], DrugBank [<xref ref-type="bibr" rid="CR18">18</xref>], PubChem [<xref ref-type="bibr" rid="CR19">19</xref>], and the ChEMBL [<xref ref-type="bibr" rid="CR20">20</xref>] databases. Additionally, databases such as CARD [<xref ref-type="bibr" rid="CR21">21</xref>] and ResFinder [<xref ref-type="bibr" rid="CR23">23</xref>] focus on collecting AMR genes.</p><p id="Par42">Numerous studies have explored antibiotic modes of action, resistance mechanisms, and bacterial screening for antibiotic resistance. (Meta)Proteomics plays a key role in elucidating how antibiotics work and uncovering cellular mechanisms of microbial adaptations to antibiotics&#x02014;i.e., resistance to antibiotics [<xref ref-type="bibr" rid="CR70">70</xref>&#x02013;<xref ref-type="bibr" rid="CR72">72</xref>].</p></sec><sec id="Sec6"><title>Antimicrobial peptides/non-ribosomal peptides</title><p id="Par43">AMPs [<xref ref-type="bibr" rid="CR73">73</xref>] are a subgroup of antimicrobials consisting of polypeptides of 12 to 50 amino acids, produced as part of the innate immune system response in all higher eukaryotes but are also found in microorganisms. They play a key role in defending against other microbial species and may even target cancer cells, fungi, or viruses [<xref ref-type="bibr" rid="CR74">74</xref>]. AMPs are synthesized either through ribosomal pathways, utilizing canonical amino acids, often followed by extensive post-translational modification as in the case of ribosomally synthesized and post-translationally modified peptides (RiPPs) [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR76">76</xref>], or via non-ribosomal peptide synthetases (NRPS), enormous multifunctional enzymes found in bacteria, fungi but also higher eukaryotes [<xref ref-type="bibr" rid="CR77">77</xref>].</p><p id="Par44">Ribosomal AMPs were once thought to be mainly linear, cationic peptides with membrane-disrupting activity, but the discovery of new RiPP classes in the past 15&#x000a0;years has challenged this view. Today, several highly complex RiPPs are known, which are so heavily post-translationally modified including via additional ring systems, epimerizations, hydroxylations, acylations, and/or C- and N-methylations that they can hardly be recognized as being of ribosomal biosynthesis origin. However, the big difference to NRPS-derived peptides is that RiPPs initially rely only on the 20 canonical amino acids while in NRPS-derived peptides more than 400 different amino acids have been described. Most of these are incorporated into the peptide during the assembly-line-like mechanism, where they can also be modified by C- and N-methylation, hydroxylation, oxidation, dehydralation, heterocyclization, acylation, or formylation. The resulting peptide can also be further modified post-NRPS by glycosylation, phosphorylation, sulfation, or deacylation. Furthermore, NRPS can occur in combination with polyketide synthases (PKS), forming the so-called NRPS-PKS hybrid enzymes, based on the shared biochemical mechanism, whereby all biosynthesis intermediates are covalently bound to a peptidyl- or acyl-carrier protein or thiolation (T) domain, ensuring an efficient combination of amino acids with (further functionalized) malonyl- or acetyl-units. The resulting gamma- (elongation with one) or epsilon- (elongation with two PKS units) amino acids can add to the complexity of NRPS-derived peptides beyond what is possible through RiPPs.</p><p id="Par45">The chemical diversity of NRPs and RiPPs, including various modifications, makes their identification difficult, as their D- or modified amino acids and cyclic structures confer protease resistance. Most known cases were identified due to strong antimicrobial activity or through detection of the biosynthetic gene cluster (BGC) with characteristic modifying enzymes (e.g., radical SAM), followed by heterologous production of the peptide. Identifying the classical linear AMPs is also very challenging; although they can be cleaved by proteases because of their linear structures, the presence of several cationic amino acids (i.e., lysine or arginine) residues often results in peptides too small for definitive identification. The potential benefit of metaproteomics is that it is possible to quantify the abundance of the NRP-producing enzymes even in microbial communities and thus predict their presence and structure, required for their targeted measurement. Furthermore, metaproteomics studies may include spectra of NRP and RiPPs, but these have largely been overlooked due to the absence of suitable bioinformatic workflows.</p></sec><sec id="Sec7"><title>Bacteriophages and archaeophages</title><p id="Par46">Phages are viruses that selectively infect and lyse bacteria and archaea, thereby shaping microbial population dynamics [<xref ref-type="bibr" rid="CR78">78</xref>].</p><p id="Par47">They are mostly divided into two groups, temperate and virulent phages. While temperate phages can integrate their genome into the genome of bacteria (prophage), virulent phages can only replicate within the bacterium and lysate cells for the viral progeny release, which occurs thanks to the production of holin and endolysin [<xref ref-type="bibr" rid="CR79">79</xref>].</p><p id="Par48">Bacteriophages are also able to target biofilm-embedded bacteria, by degrading extracellular matrix due to phage depolymerases, and to kill persister cells [<xref ref-type="bibr" rid="CR80">80</xref>].</p><p id="Par49">Phages are the most abundant biological entities in the biosphere [<xref ref-type="bibr" rid="CR81">81</xref>]. They have been identified in different matrices (wastewater, soil, feces). Considering the small number of sequenced phages, most phage proteins cannot be identified yet, due to the scarcity of primary sequenced data, and the functionality of most of their proteins remains unknown.</p><p id="Par50">Historically phage research has extensively focused on horizontal gene transfer and transduction processes, especially for toxin genes. In this context, metaproteomics might confirm the protein expression of prophages predicted by metagenome analysis. Interest has recently increased in research on phages for their potent antibacterial repertoire, including enzyme activity against antibiotic-resistant strains. These features not only support the potential use of phages as adjuvants to antibiotics for the eradication of drug-resistant bacteria but also enable the modulation of pathogenic, commensal, and pathobiont bacteria of the microbiome, thereby impacting host physiology and the immune system within a One Health framework.</p></sec></sec><sec id="Sec8"><title>Overview of metaproteomic workflows and requirements for the analysis of microbial effectors</title><p id="Par51">Metaproteomics has advanced significantly with respect to sample preparation, mass spectrometry, labeling, bioinformatics, multi-omics data integration, and model systems. These developments have facilitated the identification of microbial effectors and their impact on microbiomes. However, several challenges remain in studying microbial effectors using metaproteomics (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Furthermore, careful consideration must be given to Meta-data handling and experimental design [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR83">83</xref>] with respect to cross-sectional or longitudinal study design, appropriately age- and gender-matched healthy controls for disease populations, robust randomization procedures, careful consideration of cage effects for animal experiments, and comprehensive power analysis. Additionally, researchers should account for potential confounding variables, implement blinding techniques where applicable, and ensure adequate sample sizes to enhance the study&#x02019;s statistical validity and reproducibility.<fig id="Fig2"><label>Fig.&#x000a0;2</label><caption><p>Overview of metaproteomic workflow and key aspects that must be considered for studying microbial effectors and their impact on microbiomes. Abbreviations: RIPP ribosomally synthesized and post-translationally modified peptides, NRP non-ribosomal peptides, AMP antimicrobial peptides, SRM selected reaction monitoring, PRM parallel reaction monitoring, LOD limit of detection, LOQ limit of quantification, DIA data-independent acquisition, DDA data-dependent acquisition, SIP stable isotope probing, BONCAT bioorthogonal non-canonical amino acid tagging</p></caption><graphic xlink:href="40168_2025_2119_Fig2_HTML" id="MO3"/></fig></p><sec id="Sec9"><title>Sample preparation for metaproteomics and considerations for the detection of microbial effectors</title><p id="Par52">The initial challenge is collecting representative biomass for metaproteomic and, if needed, metagenomic analysis [<xref ref-type="bibr" rid="CR84">84</xref>], especially in heterogeneous samples (e.g., feces, soil). Proper preservation is also crucial if transport is required before processing. Metaproteomic sample preparation is often time-consuming due to complex extraction and purification steps, depending on the sample matrix complexity [<xref ref-type="bibr" rid="CR85">85</xref>&#x02013;<xref ref-type="bibr" rid="CR91">91</xref>]. Standard workflows include homogenization, cell lysis, protein extraction, and proteolytic digestion, followed by mass spectrometry-based proteomic analysis. Protocols are typically adapted to microbial complexity, sample impurities, biomass content, and research goals (e.g., broad coverage, pathway analysis, or detection of extracellular enzymes). For example, water microbiomes require microbial concentration rather than extensive impurity removal.</p><p id="Par53">In contrast, soil and wastewater sludge samples contain high levels of organic matter, phenolics, polymers, and inorganic compounds (e.g., minerals), necessitating specialized purification and extraction protocols. Proteins may adsorb onto solid particles like clay minerals, often in a partially reversible manner. The extracted proteome can be further fractionated to enable deeper proteome coverage and identification of low-abundant microbial effectors, either before proteolytic digestion (e.g., via gel electrophoresis) or afterward (e.g., ion exchange chromatography) [<xref ref-type="bibr" rid="CR92">92</xref>]. A particular challenge is posed by phages, hydrolytic enzymes, or small peptides secreted into the extracellular environment, as they require efficient extraction, concentration, and purification from complex matrices, along with target molecule enrichment (e.g., antimicrobial glycopeptides) for sensitive detection. Another challenge is detecting NRPs due to their complex and diverse structures. As a result, no universal enrichment strategy exists during sample preparation. However, possible NRPs can be predicted from genomic data, enabling the development of targeted workflows for detecting specific NRP subgroups and their associated proteins [<xref ref-type="bibr" rid="CR93">93</xref>&#x02013;<xref ref-type="bibr" rid="CR95">95</xref>].</p></sec><sec id="Sec10"><title>Mass spectrometry for the detection of microbial effectors</title><p id="Par54">High-resolution tandem mass spectrometry is a key technology for generating peptide tags from partial amino acid sequences, confirming protein presence and enabling accurate quantification. Peptides obtained by trypsin digestion are typically separated by hydrophobicity via reverse-phase chromatography and introduced into the mass spectrometer through a nanospray interface. After mass determination, peptides are either isolated (in data-dependent acquisition mode, DDA) or pooled (in data-independent acquisition mode, DIA) and then fragmented. The molecular masses of the resulting fragments are then measured. The initial peptide mass data helps to narrow down potential sequence candidates, while the fragmentation patterns enable precise identification of the amino acid sequence.</p><p id="Par55">Among a series of crucial parameters, those for the selection and fragmentation are paramount as they can significantly enhance the number of proteins identified and quantified. Recent advances in DIA mode have shown increased sensitivity and broader protein coverage. The recent introduction of a new generation of tandem mass spectrometers, specifically well adapted to address the complexity of metaproteomes, has significantly improved throughput and dynamic range [<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. Typically, 120,000 peptides can be identified and quantified within 30&#x000a0;min [<xref ref-type="bibr" rid="CR96">96</xref>]. Interestingly, 12 proteins were associated with toxins, 14 with phages 1 with virulence, and 2 with antibiotic-related function in this landscape. The dynamic range observed in this dataset enables the identification and characterizing of microorganisms comprising as little as 0.1% of the total biomass. Interestingly, NRPs can be characterized using the same experimental setup, except that specific pre-enrichment should be carried out (e.g., for glycopeptides) [<xref ref-type="bibr" rid="CR98">98</xref>]. Once peptides are characterized, targeted proteomics approaches, such as selected reaction monitoring (SRM), can facilitate the routine, cost-effective monitoring of protein marker panels across hundreds of samples. Harnessing the full potential of cutting-edge metaproteomics represents a major breakthrough for microbiome functional analysis, marking a transformative step forward in microbiome research [<xref ref-type="bibr" rid="CR99">99</xref>].</p></sec><sec id="Sec11"><title>Labeling approaches to study the impact of microbial effectors</title><p id="Par56">Strategies to label proteins, such as protein-stable isotope probing (protein-SIP), and click chemistry approaches, such as bioorthogonal non-canonical amino acid tagging (BONCAT), are additional tools to identify and quantify the impact of microbial effectors on the metabolic activities and nutrient fluxes of microbiomes. Newly synthesized proteins in actively growing cells are detectable by incorporating labels, which cause a mass shift in the peptide spectra. Protein-SIP uses the incorporation of <sup>2</sup>H, <sup>13</sup>C, <sup>15</sup>N, or <sup>18</sup>O from respectively labeled substrates [<xref ref-type="bibr" rid="CR100">100</xref>&#x02013;<xref ref-type="bibr" rid="CR102">102</xref>], whereas BONCAT is based on the incorporation of non-canonical amino acids such as l-homopropargylglycine (HPG) and l-azidohomoalanine (AHA) [<xref ref-type="bibr" rid="CR103">103</xref>]. Although BONCAT is often combined with high-resolution microscopy and spectroscopy [<xref ref-type="bibr" rid="CR104">104</xref>], the combination with mass spectrometric analyses was recently shown in studying the replication of phages during microbe-phage interactions [<xref ref-type="bibr" rid="CR105">105</xref>], and the identification of effectors on bacterial pathogen infection [<xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR107">107</xref>]. Thus, response mechanisms on various microbial effectors and the resulting physiological mechanisms can be identified with both methods. Bottlenecks such as the restricted use of single-labeled substrates in Protein-SIP and possible growth inhibitions by reactive substrate analogs must be considered and tested beforehand.</p></sec><sec id="Sec12"><title>Bioinformatics</title><p id="Par57">Bioinformatic analysis for metaproteomics [<xref ref-type="bibr" rid="CR108">108</xref>, <xref ref-type="bibr" rid="CR109">109</xref>] is challenging due to the usage of metagenomes for protein identification, redundancy from homologous proteins, and the need for comprehensive taxonomic and functional annotation. To address this, several specific tools for metaproteomics were developed [<xref ref-type="bibr" rid="CR110">110</xref>&#x02013;<xref ref-type="bibr" rid="CR112">112</xref>], improving our understanding of how microbial species contribute to resistance mechanisms across human, animal, and environmental health domains.</p><p id="Par58">As outlined above, metagenomes derived from the same or similar environments, often supplemented with protein sequences from repositories (e.g., <italic>Homo sapiens</italic> entries in UniProt for human microbiome studies), are typically used as databases for protein identification. These metagenomes are assembled, genes are predicted (gene calling), and frequently, metagenome-assembled genomes (MAGs) are constructed to define sample-specific taxonomic units. For microbial effectors, tools such as PATHOFact (virulence factors and AMR) [<xref ref-type="bibr" rid="CR61">61</xref>], antiSMASH (secondary metabolite biosynthesis) [<xref ref-type="bibr" rid="CR113">113</xref>], or Macrel (AMP prediction) [<xref ref-type="bibr" rid="CR28">28</xref>] support the annotation of genes and related proteins (e.g., polyketide synthases or resistance genes). Furthermore, VirHostMatcher [<xref ref-type="bibr" rid="CR46">46</xref>], phageAI [<xref ref-type="bibr" rid="CR42">42</xref>], What the Phage [<xref ref-type="bibr" rid="CR43">43</xref>], and PHASTEST [<xref ref-type="bibr" rid="CR44">44</xref>] can be used to identify potential bacteriophage hosts and target structures.</p><p id="Par59">A non-trivial challenge in constructing metagenome databases for metaproteomics&#x02014;particularly for cross-sample comparisons&#x02014;is mapping genes and MAGs across different metagenomes or combined datasets. These mappings must account for subspecies diversity, mutations, and sequence variations while keeping the database compact for reliable FDR estimation. This issue is closely tied to proteogenomics, which combines genomic and proteomic data for deeper analysis [<xref ref-type="bibr" rid="CR114">114</xref>]. In metaproteomics, proteogenomics has demonstrated that phages can employ alternative genetic coding strategies [<xref ref-type="bibr" rid="CR9">9</xref>]. Additionally, integrating a combined database or employing advanced tools enables a more detailed taxonomic and functional characterization of microbiomes from non-sequenced hosts [<xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par60">Another major challenge in metaproteomics is accurately identifying non-tryptic peptides and inferring homologous proteins across diverse microbial species. Due to extensive microbial genome diversity, traditional database-driven methods struggle with incomplete or mismatched databases. Many proteins, especially those involved in resistance mechanisms, are poorly represented in existing databases. This makes homologous protein identification a bottleneck where inaccurate homologous protein matching leads to gaps in understanding microbial resistance expression.</p><p id="Par61">RiPPs and NRPs can be chemically highly complex from various modifications and therefore often lack predictable structures, making them difficult to detect and identify using conventional proteomics workflows. As a result, they still need to be explored despite their crucial roles in AMR. A potential solution to identify RiPPs, NRPs, and non-tryptic peptides is to screen high-quality unidentified spectra [<xref ref-type="bibr" rid="CR29">29</xref>] and apply de novo sequencing [<xref ref-type="bibr" rid="CR9">9</xref>] and homology-based searches [<xref ref-type="bibr" rid="CR115">115</xref>], expanding the search space beyond predefined peptide sequences and databases. Moreover, integrating machine learning approaches and transfer learning can help refine peptide identification, making the detection of complex resistance mechanisms more accurate [<xref ref-type="bibr" rid="CR116">116</xref>]. Another approach for identifying NRPs or RiPPs with known BGCs involves heterologous expression or genetic manipulation of the native producer, followed by the comparison of expression, deletion, or overproduction mutants with the wild-type strain. While this facilitates compound identification, it requires genetic tools for the producer and knowledge of the biosynthetic pathway.</p><p id="Par62">To better understand microbial effectors, identified proteins can be mapped to metabolic networks and used as input for modeling microbiomes to study their impact on taxonomic and functional composition [<xref ref-type="bibr" rid="CR117">117</xref>].</p></sec><sec id="Sec13"><title>Integration of further omics methods to enhance the identification of microbial effectors</title><p id="Par63">Although metaproteomics is a powerful tool for studying microbiomes and microbial effectors, its potential is greatly enhanced by integrating additional omics approaches (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Cytomics enables monitoring and sorting microbial subpopulations, providing insights into cell-specific behaviors. Furthermore, cytomics can measure cell viability [<xref ref-type="bibr" rid="CR118">118</xref>], which is of great importance, e.g., to assess the response of microbiomes to antimicrobials and could even provide the potential to evaluate community structure, diversity, and metabolite exchange in response to microbial effectors [<xref ref-type="bibr" rid="CR119">119</xref>]. As noted above, metagenomics is key for generating sample-specific databases for protein identification, while also revealing taxonomic, functional, and genomic contexts (e.g., operons, neighboring genes, mobile elements) of microbial effectors [<xref ref-type="bibr" rid="CR61">61</xref>]. Complementarily, metabolomics&#x02014;often using liquid or gas chromatography (LC, GC) for analyte prefractionation coupled with tandem mass spectrometry (MS/MS)&#x02014;is a valuable tool for studying microbiomes, enabling metabolite quantification. It offers a key advantage in effector analysis by allowing broad chemical screening to identify, for example, novel antibiotics and NRPs [<xref ref-type="bibr" rid="CR120">120</xref>, <xref ref-type="bibr" rid="CR121">121</xref>]. A key challenge in multi-omics research is integrating diverse data types, requiring standardized identifiers and ontologies [<xref ref-type="bibr" rid="CR122">122</xref>, <xref ref-type="bibr" rid="CR123">123</xref>]. An effective approach is aggregating all data into a graph-based structure or linking it to a knowledge graph. The benefit of knowledge graphs lies in their ability to integrate heterogeneous data, apply graph algorithms [<xref ref-type="bibr" rid="CR124">124</xref>], and facilitate connections with large language models, enabling improved data exploration and predictive analysis. Another strategy for multi-omics data integration is calculating correlation factors between the different omics features, which could be nicely visualized as co-occurrence networks [<xref ref-type="bibr" rid="CR125">125</xref>].<fig id="Fig3"><label>Fig.&#x000a0;3</label><caption><p>Strategies for combining metaproteomics with other omics tools</p></caption><graphic xlink:href="40168_2025_2119_Fig3_HTML" id="MO4"/></fig></p></sec><sec id="Sec14"><title>Model systems to study microbial communities for the validation of microbial effectors</title><p id="Par64">Researchers require controlled experimental models incorporating both in vitro and in vivo approaches to identify and validate novel microbial effectors and their impact on microbiomes. Furthermore, controlled experiments are required to obtain ground truth datasets for method development validation [<xref ref-type="bibr" rid="CR126">126</xref>]. Synthetic microbial communities (SynComs) represent gold-standard systems for studying microbial interactions and responses [<xref ref-type="bibr" rid="CR127">127</xref>]. These models provide controlled environments that simulate natural microbial ecosystems, allowing for precise examination of effector molecules and their roles in community dynamics, signaling, and host interactions. SynComs offers a robust foundation for investigating microbial functions within microbiomes by enabling direct observation of cause-and-effect relationships while minimizing confounding variables. SynComs also enhances metaproteomic research by using annotated genomes for each community member, which improves protein identification accuracy. This genomic information enables detailed insights into strain-level interactions, often unachievable in natural microbiomes due to unknown protein sequences. Additionally, SynComs allow for the study of low-abundance species, such as keystone taxa [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR129">129</xref>], which play essential roles within the microbiome but are often undetectable in conventional metaproteomic analyses. In vivo mouse models replicate human physiological responses for host-relevant microbial studies, providing insights into microbial-host interactions and discovering microbial effectors pertinent to disease. Emerging &#x0201c;lab-on-a-chip&#x0201d; microfluidic platforms complement, these models by allowing precise control and monitoring of microbial communities in high-throughput formats, enhancing our understanding of microbial dynamics under controlled conditions [<xref ref-type="bibr" rid="CR130">130</xref>]. Fermentation systems simulate gastrointestinal conditions, supporting long-term studies of microbial fermentation and gut ecology [<xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR132">132</xref>]. Of particular interest for the fermentation are systems that enable co-cultures of microorganisms and human cells, to ascertain the effect of different microbiota-expressed effectors on human cells to ascertain the effect of different microbiota-expressed effectors on the human cells [<xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>].</p><p id="Par65">Together, these models offer a comprehensive toolkit for assessing microbial effects on host health, advancing our understanding of microbial communities in health and disease.</p></sec><sec id="Sec15"><title>Challenges and limitations of metaproteomics</title><p id="Par66">While previous sections have addressed the individual limitations and challenges of metaproteomics, we would like to highlight these points more explicitly [<xref ref-type="bibr" rid="CR109">109</xref>, <xref ref-type="bibr" rid="CR135">135</xref>, <xref ref-type="bibr" rid="CR136">136</xref>], particularly in the context of clinical applications. Although significant progress has been made in recent years&#x02014;such as the development of combined multi-omics workflows [<xref ref-type="bibr" rid="CR137">137</xref>], analysis times of under 24&#x000a0;h [<xref ref-type="bibr" rid="CR138">138</xref>], advanced mass spectrometry methods for comprehensive microbiome characterization [<xref ref-type="bibr" rid="CR139">139</xref>], and improvements in standardization [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR140">140</xref>]&#x02014;metaproteomics has yet to be established in routine clinical practice. The primary limitation is that no single metaproteomics workflow has been certified according to international standards for clinical use, such as ISO 13485 (quality management for medical devices) and ISO 15189 (laboratory quality and safety). Overcoming this limitation requires substantial resources, which often exceed the budgets of individual research groups, as well as identifying a valuable use case for clinical application.</p><p id="Par67">In addition to this major hurdle, there are several smaller challenges in metaproteomics that require further refinement. First, metaproteomics remains susceptible to biases in sample preparation and needs further improvements in quantification accuracy. Additionally, the resolution of current MS devices is still insufficient to fully capture the microbiome&#x02019;s complexity or to analyze it at single-cell resolution [<xref ref-type="bibr" rid="CR141">141</xref>]. Reducing the high investment costs associated with mass spectrometers, maintenance, and specialized laboratory infrastructure would be advantageous for wider clinical adoption.</p><p id="Par68">Another significant challenge lies in the bioinformatic analysis of metaproteomics data. This process is hindered by the lack of appropriate routine protein search databases, difficulties in calculating the FDR, and challenges in identifying medically relevant post-translationally modified peptides.</p></sec></sec><sec id="Sec16"><title>Application of metaproteomics for studying microbial effectors and microbiomes in the One Health framework</title><p id="Par69">To evaluate the potential for identifying and studying microbial effectors in the One Health framework, we assessed the current usage of microbiomes in the clinical (Chapter 4.1) and non-clinical context (Chapter 4.2).</p><sec id="Sec17"><title>Usage of microbiomes in the clinical context and potential for metaproteomics and microbial effectors</title><p id="Par70">Currently, over 2400 clinical studies are investigating the microbiome&#x02019;s relationship with various health factors (<ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/">https://clinicaltrials.gov/</ext-link>). Of these, over 1000 focus on the microbiome&#x02019;s role in 70 diseases, including autoimmune disorders, cancer, cardiovascular, digestive, and metabolic diseases (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). These clinical studies reflect the growing recognition of the microbiome as a key factor influencing disease diagnosis, prognosis, and treatment response.<fig id="Fig4"><label>Fig.&#x000a0;4</label><caption><p>Summary of over 2400 clinical studies exploring the microbiome&#x02019;s role in health, distributed by its relation to 70 diseases. Cases where multiple types of cancers or diseases are studied are detailed on the right. The figure was created using R programming language v.4.4.1, with core-base functions and in-house scripts</p></caption><graphic xlink:href="40168_2025_2119_Fig4_HTML" id="MO5"/></fig></p><p id="Par71">The importance of the microbiome extends beyond the human microbiome and health to encompass the interconnected animal and environmental dimensions of the One Health framework. Microbial communities in animals and the environment actively shape human microbiome composition and functionality. Through direct exposure, shared ecosystems, and environmental reservoirs, these interactions influence the microbiome&#x02019;s clinical impact. For instance, zoonotic pathogens, or AMR genes are often mediated by microbial exchanges between humans, animals, and their habitats, demonstrating the profound interplay within these domains.</p><p id="Par72">The high interest in the microbiome is particularly pertinent in diseases where immune and inflammatory mechanisms play a central role, as the microbiome may modulate both immune-suppressive and stimulatory pathways [<xref ref-type="bibr" rid="CR142">142</xref>]. Furthermore, microbiome-host interactions extend beyond individual organs vital for maintaining homeostasis and influencing disease progression [<xref ref-type="bibr" rid="CR143">143</xref>]. Therefore, the interrelationship between microbial communities colonizing different human surfaces provides the advantage of collecting highly informative profiles from more accessible microbiome samples in clinical contexts where pathology mainly affects less accessible organs.</p><p id="Par73">Although different diseases are associated with distinct microbiome-host interactions, key areas of investigation remain. These include understanding the microbiome&#x02019;s treatment response, metabolic consequences, and underlying molecular pathways and identifying microbiome components that enhance clinical status. To illustrate the need for microbiome studies and the microbial effectors, we present the following four clinical use cases:<list list-type="simple"><list-item><label>(i))</label><p id="Par74">Recent studies have shown that microbial proteins, which accumulate under specific conditions, as well as their sequence diversity, structural features, and post-translational modifications (PTMs) like acetylations, deaminations, hydroxylations, methylations, nitrosylations, oxidations, and phosphorylations, are critical for priming immune cells effectively [<xref ref-type="bibr" rid="CR117">117</xref>]. Understanding these variations in proteins, whose nature can be revealed through metaproteome analysis, combined with advanced computational methods such as protein structure prediction [<xref ref-type="bibr" rid="CR144">144</xref>] and all-atom molecular dynamics (MD) simulations [<xref ref-type="bibr" rid="CR145">145</xref>], provides insights into the role of microbial proteins in immune regulation. This insight could potentially guide the development of targeted therapeutic strategies.</p></list-item><list-item><label>(ii))</label><p id="Par75">Cancer and infectious diseases, including HIV, underscore the importance of identifying specific microbiome-derived proteins that can boost immune function and mitigate inflammation while simultaneously managing antibiotic resistance in frequently hospitalized individuals [<xref ref-type="bibr" rid="CR146">146</xref>]. Such patients often require repeated antibiotic cycles, which further complicate treatment by promoting resistance.</p></list-item><list-item><label>(iii))</label><p id="Par76">Furthermore, understanding disease requires a more holistic view. For example, <italic>Helicobacter pylor</italic>i was, until recently, considered the strongest risk factor for the development of gastric cancer, which is the fifth most common cancer worldwide. However, recent advances in metagenomics and metaproteomics techniques demonstrated changes in the complete microbiome during gastric carcinogenesis rather than that of single microbes. Hypochlorhydria, a state of low hydrochloric acid levels that affect the stomach&#x02019;s ability to digest and absorb proteins, induces changes in the complete microbiome (reducing diversity and abundance of commensal bacteria and promoting overgrowth of pathogenic and carcinogenic species) that might have a direct link with gastric cancer [<xref ref-type="bibr" rid="CR147">147</xref>]. This is further enhanced by the prolonged use of proton pump inhibitors, which are widely used medications [<xref ref-type="bibr" rid="CR148">148</xref>]. Thus, the risk of cancer could be identified by characterizing microbiome alterations in patients&#x02019; gastric juices and/or feces. Monitoring microbial alterations could also help physicians and healthcare professionals assess the risks and benefits of using medications such as proton pump inhibitors, monitor medical care protocols, and optimize treatments for high-risk patients.</p></list-item><list-item><label>(iv))</label><p id="Par77">Preclinical and clinical trials suggest that the alterations in the gut microbiome are also linked with toxicities induced by chemotherapies [<xref ref-type="bibr" rid="CR149">149</xref>] and immunotherapies [<xref ref-type="bibr" rid="CR150">150</xref>]. It has also been suggested that modulation of the gut microbiome before and during chemotherapy in cancer patients could reduce the occurrence of adverse events and improve the effectiveness of treatments [<xref ref-type="bibr" rid="CR151">151</xref>]. Recent studies also suggested that the gut microbiome, available via fecal material, constitutes a promising source of biomarkers to predict and monitor treatment outcomes and potentially related adverse events [<xref ref-type="bibr" rid="CR152">152</xref>]. Furthermore, tongue swab metaproteomics has, for instance, enhanced our understanding of the mechanism behind specific tongue coating formation and its potential role as an indicator of gastric cancer [<xref ref-type="bibr" rid="CR153">153</xref>].</p></list-item></list></p><p id="Par78">In sum to these examples, clinical needs for microbiome research include (i) accurate and timely diagnosis of microbiome functional alterations, (ii) monitoring the disturbances in microbial communities and their components (genes, transcripts, proteins, metabolites) triggered by clinical protocols, (iii) evidence-based therapy to modulate the microbiome and regain its homeostasis, and (iv) the identification of novel microbial effectors for targeted microbiome management. Metaproteomics can provide solutions to these critical domains by profiling how clinical traits shape the microbiome, identifying microbial effectors involved in variations of the microbial community structure and functions, and monitoring the outcome of experimental clinical protocols based on microbial modulators, including AMPs and phages.</p><p id="Par79">In the context of microbial effectors, metaproteomics holds great potential for (i) investigating the therapeutic use of phages as antibacterial agents across various clinical conditions, (ii) monitoring the functional dynamics of their bactericidal activity, and (iii) assessing therapy responses by analyzing correlations between bacterial and host protein profiles.</p></sec><sec id="Sec18"><title>Non-clinical microbiomes and microbial effectors in the One Health framework</title><p id="Par80">The connection between microbiomes across environmental, agricultural, and biotechnological domains and the One Health framework extends beyond serving as a reservoir of novel microbial effectors for human therapeutics. Many microbial effectors developed for human use can also benefit pet and livestock health.</p><p id="Par81">In crop and horticulture science, microbial antimicrobials such as cyclic lipopeptides produced by <italic>Pseudomonas</italic> strains can act as natural insecticides, effectively targeting insect larvae. Phages may be employed to combat plant pathogens like <italic>Pectobacterium atrosepticum</italic>, which causes potato soft rot [<xref ref-type="bibr" rid="CR154">154</xref>], while seed coatings with antimicrobial agents offer protective benefits [<xref ref-type="bibr" rid="CR155">155</xref>]. Additionally, antimicrobials can enhance food safety by reducing microbial contamination in production and food supply chains [<xref ref-type="bibr" rid="CR154">154</xref>, <xref ref-type="bibr" rid="CR156">156</xref>].</p><p id="Par82">In environmental management, cyanophages could be harnessed to mitigate harmful algal blooms, thus safeguarding aquatic ecosystems like oceans, seas, and lakes [<xref ref-type="bibr" rid="CR157">157</xref>]. Meanwhile, antibiotics and other antimicrobials might stimulate the growth of contaminant-degrading microbes in nutrient-limited environments, such as certain groundwater systems, aiding in bioremediation [<xref ref-type="bibr" rid="CR158">158</xref>].</p><p id="Par83">Within biotechnological applications, phages offer a targeted approach to controlling filamentous bacteria, including <italic>Microthrix parvicella</italic> and <italic>Nocardia</italic> species, which cause foaming issues in wastewater treatment plants [<xref ref-type="bibr" rid="CR159">159</xref>]. Phages also have emerging applications as structural components in nanomaterials, presenting exciting opportunities in materials science [<xref ref-type="bibr" rid="CR160">160</xref>].</p><p id="Par84">While microbial effectors offer significant potential, it is crucial to consider potential unintended impacts on microbiomes, such as effects on non-target species and the development of resistance mechanisms. Additionally, stressors&#x02014;including those from human activities&#x02014;can accelerate the release of phages within microbiomes, leading to self-amplifying cycles and other stress responses. For instance, exposure to pesticides has been shown to increase bacterial antibiotic resistance by activating efflux pumps, reducing outer membrane permeability, and inducing gene mutations [<xref ref-type="bibr" rid="CR161">161</xref>].</p></sec></sec><sec id="Sec19"><title>Future potential of microbial effectors and metaproteomics in the One Health framework</title><p id="Par85">Reverse to the spread of pathogenic species across different hosts (zoonoses), using microbial effectors from diverse environments holds transformative potential for treating diseases and controlling microbiomes in biotechnological systems. Just as the &#x0201c;golden age&#x0201d; of antibiotic discovery opened new frontiers in medicine, broader screening of microbial effectors now offers the potential to treat pathogen-associated diseases. One advantage of many microbial effectors is their ability to target specific microorganisms, allowing for more precise treatment options and enhanced microbiome control. However, this specificity also increases the risk of resistance mechanisms, such as escape mutations, which require continuous adaptation of microbial effectors to maintain efficacy.</p><p id="Par86">In this context, metaproteomics plays a crucial role in advancing microbial effector research through two key contributions: (i) metaproteomics enables the comprehensive characterization of microbiomes and their expressed proteins, leading to the identification of novel microbial effectors and their mode of action.</p><p id="Par87">Therefore, it should be applied across various environments to maximize the number of novel microbial effectors identified. Environments under selective pressure&#x02014;such as reptile saliva, amphibian skin, hospital wastewater, and livestock enclosures&#x02014;are particularly interesting for discovering novel compounds. (ii) Metaproteomics allows for the analysis of expressed proteins and phages, and it is an ideal tool for examining the effects of microbial effectors.</p><p id="Par88">Beyond microbiome monitoring, metaproteomics data can inform microbial abundance estimates, which are essential for developing control algorithms to manage microbiomes effectively [<xref ref-type="bibr" rid="CR117">117</xref>]. Using these algorithms, control variables such as nutrient supply, process parameters (e.g., temperature), or the introduction of microbial effectors can be adjusted to achieve the desired microbiome functionality. This concept of microbiome management is indeed analogous to animal gastrointestinal tracts regulating their microbiomes. Closing the gap to the One Health framework, the most comprehensively studied system for microbiome management is the human gut, whose control mechanism (e.g., AMPs) could also be applied to manage microbiomes in environment and biotechnological applications.</p><p id="Par89">Another application of metaproteomics lies in &#x0201c;pandemic preparedness&#x0201d; within a One Health framework. For example, tracking pathogen concentrations in wastewater treatment plants, as seen with COVID-19, enables early detection of disease outbreaks before hospitals or government agencies identify them. Sequencing methods with low detection limits (enabled by gene amplification) are primarily used for such monitoring. As demonstrated with the selective enrichment of COVID-19 peptides using advanced mass spectrometry (LC&#x02013;MS/MS), proteomic methods could also play a valuable role in pandemic preparedness, offering timely and reliable pathogen monitoring enabling the monitoring of the actual expression of the pathogens [<xref ref-type="bibr" rid="CR162">162</xref>]. To accomplish this, tools have been developed to identify viruses from LC&#x02013;MS/MS-based peptide identifications [<xref ref-type="bibr" rid="CR45">45</xref>]. As a result, the holistic tracking of wastewater through metaproteomics emerges as a powerful approach for detecting emerging pathogens and microbiome dysbioses associated with human diseases.</p></sec><sec id="Sec20"><title>Concluding remarks</title><p id="Par90">In summary, metaproteomics holds significant potential for elucidating microbial effectors and their impact on microbiomes and for monitoring the molecular processes underlying the One Health framework. However, integrating information across various levels is essential to holistically understand microbiomes and One Health. This integration requires interdisciplinary collaboration among experts from diverse microbiome-related fields and the complementary use of different methods. Metaproteomics uniquely enables the quantification of expressed proteins, including their modifications. This information allows for assessing the microbiome&#x02019;s functional expression (e.g., phages, AMPs) and catalytic potential. However, to capture the complete picture of the microbiome, metagenomics is essential for monitoring genetic potential and providing the necessary databases for metaproteomics. Additionally, combining metabolomics with metaproteomics data offers insights into the actual activity of the microbiome. Beyond omics-level analyses, further mechanistic studies are crucial to validate the identified findings and mechanisms and develop mathematical models to control and optimize microbiomes.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>AHA</term><def><p id="Par4">L-azidohomoalanine</p></def></def-item><def-item><term>AMP</term><def><p id="Par5">Antimicrobial peptide</p></def></def-item><def-item><term>AMR</term><def><p id="Par6">Antimicrobial resistance</p></def></def-item><def-item><term>BGC</term><def><p id="Par7">Biosynthetic gene cluster</p></def></def-item><def-item><term>BONCAT</term><def><p id="Par8">Bioorthogonal non-canonical amino acid tagging</p></def></def-item><def-item><term>DDA</term><def><p id="Par9">Data-dependent acquisition</p></def></def-item><def-item><term>DIA</term><def><p id="Par10">Data-independent acquisition</p></def></def-item><def-item><term>FDR</term><def><p id="Par11">False discovery rate</p></def></def-item><def-item><term>HPG</term><def><p id="Par12">L-homopropargylglycine</p></def></def-item><def-item><term>LC</term><def><p id="Par13">Liquid chromatography</p></def></def-item><def-item><term>LOD</term><def><p id="Par14">Limit of detection</p></def></def-item><def-item><term>LOQ</term><def><p id="Par15">Limit of quantification</p></def></def-item><def-item><term>MAG</term><def><p id="Par16">Metagenome-assembled genome</p></def></def-item><def-item><term>MD</term><def><p id="Par17">Molecular dynamics</p></def></def-item><def-item><term>MS/MS</term><def><p id="Par18">Tandem mass spectrometry</p></def></def-item><def-item><term>NRP</term><def><p id="Par19">Non-ribosomal peptide</p></def></def-item><def-item><term>NRPS</term><def><p id="Par20">Non-ribosomal peptide synthetases</p></def></def-item><def-item><term>ompA</term><def><p id="Par21">Outer membrane proteins</p></def></def-item><def-item><term>PKS</term><def><p id="Par22">Polyketide synthases</p></def></def-item><def-item><term>PRM</term><def><p id="Par23">Parallel reaction monitoring</p></def></def-item><def-item><term>PTMs</term><def><p id="Par24">Post-translational modifications</p></def></def-item><def-item><term>RIPP</term><def><p id="Par25">Ribosomally synthesized and post-translationally modified peptides</p></def></def-item><def-item><term>Protein-SIP</term><def><p id="Par26">Protein-stable isotope probing</p></def></def-item><def-item><term>SRM</term><def><p id="Par27">Selected reaction monitoring</p></def></def-item><def-item><term>SynComs</term><def><p id="Par28">Synthetic microbial communities</p></def></def-item><def-item><term>T</term><def><p id="Par29">Thiolation</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>M. Ferrer thanks Rafael Bargiela for retrieving clinical studies exploring the microbiome's role in health from <ext-link ext-link-type="uri" xlink:href="https://clinicaltrials.gov/">https://clinicaltrials.gov/</ext-link>.&#x000a0;Figure 1 was created with BioRender.com.</p><sec id="FPar1"><title>AE</title><p id="Par91">Grammarly and ChatGPT were used for spelling and language improvements.</p></sec></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>Conceptualization: R.H., P.W. Project administration: R.H. Supervision: R.H., P.W. Writing&#x02014;original draft: ALL. Writing&#x02014;review and editing: ALL. All authors have read and agreed to the published version of the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Manuel Ferrer acknowledges funding from the Agencia Estatal de Investigaci&#x000f3;n (AEI) (<ext-link ext-link-type="uri" xlink:href="https://www.mciu/AEI/10.13039/501100011033">https://www.mciu/AEI/10.13039/501100011033</ext-link>),&#x000a0;FSE+,&#x000a0;the European Union, the NextGenerationEU/PRTR, and CSIC (COCREA program), under grants PID2023-153370OB-I00 and INMUNOBIOTA.&#x000a0;Sergio Serrano-Villar acknowledgess funding from Instituto de Salud Carlos III (projects&#x000a0;ICI20/00058, PI21/00141, and PI24/00078), including the FORTALECE program (FORT23/0004), supported by&#x000a0;the Next Generation EU funds, which finance the initiatives under the Recovery and Resilience Facility (RRF) Tim Van Den Bossche acknowledges funding from the Research Foundation Flanders (FWO) [1286824N]. Lucia Grenga and Jean Armengaud express their gratitude to the R&#x000e9;gion Occitanie (DeepMicro grant) and the Agence Nationale de la Recherche (ANR-20-CE34-0012 and ANR-24-INBS-0015).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par92">Not applicable.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par93">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par94">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Naghavi</surname><given-names>M</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name><name><surname>Ikuta</surname><given-names>KS</given-names></name><name><surname>Swetschinski</surname><given-names>LR</given-names></name><name><surname>Gray</surname><given-names>AP</given-names></name><name><surname>Wool</surname><given-names>EE</given-names></name><etal/></person-group><article-title>Global burden of bacterial antimicrobial resistance 1990&#x02013;2021: a systematic analysis with forecasts to 2050</article-title><source>Lancet</source><year>2024</year><volume>404</volume><fpage>1199</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(24)01867-1</pub-id><pub-id pub-id-type="pmid">39299261</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Naghavi M, Vollset SE, Ikuta KS, Swetschinski LR, Gray AP, Wool EE, et al. Global burden of bacterial antimicrobial resistance 1990&#x02013;2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404:1199&#x02013;226. 10.1016/S0140-6736(24)01867-1.<pub-id pub-id-type="pmid">39299261</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Joerger</surname><given-names>RD</given-names></name></person-group><article-title>Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages</article-title><source>Poult Sci</source><year>2003</year><volume>82</volume><fpage>640</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1093/ps/82.4.640</pub-id><pub-id pub-id-type="pmid">12710486</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Joerger RD. Alternatives to antibiotics: bacteriocins, antimicrobial peptides and bacteriophages. Poult Sci. 2003;82:640&#x02013;7. 10.1093/ps/82.4.640.<pub-id pub-id-type="pmid">12710486</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Cyco&#x00144;</surname><given-names>M</given-names></name></person-group><article-title>Mrozik a, piotrowska-seget z. antibiotics in the soil environment-degradation and their impact on microbial activity and diversity</article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><fpage>338</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.00338</pub-id><pub-id pub-id-type="pmid">30906284</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Cyco&#x00144; M. Mrozik a, piotrowska-seget z. antibiotics in the soil environment-degradation and their impact on microbial activity and diversity. Front Microbiol. 2019;10:338. 10.3389/fmicb.2019.00338.<pub-id pub-id-type="pmid">30906284</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Wilmes</surname><given-names>P</given-names></name><name><surname>Bond</surname><given-names>PL</given-names></name></person-group><article-title>The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms</article-title><source>Environ Microbiol</source><year>2004</year><volume>6</volume><fpage>911</fpage><lpage>920</lpage><pub-id pub-id-type="doi">10.1111/j.1462-2920.2004.00687.x</pub-id><pub-id pub-id-type="pmid">15305916</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Wilmes P, Bond PL. The application of two-dimensional polyacrylamide gel electrophoresis and downstream analyses to a mixed community of prokaryotic microorganisms. Environ Microbiol. 2004;6:911&#x02013;20. 10.1111/j.1462-2920.2004.00687.x.<pub-id pub-id-type="pmid">15305916</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>P&#x000e9;rez-Cobas</surname><given-names>AE</given-names></name><name><surname>Gosalbes</surname><given-names>MJ</given-names></name><name><surname>Friedrichs</surname><given-names>A</given-names></name><name><surname>Knecht</surname><given-names>H</given-names></name><name><surname>Artacho</surname><given-names>A</given-names></name><name><surname>Eismann</surname><given-names>K</given-names></name><etal/></person-group><article-title>Gut microbiota disturbance during antibiotic therapy: a multi-omic approach</article-title><source>Gut</source><year>2013</year><volume>62</volume><fpage>1591</fpage><lpage>1601</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2012-303184</pub-id><pub-id pub-id-type="pmid">23236009</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">P&#x000e9;rez-Cobas AE, Gosalbes MJ, Friedrichs A, Knecht H, Artacho A, Eismann K, et al. Gut microbiota disturbance during antibiotic therapy: a multi-omic approach. Gut. 2013;62:1591&#x02013;601. 10.1136/gutjnl-2012-303184.<pub-id pub-id-type="pmid">23236009</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Buthasane</surname><given-names>P</given-names></name><name><surname>Roytrakul</surname><given-names>S</given-names></name><name><surname>Phaonakrop</surname><given-names>N</given-names></name><name><surname>Tunsagool</surname><given-names>P</given-names></name><name><surname>Buthasane</surname><given-names>W</given-names></name><name><surname>Am-In</surname><given-names>N</given-names></name><name><surname>Suriyaphol</surname><given-names>G</given-names></name></person-group><article-title>Metaproteomic analysis of gut resistome in the cecal microbiota of fattening pigs raised without antibiotics</article-title><source>Microbiol Spectr</source><year>2023</year><volume>11</volume><fpage>e0222323</fpage><pub-id pub-id-type="doi">10.1128/spectrum.02223-23</pub-id><pub-id pub-id-type="pmid">37439677</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Buthasane P, Roytrakul S, Phaonakrop N, Tunsagool P, Buthasane W, Am-In N, Suriyaphol G. Metaproteomic analysis of gut resistome in the cecal microbiota of fattening pigs raised without antibiotics. Microbiol Spectr. 2023;11: e0222323. 10.1128/spectrum.02223-23.<pub-id pub-id-type="pmid">37439677</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Sha</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name></person-group><article-title>Aerobic composting as an effective cow manure management strategy for reducing the dissemination of antibiotic resistance genes: an integrated meta-omics study</article-title><source>J Hazard Mater</source><year>2020</year><volume>386</volume><fpage>121895</fpage><pub-id pub-id-type="doi">10.1016/j.jhazmat.2019.121895</pub-id><pub-id pub-id-type="pmid">31884359</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Zhang L, Li L, Sha G, Liu C, Wang Z, Wang L. Aerobic composting as an effective cow manure management strategy for reducing the dissemination of antibiotic resistance genes: an integrated meta-omics study. J Hazard Mater. 2020;386: 121895. 10.1016/j.jhazmat.2019.121895.<pub-id pub-id-type="pmid">31884359</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Saenz</surname><given-names>JS</given-names></name><name><surname>Kurz</surname><given-names>A</given-names></name><name><surname>Ruczizka</surname><given-names>U</given-names></name><name><surname>B&#x000fc;nger</surname><given-names>M</given-names></name><name><surname>Dippel</surname><given-names>M</given-names></name><name><surname>Nagl</surname><given-names>V</given-names></name><etal/></person-group><article-title>Metaproteomics reveals alteration of the gut microbiome in weaned piglets due to the ingestion of the mycotoxins deoxynivalenol and zearalenone</article-title><source>Toxins (Basel)</source><year>2021</year><pub-id pub-id-type="doi">10.3390/toxins13080583</pub-id><pub-id pub-id-type="pmid">34437454</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Saenz JS, Kurz A, Ruczizka U, B&#x000fc;nger M, Dippel M, Nagl V, et al. Metaproteomics reveals alteration of the gut microbiome in weaned piglets due to the ingestion of the mycotoxins deoxynivalenol and zearalenone. Toxins (Basel). 2021. 10.3390/toxins13080583.<pub-id pub-id-type="pmid">34437454</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Peters</surname><given-names>SL</given-names></name><name><surname>Borges</surname><given-names>AL</given-names></name><name><surname>Giannone</surname><given-names>RJ</given-names></name><name><surname>Morowitz</surname><given-names>MJ</given-names></name><name><surname>Banfield</surname><given-names>JF</given-names></name><name><surname>Hettich</surname><given-names>RL</given-names></name></person-group><article-title>Experimental validation that human microbiome phages use alternative genetic coding</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><fpage>5710</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-32979-6</pub-id><pub-id pub-id-type="pmid">36175428</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Peters SL, Borges AL, Giannone RJ, Morowitz MJ, Banfield JF, Hettich RL. Experimental validation that human microbiome phages use alternative genetic coding. Nat Commun. 2022;13:5710. 10.1038/s41467-022-32979-6.<pub-id pub-id-type="pmid">36175428</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Pible</surname><given-names>O</given-names></name><name><surname>Eschlimann</surname><given-names>M</given-names></name><name><surname>Giraud</surname><given-names>M</given-names></name><name><surname>Debroas</surname><given-names>S</given-names></name><name><surname>Gaillard</surname><given-names>J-C</given-names></name><etal/></person-group><article-title>Universal identification of pathogenic viruses by liquid chromatography coupled with tandem mass spectrometry proteotyping</article-title><source>Mol Cell Proteomics</source><year>2024</year><volume>23</volume><fpage>100822</fpage><pub-id pub-id-type="doi">10.1016/j.mcpro.2024.100822</pub-id><pub-id pub-id-type="pmid">39084562</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Lozano C, Pible O, Eschlimann M, Giraud M, Debroas S, Gaillard J-C, et al. Universal identification of pathogenic viruses by liquid chromatography coupled with tandem mass spectrometry proteotyping. Mol Cell Proteomics. 2024;23: 100822. 10.1016/j.mcpro.2024.100822.<pub-id pub-id-type="pmid">39084562</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Schallert</surname><given-names>K</given-names></name><name><surname>Siewert</surname><given-names>C</given-names></name><name><surname>Kohrs</surname><given-names>F</given-names></name><name><surname>Greve</surname><given-names>J</given-names></name><name><surname>Maus</surname><given-names>I</given-names></name><etal/></person-group><article-title>Metaproteome analysis reveals that syntrophy, competition, and phage-host interaction shape microbial communities in biogas plants</article-title><source>Microbiome</source><year>2019</year><volume>7</volume><fpage>69</fpage><pub-id pub-id-type="doi">10.1186/s40168-019-0673-y</pub-id><pub-id pub-id-type="pmid">31029164</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Heyer R, Schallert K, Siewert C, Kohrs F, Greve J, Maus I, et al. Metaproteome analysis reveals that syntrophy, competition, and phage-host interaction shape microbial communities in biogas plants. Microbiome. 2019;7:69. 10.1186/s40168-019-0673-y.<pub-id pub-id-type="pmid">31029164</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name></person-group><article-title>VFDB 2025: an integrated resource for exploring anti-virulence compounds</article-title><source>Nucleic Acids Res</source><year>2025</year><volume>53</volume><fpage>D871</fpage><lpage>D877</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae968</pub-id><pub-id pub-id-type="pmid">39470738</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Zhou S, Liu B, Zheng D, Chen L, Yang J. VFDB 2025: an integrated resource for exploring anti-virulence compounds. Nucleic Acids Res. 2025;53:D871&#x02013;7. 10.1093/nar/gkae968.<pub-id pub-id-type="pmid">39470738</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Sunyer JO, Delgado LF, Hickl O, Laczny CC, May P, Wilmes P. PathoFact 2.0: an integrative pipeline for predicting antimicrobial resistance genes, virulence factors, toxins and biosynthetic gene clusters in metagenomes 2024. 10.1101/2024.12.09.627531.</mixed-citation></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>W</given-names></name><name><surname>Fan</surname><given-names>X</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Jia</surname><given-names>S</given-names></name><name><surname>Lv</surname><given-names>N</given-names></name><etal/></person-group><article-title>An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><fpage>8084</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-51864-y</pub-id><pub-id pub-id-type="pmid">39278950</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Dong W, Fan X, Guo Y, Wang S, Jia S, Lv N, et al. An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases. Nat Commun. 2024;15:8084. 10.1038/s41467-024-51864-y.<pub-id pub-id-type="pmid">39278950</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Danov</surname><given-names>A</given-names></name><name><surname>Segev</surname><given-names>O</given-names></name><name><surname>Bograd</surname><given-names>A</given-names></name><name><surname>Ben Eliyahu</surname><given-names>Y</given-names></name><name><surname>Dotan</surname><given-names>N</given-names></name><name><surname>Kaplan</surname><given-names>T</given-names></name><name><surname>Levy</surname><given-names>A</given-names></name></person-group><article-title>Toxinome-the bacterial protein toxin database</article-title><source>mBio</source><year>2024</year><volume>15</volume><fpage> e0191123</fpage><pub-id pub-id-type="doi">10.1128/mbio.01911-23</pub-id><pub-id pub-id-type="pmid">38117054</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Danov A, Segev O, Bograd A, Ben Eliyahu Y, Dotan N, Kaplan T, Levy A. Toxinome-the bacterial protein toxin database. mBio. 2024;15:e0191123. 10.1128/mbio.01911-23.<pub-id pub-id-type="pmid">38117054</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Goh</surname><given-names>Y-X</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Tai</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>Z</given-names></name><etal/></person-group><article-title>TADB 3.0: an updated database of bacterial toxin-antitoxin loci and associated mobile genetic elements</article-title><source>Nucleic Acids Res</source><year>2024</year><volume>52</volume><fpage>D784</fpage><lpage>D790</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad962</pub-id><pub-id pub-id-type="pmid">37897352</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Guan J, Chen Y, Goh Y-X, Wang M, Tai C, Deng Z, et al. TADB 3.0: an updated database of bacterial toxin-antitoxin loci and associated mobile genetic elements. Nucleic Acids Res. 2024;52:D784&#x02013;90. 10.1093/nar/gkad962.<pub-id pub-id-type="pmid">37897352</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Farrell</surname><given-names>LJ</given-names></name><name><surname>Lo</surname><given-names>R</given-names></name><name><surname>Wanford</surname><given-names>JJ</given-names></name><name><surname>Jenkins</surname><given-names>A</given-names></name><name><surname>Maxwell</surname><given-names>A</given-names></name><name><surname>Piddock</surname><given-names>LJV</given-names></name></person-group><article-title>Revitalizing the drug pipeline: antibioticDB, an open access database to aid antibacterial research and development</article-title><source>J Antimicrob Chemother</source><year>2018</year><volume>73</volume><fpage>2284</fpage><lpage>2297</lpage><pub-id pub-id-type="doi">10.1093/jac/dky208</pub-id><pub-id pub-id-type="pmid">29897476</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Farrell LJ, Lo R, Wanford JJ, Jenkins A, Maxwell A, Piddock LJV. Revitalizing the drug pipeline: antibioticDB, an open access database to aid antibacterial research and development. J Antimicrob Chemother. 2018;73:2284&#x02013;97. 10.1093/jac/dky208.<pub-id pub-id-type="pmid">29897476</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Knox</surname><given-names>C</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Klinger</surname><given-names>CM</given-names></name><name><surname>Franklin</surname><given-names>M</given-names></name><name><surname>Oler</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>A</given-names></name><etal/></person-group><article-title>DrugBank 6.0: the DrugBank Knowledgebase for 2024</article-title><source>Nucleic Acids Res.</source><year>2024</year><volume>52</volume><fpage>D1265</fpage><lpage>D1275</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad976</pub-id><pub-id pub-id-type="pmid">37953279</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Knox C, Wilson M, Klinger CM, Franklin M, Oler E, Wilson A, et al. DrugBank 6.0: the DrugBank Knowledgebase for 2024. Nucleic Acids Res. 2024;52:D1265&#x02013;75. 10.1093/nar/gkad976.<pub-id pub-id-type="pmid">37953279</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Cheng</surname><given-names>T</given-names></name><name><surname>Gindulyte</surname><given-names>A</given-names></name><name><surname>He</surname><given-names>J</given-names></name><name><surname>He</surname><given-names>S</given-names></name><etal/></person-group><article-title>PubChem 2023 update</article-title><source>Nucleic Acids Res</source><year>2022</year><volume>51</volume><fpage>D1373</fpage><lpage>D1380</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac956</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem 2023 update. Nucleic Acids Res. 2022;51:D1373&#x02013;80. 10.1093/nar/gkac956.</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Zdrazil</surname><given-names>B</given-names></name><name><surname>Felix</surname><given-names>E</given-names></name><name><surname>Hunter</surname><given-names>F</given-names></name><name><surname>Manners</surname><given-names>EJ</given-names></name><name><surname>Blackshaw</surname><given-names>J</given-names></name><name><surname>Corbett</surname><given-names>S</given-names></name><etal/></person-group><article-title>The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods</article-title><source>Nucleic Acids Res</source><year>2024</year><volume>52</volume><fpage>D1180</fpage><lpage>D1192</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad1004</pub-id><pub-id pub-id-type="pmid">37933841</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, et al. The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res. 2024;52:D1180&#x02013;92. 10.1093/nar/gkad1004.<pub-id pub-id-type="pmid">37933841</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Alcock</surname><given-names>BP</given-names></name><name><surname>Huynh</surname><given-names>W</given-names></name><name><surname>Chalil</surname><given-names>R</given-names></name><name><surname>Smith</surname><given-names>KW</given-names></name><name><surname>Raphenya</surname><given-names>AR</given-names></name><name><surname>Wlodarski</surname><given-names>MA</given-names></name><etal/></person-group><article-title>CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>D690</fpage><lpage>D699</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac920</pub-id><pub-id pub-id-type="pmid">36263822</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Alcock BP, Huynh W, Chalil R, Smith KW, Raphenya AR, Wlodarski MA, et al. CARD 2023: expanded curation, support for machine learning, and resistome prediction at the Comprehensive Antibiotic Resistance Database. Nucleic Acids Res. 2023;51:D690&#x02013;9. 10.1093/nar/gkac920.<pub-id pub-id-type="pmid">36263822</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Blin</surname><given-names>K</given-names></name><name><surname>Shaw</surname><given-names>S</given-names></name><name><surname>Augustijn</surname><given-names>HE</given-names></name><name><surname>Reitz</surname><given-names>ZL</given-names></name><name><surname>Biermann</surname><given-names>F</given-names></name><name><surname>Alanjary</surname><given-names>M</given-names></name><etal/></person-group><article-title>antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>51</volume><fpage>W46</fpage><lpage>W50</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad344</pub-id><pub-id pub-id-type="pmid">37140036</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Blin K, Shaw S, Augustijn HE, Reitz ZL, Biermann F, Alanjary M, et al. antiSMASH 7.0: new and improved predictions for detection, regulation, chemical structures and visualisation. Nucleic Acids Res. 2023;51:W46&#x02013;50. 10.1093/nar/gkad344.<pub-id pub-id-type="pmid">37140036</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Florensa</surname><given-names>AF</given-names></name><name><surname>Kaas</surname><given-names>RS</given-names></name><name><surname>Clausen</surname><given-names>PTLC</given-names></name><name><surname>Aytan-Aktug</surname><given-names>D</given-names></name><name><surname>Aarestrup</surname><given-names>FM</given-names></name></person-group><article-title>ResFinder - an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes</article-title><source>Microb Genom</source><year>2022</year><pub-id pub-id-type="doi">10.1099/mgen.0.000748</pub-id><pub-id pub-id-type="pmid">35072601</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Florensa AF, Kaas RS, Clausen PTLC, Aytan-Aktug D, Aarestrup FM. ResFinder - an open online resource for identification of antimicrobial resistance genes in next-generation sequencing data and prediction of phenotypes from genotypes. Microb Genom. 2022. 10.1099/mgen.0.000748.<pub-id pub-id-type="pmid">35072601</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Gawde</surname><given-names>U</given-names></name><name><surname>Chakraborty</surname><given-names>S</given-names></name><name><surname>Waghu</surname><given-names>FH</given-names></name><name><surname>Barai</surname><given-names>RS</given-names></name><name><surname>Khanderkar</surname><given-names>A</given-names></name><name><surname>Indraguru</surname><given-names>R</given-names></name><etal/></person-group><article-title>CAMPR4: a database of natural and synthetic antimicrobial peptides</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>D377</fpage><lpage>D383</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac933</pub-id><pub-id pub-id-type="pmid">36370097</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Gawde U, Chakraborty S, Waghu FH, Barai RS, Khanderkar A, Indraguru R, et al. CAMPR4: a database of natural and synthetic antimicrobial peptides. Nucleic Acids Res. 2023;51:D377&#x02013;83. 10.1093/nar/gkac933.<pub-id pub-id-type="pmid">36370097</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>L</given-names></name><name><surname>Guan</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>P</given-names></name><name><surname>Chung</surname><given-names>C-R</given-names></name><name><surname>Zhao</surname><given-names>Z</given-names></name><name><surname>Dong</surname><given-names>D</given-names></name><etal/></person-group><article-title>dbAMP 3.0: updated resource of antimicrobial activity and structural annotation of peptides in the post-pandemic era</article-title><source>Nucleic Acids Res.</source><year>2025</year><volume>53</volume><fpage>D364</fpage><lpage>D376</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae1019</pub-id><pub-id pub-id-type="pmid">39540425</pub-id>
</element-citation><mixed-citation id="mc-CR25" publication-type="journal">Yao L, Guan J, Xie P, Chung C-R, Zhao Z, Dong D, et al. dbAMP 3.0: updated resource of antimicrobial activity and structural annotation of peptides in the post-pandemic era. Nucleic Acids Res. 2025;53:D364&#x02013;76. 10.1093/nar/gkae1019.<pub-id pub-id-type="pmid">39540425</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Pirtskhalava</surname><given-names>M</given-names></name><name><surname>Amstrong</surname><given-names>AA</given-names></name><name><surname>Grigolava</surname><given-names>M</given-names></name><name><surname>Chubinidze</surname><given-names>M</given-names></name><name><surname>Alimbarashvili</surname><given-names>E</given-names></name><name><surname>Vishnepolsky</surname><given-names>B</given-names></name><etal/></person-group><article-title>DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics</article-title><source>Nucleic Acids Res</source><year>2021</year><volume>49</volume><fpage>D288</fpage><lpage>D297</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa991</pub-id><pub-id pub-id-type="pmid">33151284</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Pirtskhalava M, Amstrong AA, Grigolava M, Chubinidze M, Alimbarashvili E, Vishnepolsky B, et al. DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucleic Acids Res. 2021;49:D288&#x02013;97. 10.1093/nar/gkaa991.<pub-id pub-id-type="pmid">33151284</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Yao</surname><given-names>H</given-names></name><name><surname>Hao</surname><given-names>C</given-names></name><etal/></person-group><article-title>DRAMP 4.0: an open-access data repository dedicated to the clinical translation of antimicrobial peptides</article-title><source>Nucleic Acids Res.</source><year>2025</year><volume>53</volume><fpage>D403</fpage><lpage>D410</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae1046</pub-id><pub-id pub-id-type="pmid">39526377</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Ma T, Liu Y, Yu B, Sun X, Yao H, Hao C, et al. DRAMP 4.0: an open-access data repository dedicated to the clinical translation of antimicrobial peptides. Nucleic Acids Res. 2025;53:D403&#x02013;10. 10.1093/nar/gkae1046.<pub-id pub-id-type="pmid">39526377</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Santos-J&#x000fa;nior</surname><given-names>CD</given-names></name><name><surname>Pan</surname><given-names>S</given-names></name><name><surname>Zhao</surname><given-names>X-M</given-names></name><name><surname>Coelho</surname><given-names>LP</given-names></name></person-group><article-title>Macrel: antimicrobial peptide screening in genomes and metagenomes</article-title><source>PeerJ</source><year>2020</year><volume>8</volume><fpage>e10555</fpage><pub-id pub-id-type="doi">10.7717/peerj.10555</pub-id><pub-id pub-id-type="pmid">33384902</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Santos-J&#x000fa;nior CD, Pan S, Zhao X-M, Coelho LP. Macrel: antimicrobial peptide screening in genomes and metagenomes. PeerJ. 2020;8: e10555. 10.7717/peerj.10555.<pub-id pub-id-type="pmid">33384902</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Gholamizoj</surname><given-names>S</given-names></name><name><surname>Ma</surname><given-names>B</given-names></name></person-group><article-title>SPEQ: quality assessment of peptide tandem mass spectra with deep learning</article-title><source>Bioinformatics</source><year>2022</year><volume>38</volume><fpage>1568</fpage><lpage>1574</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btab874</pub-id><pub-id pub-id-type="pmid">34978568</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Gholamizoj S, Ma B. SPEQ: quality assessment of peptide tandem mass spectra with deep learning. Bioinformatics. 2022;38:1568&#x02013;74. 10.1093/bioinformatics/btab874.<pub-id pub-id-type="pmid">34978568</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Lertampaiporn</surname><given-names>S</given-names></name><name><surname>Vorapreeda</surname><given-names>T</given-names></name><name><surname>Hongsthong</surname><given-names>A</given-names></name><name><surname>Thammarongtham</surname><given-names>C</given-names></name></person-group><article-title>Ensemble-AMPPred: robust AMP prediction and recognition using the ensemble learning method with a new hybrid feature for differentiating AMPs</article-title><source>Genes (Basel)</source><year>2021</year><pub-id pub-id-type="doi">10.3390/genes12020137</pub-id><pub-id pub-id-type="pmid">33494403</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Lertampaiporn S, Vorapreeda T, Hongsthong A, Thammarongtham C. Ensemble-AMPPred: robust AMP prediction and recognition using the ensemble learning method with a new hybrid feature for differentiating AMPs. Genes (Basel). 2021. 10.3390/genes12020137.<pub-id pub-id-type="pmid">33494403</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>J</given-names></name><name><surname>Bhadra</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>A</given-names></name><name><surname>Sethiya</surname><given-names>P</given-names></name><name><surname>Qin</surname><given-names>L</given-names></name><name><surname>Tai</surname><given-names>HK</given-names></name><etal/></person-group><article-title>Deep-AmPEP30: improve short antimicrobial peptides prediction with deep learning</article-title><source>Mol Ther Nucleic Acids</source><year>2020</year><volume>20</volume><fpage>882</fpage><lpage>894</lpage><pub-id pub-id-type="doi">10.1016/j.omtn.2020.05.006</pub-id><pub-id pub-id-type="pmid">32464552</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Yan J, Bhadra P, Li A, Sethiya P, Qin L, Tai HK, et al. Deep-AmPEP30: improve short antimicrobial peptides prediction with deep learning. Mol Ther Nucleic Acids. 2020;20:882&#x02013;94. 10.1016/j.omtn.2020.05.006.<pub-id pub-id-type="pmid">32464552</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Agrawal</surname><given-names>P</given-names></name><name><surname>Mohanty</surname><given-names>D</given-names></name></person-group><article-title>A machine learning-based method for prediction of macrocyclization patterns of polyketides and non-ribosomal peptides</article-title><source>Bioinformatics</source><year>2021</year><volume>37</volume><fpage>603</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btaa851</pub-id><pub-id pub-id-type="pmid">33010151</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Agrawal P, Mohanty D. A machine learning-based method for prediction of macrocyclization patterns of polyketides and non-ribosomal peptides. Bioinformatics. 2021;37:603&#x02013;11. 10.1093/bioinformatics/btaa851.<pub-id pub-id-type="pmid">33010151</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Behsaz</surname><given-names>B</given-names></name><name><surname>Bode</surname><given-names>E</given-names></name><name><surname>Gurevich</surname><given-names>A</given-names></name><name><surname>Shi</surname><given-names>Y-N</given-names></name><name><surname>Grundmann</surname><given-names>F</given-names></name><name><surname>Acharya</surname><given-names>D</given-names></name><etal/></person-group><article-title>Integrating genomics and metabolomics for scalable non-ribosomal peptide discovery</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><fpage>3225</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-23502-4</pub-id><pub-id pub-id-type="pmid">34050176</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Behsaz B, Bode E, Gurevich A, Shi Y-N, Grundmann F, Acharya D, et al. Integrating genomics and metabolomics for scalable non-ribosomal peptide discovery. Nat Commun. 2021;12:3225. 10.1038/s41467-021-23502-4.<pub-id pub-id-type="pmid">34050176</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira-Flores</surname><given-names>E</given-names></name><name><surname>Medema</surname><given-names>M</given-names></name><name><surname>Buttigieg</surname><given-names>PL</given-names></name><name><surname>Meinicke</surname><given-names>P</given-names></name><name><surname>Gl&#x000f6;ckner</surname><given-names>FO</given-names></name><name><surname>Fern&#x000e1;ndez-Guerra</surname><given-names>A</given-names></name></person-group><source>Mining metagenomes for natural product biosynthetic gene clusters: unlocking new potential with ultrafast techniques</source><year>2021</year><pub-id pub-id-type="doi">10.1101/2021.01.20.427441</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Pereira-Flores E, Medema M, Buttigieg PL, Meinicke P, Gl&#x000f6;ckner FO, Fern&#x000e1;ndez-Guerra A. Mining metagenomes for natural product biosynthetic gene clusters: unlocking new potential with ultrafast techniques. 2021. 10.1101/2021.01.20.427441.</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro-Mu&#x000f1;oz</surname><given-names>JC</given-names></name><name><surname>Selem-Mojica</surname><given-names>N</given-names></name><name><surname>Mullowney</surname><given-names>MW</given-names></name><name><surname>Kautsar</surname><given-names>SA</given-names></name><name><surname>Tryon</surname><given-names>JH</given-names></name><name><surname>Parkinson</surname><given-names>EI</given-names></name><etal/></person-group><article-title>A computational framework to explore large-scale biosynthetic diversity</article-title><source>Nat Chem Biol</source><year>2020</year><volume>16</volume><fpage>60</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1038/s41589-019-0400-9</pub-id><pub-id pub-id-type="pmid">31768033</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Navarro-Mu&#x000f1;oz JC, Selem-Mojica N, Mullowney MW, Kautsar SA, Tryon JH, Parkinson EI, et al. A computational framework to explore large-scale biosynthetic diversity. Nat Chem Biol. 2020;16:60&#x02013;8. 10.1038/s41589-019-0400-9.<pub-id pub-id-type="pmid">31768033</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Ziemert</surname><given-names>N</given-names></name><name><surname>Podell</surname><given-names>S</given-names></name><name><surname>Penn</surname><given-names>K</given-names></name><name><surname>Badger</surname><given-names>JH</given-names></name><name><surname>Allen</surname><given-names>E</given-names></name><name><surname>Jensen</surname><given-names>PR</given-names></name></person-group><article-title>The natural product domain seeker NaPDoS: a phylogeny based bioinformatic tool to classify secondary metabolite gene diversity</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><fpage>e34064</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0034064</pub-id><pub-id pub-id-type="pmid">22479523</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Ziemert N, Podell S, Penn K, Badger JH, Allen E, Jensen PR. The natural product domain seeker NaPDoS: a phylogeny based bioinformatic tool to classify secondary metabolite gene diversity. PLoS ONE. 2012;7: e34064. 10.1371/journal.pone.0034064.<pub-id pub-id-type="pmid">22479523</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Rolland</surname><given-names>C</given-names></name><name><surname>Wittmann</surname><given-names>J</given-names></name><name><surname>Reimer</surname><given-names>LC</given-names></name><name><surname>Sard&#x000e0; Carbasse</surname><given-names>J</given-names></name><name><surname>Schober</surname><given-names>I</given-names></name><name><surname>Dudek</surname><given-names>C-A</given-names></name><etal/></person-group><article-title>PhageDive: the comprehensive strain database of prokaryotic viral diversity</article-title><source>Nucleic Acids Res</source><year>2025</year><volume>53</volume><fpage>D819</fpage><lpage>D825</lpage><pub-id pub-id-type="doi">10.1093/nar/gkae878</pub-id><pub-id pub-id-type="pmid">39373542</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Rolland C, Wittmann J, Reimer LC, Sard&#x000e0; Carbasse J, Schober I, Dudek C-A, et al. PhageDive: the comprehensive strain database of prokaryotic viral diversity. Nucleic Acids Res. 2025;53:D819&#x02013;25. 10.1093/nar/gkae878.<pub-id pub-id-type="pmid">39373542</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Camarillo-Guerrero</surname><given-names>LF</given-names></name><name><surname>Almeida</surname><given-names>A</given-names></name><name><surname>Rangel-Pineros</surname><given-names>G</given-names></name><name><surname>Finn</surname><given-names>RD</given-names></name><name><surname>Lawley</surname><given-names>TD</given-names></name></person-group><article-title>Massive expansion of human gut bacteriophage diversity</article-title><source>Cell</source><year>2021</year><volume>184</volume><fpage>1098</fpage><lpage>1109.e9</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2021.01.029</pub-id><pub-id pub-id-type="pmid">33606979</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Camarillo-Guerrero LF, Almeida A, Rangel-Pineros G, Finn RD, Lawley TD. Massive expansion of human gut bacteriophage diversity. Cell. 2021;184:1098-1109.e9. 10.1016/j.cell.2021.01.029.<pub-id pub-id-type="pmid">33606979</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>NL</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Hu</surname><given-names>S</given-names></name><name><surname>Lercher</surname><given-names>MJ</given-names></name><name><surname>Zhao</surname><given-names>X-M</given-names></name><etal/></person-group><article-title>MVP: a microbe-phage interaction database</article-title><source>Nucleic Acids Res</source><year>2018</year><volume>46</volume><fpage>D700</fpage><lpage>D707</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx1124</pub-id><pub-id pub-id-type="pmid">29177508</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Gao NL, Zhang C, Zhang Z, Hu S, Lercher MJ, Zhao X-M, et al. MVP: a microbe-phage interaction database. Nucleic Acids Res. 2018;46:D700&#x02013;7. 10.1093/nar/gkx1124.<pub-id pub-id-type="pmid">29177508</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>DA</given-names></name><name><surname>Hatfull</surname><given-names>GF</given-names></name></person-group><article-title>PhagesDB: the actinobacteriophage database</article-title><source>Bioinformatics</source><year>2017</year><volume>33</volume><fpage>784</fpage><lpage>786</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btw711</pub-id><pub-id pub-id-type="pmid">28365761</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Russell DA, Hatfull GF. PhagesDB: the actinobacteriophage database. Bioinformatics. 2017;33:784&#x02013;6. 10.1093/bioinformatics/btw711.<pub-id pub-id-type="pmid">28365761</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Criel</surname><given-names>B</given-names></name><name><surname>Taelman</surname><given-names>S</given-names></name><name><surname>van Criekinge</surname><given-names>W</given-names></name><name><surname>Stock</surname><given-names>M</given-names></name><name><surname>Briers</surname><given-names>Y</given-names></name></person-group><article-title>PhaLP: a database for the study of phage lytic proteins and their evolution</article-title><source>Viruses</source><year>2021</year><pub-id pub-id-type="doi">10.3390/v13071240</pub-id><pub-id pub-id-type="pmid">34206969</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Criel B, Taelman S, van Criekinge W, Stock M, Briers Y. PhaLP: a database for the study of phage lytic proteins and their evolution. Viruses. 2021. 10.3390/v13071240.<pub-id pub-id-type="pmid">34206969</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Tynecki</surname><given-names>P</given-names></name><name><surname>Guzi&#x00144;ski</surname><given-names>A</given-names></name><name><surname>Kazimierczak</surname><given-names>J</given-names></name><name><surname>Jadczuk</surname><given-names>M</given-names></name><name><surname>Dastych</surname><given-names>J</given-names></name><name><surname>Onisko</surname><given-names>A</given-names></name></person-group><source>PhageAI - bacteriophage life cycle recognition with machine learning and natural language processing</source><year>2020</year><pub-id pub-id-type="doi">10.1101/2020.07.11.198606</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Tynecki P, Guzi&#x00144;ski A, Kazimierczak J, Jadczuk M, Dastych J, Onisko A. PhageAI - bacteriophage life cycle recognition with machine learning and natural language processing. 2020. 10.1101/2020.07.11.198606.</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Marquet</surname><given-names>M</given-names></name><name><surname>H&#x000f6;lzer</surname><given-names>M</given-names></name><name><surname>Pletz</surname><given-names>MW</given-names></name><name><surname>Viehweger</surname><given-names>A</given-names></name><name><surname>Makarewicz</surname><given-names>O</given-names></name><name><surname>Ehricht</surname><given-names>R</given-names></name><name><surname>Brandt</surname><given-names>C</given-names></name></person-group><article-title>What the phage: a scalable workflow for the identification and analysis of phage sequences</article-title><source>Gigascience</source><year>2022</year><pub-id pub-id-type="doi">10.1093/gigascience/giac110</pub-id><pub-id pub-id-type="pmid">36399058</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Marquet M, H&#x000f6;lzer M, Pletz MW, Viehweger A, Makarewicz O, Ehricht R, Brandt C. What the phage: a scalable workflow for the identification and analysis of phage sequences. Gigascience. 2022. 10.1093/gigascience/giac110.<pub-id pub-id-type="pmid">36399058</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Wishart</surname><given-names>DS</given-names></name><name><surname>Han</surname><given-names>S</given-names></name><name><surname>Saha</surname><given-names>S</given-names></name><name><surname>Oler</surname><given-names>E</given-names></name><name><surname>Peters</surname><given-names>H</given-names></name><name><surname>Grant</surname><given-names>JR</given-names></name><etal/></person-group><article-title>PHASTEST: faster than PHASTER, better than PHAST</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>W443</fpage><lpage>W450</lpage><pub-id pub-id-type="doi">10.1093/nar/gkad382</pub-id><pub-id pub-id-type="pmid">37194694</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Wishart DS, Han S, Saha S, Oler E, Peters H, Grant JR, et al. PHASTEST: faster than PHASTER, better than PHAST. Nucleic Acids Res. 2023;51:W443&#x02013;50. 10.1093/nar/gkad382.<pub-id pub-id-type="pmid">37194694</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Holstein</surname><given-names>T</given-names></name><name><surname>Kistner</surname><given-names>F</given-names></name><name><surname>Martens</surname><given-names>L</given-names></name><name><surname>Muth</surname><given-names>T</given-names></name></person-group><article-title>PepGM: a probabilistic graphical model for taxonomic inference of viral proteome samples with associated confidence scores</article-title><source>Bioinformatics</source><year>2023</year><pub-id pub-id-type="doi">10.1093/bioinformatics/btad289</pub-id><pub-id pub-id-type="pmid">37129543</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Holstein T, Kistner F, Martens L, Muth T. PepGM: a probabilistic graphical model for taxonomic inference of viral proteome samples with associated confidence scores. Bioinformatics. 2023. 10.1093/bioinformatics/btad289.<pub-id pub-id-type="pmid">37129543</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Tang</surname><given-names>K</given-names></name><name><surname>Dart</surname><given-names>E</given-names></name><name><surname>Ignacio-Espinoza</surname><given-names>JC</given-names></name><name><surname>Fuhrman</surname><given-names>JA</given-names></name><etal/></person-group><article-title>A network-based integrated framework for predicting virus-prokaryote interactions</article-title><source>NAR Genom Bioinform.</source><year>2020</year><volume>2</volume><fpage>lqaa044</fpage><pub-id pub-id-type="doi">10.1093/nargab/lqaa044</pub-id><pub-id pub-id-type="pmid">32626849</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Wang W, Ren J, Tang K, Dart E, Ignacio-Espinoza JC, Fuhrman JA, et al. A network-based integrated framework for predicting virus-prokaryote interactions. NAR Genom Bioinform. 2020;2: lqaa044. 10.1093/nargab/lqaa044.<pub-id pub-id-type="pmid">32626849</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Graf</surname><given-names>AC</given-names></name><name><surname>Striesow</surname><given-names>J</given-names></name><name><surname>Pan&#x000e9;-Farr&#x000e9;</surname><given-names>J</given-names></name><name><surname>Sura</surname><given-names>T</given-names></name><name><surname>Wurster</surname><given-names>M</given-names></name><name><surname>Lalk</surname><given-names>M</given-names></name><etal/></person-group><article-title>An innovative protocol for metaproteomic analyses of microbial pathogens in cystic fibrosis sputum</article-title><source>Front Cell Infect Microbiol</source><year>2021</year><volume>11</volume><fpage>724569</fpage><pub-id pub-id-type="doi">10.3389/fcimb.2021.724569</pub-id><pub-id pub-id-type="pmid">34513734</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Graf AC, Striesow J, Pan&#x000e9;-Farr&#x000e9; J, Sura T, Wurster M, Lalk M, et al. An innovative protocol for metaproteomic analyses of microbial pathogens in cystic fibrosis sputum. Front Cell Infect Microbiol. 2021;11: 724569. 10.3389/fcimb.2021.724569.<pub-id pub-id-type="pmid">34513734</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Messer</surname><given-names>LF</given-names></name><name><surname>Lee</surname><given-names>CE</given-names></name><name><surname>Wattiez</surname><given-names>R</given-names></name><name><surname>Matallana-Surget</surname><given-names>S</given-names></name></person-group><article-title>Novel functional insights into the microbiome inhabiting marine plastic debris: critical considerations to counteract the challenges of thin biofilms using multi-omics and comparative metaproteomics</article-title><source>Microbiome</source><year>2024</year><volume>12</volume><fpage>36</fpage><pub-id pub-id-type="doi">10.1186/s40168-024-01751-x</pub-id><pub-id pub-id-type="pmid">38389111</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Messer LF, Lee CE, Wattiez R, Matallana-Surget S. Novel functional insights into the microbiome inhabiting marine plastic debris: critical considerations to counteract the challenges of thin biofilms using multi-omics and comparative metaproteomics. Microbiome. 2024;12:36. 10.1186/s40168-024-01751-x.<pub-id pub-id-type="pmid">38389111</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>D-Z</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Hong</surname><given-names>H-S</given-names></name></person-group><article-title>Comparative proteomic analysis reveals proteins putatively involved in toxin biosynthesis in the marine dinoflagellate Alexandrium catenella</article-title><source>Mar Drugs</source><year>2013</year><volume>11</volume><fpage>213</fpage><lpage>232</lpage><pub-id pub-id-type="doi">10.3390/md11010213</pub-id><pub-id pub-id-type="pmid">23340676</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Wang D-Z, Gao Y, Lin L, Hong H-S. Comparative proteomic analysis reveals proteins putatively involved in toxin biosynthesis in the marine dinoflagellate Alexandrium catenella. Mar Drugs. 2013;11:213&#x02013;32. 10.3390/md11010213.<pub-id pub-id-type="pmid">23340676</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>TC</given-names></name><name><surname>Mok</surname><given-names>WWK</given-names></name><name><surname>Murawski</surname><given-names>AM</given-names></name><name><surname>Brynildsen</surname><given-names>MP</given-names></name></person-group><article-title>Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><fpage>1177</fpage><pub-id pub-id-type="doi">10.1038/s41467-019-09058-4</pub-id><pub-id pub-id-type="pmid">30862812</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Barrett TC, Mok WWK, Murawski AM, Brynildsen MP. Enhanced antibiotic resistance development from fluoroquinolone persisters after a single exposure to antibiotic. Nat Commun. 2019;10:1177. 10.1038/s41467-019-09058-4.<pub-id pub-id-type="pmid">30862812</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Sidjabat</surname><given-names>HE</given-names></name><name><surname>Gien</surname><given-names>J</given-names></name><name><surname>Kvaskoff</surname><given-names>D</given-names></name><name><surname>Ashman</surname><given-names>K</given-names></name><name><surname>Vaswani</surname><given-names>K</given-names></name><name><surname>Reed</surname><given-names>S</given-names></name><etal/></person-group><article-title>The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>3871</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-21984-9</pub-id><pub-id pub-id-type="pmid">29497067</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Sidjabat HE, Gien J, Kvaskoff D, Ashman K, Vaswani K, Reed S, et al. The use of SWATH to analyse the dynamic changes of bacterial proteome of carbapanemase-producing Escherichia coli under antibiotic pressure. Sci Rep. 2018;8:3871. 10.1038/s41598-018-21984-9.<pub-id pub-id-type="pmid">29497067</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Doron</surname><given-names>S</given-names></name><name><surname>Melamed</surname><given-names>S</given-names></name><name><surname>Ofir</surname><given-names>G</given-names></name><name><surname>Leavitt</surname><given-names>A</given-names></name><name><surname>Lopatina</surname><given-names>A</given-names></name><name><surname>Keren</surname><given-names>M</given-names></name><etal/></person-group><article-title>Systematic discovery of anti-phage defense systems in the microbial pan-genome</article-title><source>Science</source><year>2018</year><pub-id pub-id-type="doi">10.1126/science.aar4120</pub-id><pub-id pub-id-type="pmid">29371424</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Doron S, Melamed S, Ofir G, Leavitt A, Lopatina A, Keren M, et al. Systematic discovery of anti-phage defense systems in the microbial pan-genome. Science. 2018. 10.1126/science.aar4120.<pub-id pub-id-type="pmid">29371424</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ed;nez Arbas</surname><given-names>S</given-names></name><name><surname>Narayanasamy</surname><given-names>S</given-names></name><name><surname>Herold</surname><given-names>M</given-names></name><name><surname>Lebrun</surname><given-names>LA</given-names></name><name><surname>Hoopmann</surname><given-names>MR</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Roles of bacteriophages, plasmids and CRISPR immunity in microbial community dynamics revealed using time-series integrated meta-omics</article-title><source>Nat Microbiol</source><year>2021</year><volume>6</volume><fpage>123</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1038/s41564-020-00794-8</pub-id><pub-id pub-id-type="pmid">33139880</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Mart&#x000ed;nez Arbas S, Narayanasamy S, Herold M, Lebrun LA, Hoopmann MR, Li S, et al. Roles of bacteriophages, plasmids and CRISPR immunity in microbial community dynamics revealed using time-series integrated meta-omics. Nat Microbiol. 2021;6:123&#x02013;35. 10.1038/s41564-020-00794-8.<pub-id pub-id-type="pmid">33139880</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>AK</given-names></name><name><surname>Dhasmana</surname><given-names>N</given-names></name><name><surname>Dubey</surname><given-names>N</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Gangwal</surname><given-names>A</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Singh</surname><given-names>Y</given-names></name></person-group><article-title>Bacterial virulence factors: secreted for survival</article-title><source>Indian J Microbiol</source><year>2017</year><volume>57</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1007/s12088-016-0625-1</pub-id><pub-id pub-id-type="pmid">28148975</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Sharma AK, Dhasmana N, Dubey N, Kumar N, Gangwal A, Gupta M, Singh Y. Bacterial virulence factors: secreted for survival. Indian J Microbiol. 2017;57:1&#x02013;10. 10.1007/s12088-016-0625-1.<pub-id pub-id-type="pmid">28148975</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>YM</given-names></name><name><surname>Almqvist</surname><given-names>F</given-names></name><name><surname>Hultgren</surname><given-names>SJ</given-names></name></person-group><article-title>Targeting virulence for antimicrobial chemotherapy</article-title><source>Curr Opin Pharmacol</source><year>2003</year><volume>3</volume><fpage>513</fpage><lpage>519</lpage><pub-id pub-id-type="doi">10.1016/j.coph.2003.04.001</pub-id><pub-id pub-id-type="pmid">14559097</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Lee YM, Almqvist F, Hultgren SJ. Targeting virulence for antimicrobial chemotherapy. Curr Opin Pharmacol. 2003;3:513&#x02013;9. 10.1016/j.coph.2003.04.001.<pub-id pub-id-type="pmid">14559097</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Friesen</surname><given-names>TL</given-names></name><name><surname>Stukenbrock</surname><given-names>EH</given-names></name><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Meinhardt</surname><given-names>S</given-names></name><name><surname>Ling</surname><given-names>H</given-names></name><name><surname>Faris</surname><given-names>JD</given-names></name><etal/></person-group><article-title>Emergence of a new disease as a result of interspecific virulence gene transfer</article-title><source>Nat Genet</source><year>2006</year><volume>38</volume><fpage>953</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1038/ng1839</pub-id><pub-id pub-id-type="pmid">16832356</pub-id>
</element-citation><mixed-citation id="mc-CR56" publication-type="journal">Friesen TL, Stukenbrock EH, Liu Z, Meinhardt S, Ling H, Faris JD, et al. Emergence of a new disease as a result of interspecific virulence gene transfer. Nat Genet. 2006;38:953&#x02013;6. 10.1038/ng1839.<pub-id pub-id-type="pmid">16832356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Gyles</surname><given-names>C</given-names></name><name><surname>Boerlin</surname><given-names>P</given-names></name></person-group><article-title>Horizontally transferred genetic elements and their role in pathogenesis of bacterial disease</article-title><source>Vet Pathol</source><year>2014</year><volume>51</volume><fpage>328</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1177/0300985813511131</pub-id><pub-id pub-id-type="pmid">24318976</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Gyles C, Boerlin P. Horizontally transferred genetic elements and their role in pathogenesis of bacterial disease. Vet Pathol. 2014;51:328&#x02013;40. 10.1177/0300985813511131.<pub-id pub-id-type="pmid">24318976</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><mixed-citation publication-type="other">P&#x000e9;rez-Etayo L, Gonz&#x000e1;lez D, Vitas AI. The aquatic ecosystem, a good environment for the horizontal transfer of antimicrobial resistance and virulence-associated factors among extended spectrum &#x003b2;-lactamases producing E. coli. microorganisms 2020. 10.3390/microorganisms8040568.</mixed-citation></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000f8;borg</surname><given-names>DA</given-names></name><name><surname>Hendriksen</surname><given-names>NB</given-names></name><name><surname>Kilian</surname><given-names>M</given-names></name><name><surname>Christensen</surname><given-names>JH</given-names></name><name><surname>Kroer</surname><given-names>N</given-names></name></person-group><article-title>Bacterial human virulence genes across diverse habitats as assessed by in silico analysis of environmental metagenomes</article-title><source>Front Microbiol</source><year>2016</year><volume>7</volume><fpage>1712</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2016.01712</pub-id><pub-id pub-id-type="pmid">27857707</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">S&#x000f8;borg DA, Hendriksen NB, Kilian M, Christensen JH, Kroer N. Bacterial human virulence genes across diverse habitats as assessed by in silico analysis of environmental metagenomes. Front Microbiol. 2016;7: 1712. 10.3389/fmicb.2016.01712.<pub-id pub-id-type="pmid">27857707</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Hoorzook</surname><given-names>KB</given-names></name><name><surname>Barnard</surname><given-names>TG</given-names></name></person-group><article-title>Absolute quantification of E. coli virulence and housekeeping genes to determine pathogen loads in enumerated environmental samples</article-title><source>PLoS One.</source><year>2021</year><volume>16</volume><fpage>e0260082</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0260082</pub-id><pub-id pub-id-type="pmid">34843501</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Hoorzook KB, Barnard TG. Absolute quantification of E. coli virulence and housekeeping genes to determine pathogen loads in enumerated environmental samples. PLoS One. 2021;16: e0260082. 10.1371/journal.pone.0260082.<pub-id pub-id-type="pmid">34843501</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>de Nies</surname><given-names>L</given-names></name><name><surname>Lopes</surname><given-names>S</given-names></name><name><surname>Busi</surname><given-names>SB</given-names></name><name><surname>Galata</surname><given-names>V</given-names></name><name><surname>Heintz-Buschart</surname><given-names>A</given-names></name><name><surname>Laczny</surname><given-names>CC</given-names></name><etal/></person-group><article-title>PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data</article-title><source>Microbiome</source><year>2021</year><volume>9</volume><fpage>49</fpage><pub-id pub-id-type="doi">10.1186/s40168-020-00993-9</pub-id><pub-id pub-id-type="pmid">33597026</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">de Nies L, Lopes S, Busi SB, Galata V, Heintz-Buschart A, Laczny CC, et al. PathoFact: a pipeline for the prediction of virulence factors and antimicrobial resistance genes in metagenomic data. Microbiome. 2021;9:49. 10.1186/s40168-020-00993-9.<pub-id pub-id-type="pmid">33597026</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Hosseini</surname><given-names>H</given-names></name><name><surname>Mahmoudi</surname><given-names>R</given-names></name><name><surname>Pakbin</surname><given-names>B</given-names></name><name><surname>Manafi</surname><given-names>L</given-names></name><name><surname>Hosseini</surname><given-names>S</given-names></name><name><surname>Pilevar</surname><given-names>Z</given-names></name><name><surname>Br&#x000fc;ck</surname><given-names>WM</given-names></name></person-group><article-title>Effects of intrinsic and extrinsic growth factors on virulence gene expression of foodborne pathogens in vitro and in food model systems; a review</article-title><source>Food Sci Nutr</source><year>2024</year><volume>12</volume><fpage>6093</fpage><lpage>6107</lpage><pub-id pub-id-type="doi">10.1002/fsn3.4281</pub-id><pub-id pub-id-type="pmid">39554324</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Hosseini H, Mahmoudi R, Pakbin B, Manafi L, Hosseini S, Pilevar Z, Br&#x000fc;ck WM. Effects of intrinsic and extrinsic growth factors on virulence gene expression of foodborne pathogens in vitro and in food model systems; a review. Food Sci Nutr. 2024;12:6093&#x02013;107. 10.1002/fsn3.4281.<pub-id pub-id-type="pmid">39554324</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Penttinen</surname><given-names>R</given-names></name><name><surname>Kinnula</surname><given-names>H</given-names></name><name><surname>Lipponen</surname><given-names>A</given-names></name><name><surname>Bamford</surname><given-names>JKH</given-names></name><name><surname>Sundberg</surname><given-names>L-R</given-names></name></person-group><article-title>High nutrient concentration can induce virulence factor expression and cause higher virulence in an environmentally transmitted pathogen</article-title><source>Microb Ecol</source><year>2016</year><volume>72</volume><fpage>955</fpage><lpage>964</lpage><pub-id pub-id-type="doi">10.1007/s00248-016-0781-1</pub-id><pub-id pub-id-type="pmid">27193154</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Penttinen R, Kinnula H, Lipponen A, Bamford JKH, Sundberg L-R. High nutrient concentration can induce virulence factor expression and cause higher virulence in an environmentally transmitted pathogen. Microb Ecol. 2016;72:955&#x02013;64. 10.1007/s00248-016-0781-1.<pub-id pub-id-type="pmid">27193154</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Nwaji</surname><given-names>AR</given-names></name><name><surname>Arieri</surname><given-names>O</given-names></name><name><surname>Anyang</surname><given-names>AS</given-names></name><name><surname>Nguedia</surname><given-names>K</given-names></name><name><surname>Abiade</surname><given-names>EB</given-names></name><name><surname>Forcados</surname><given-names>GE</given-names></name><etal/></person-group><article-title>Natural toxins and One Health: a review</article-title><source>Sci One Health</source><year>2022</year><volume>1</volume><fpage>100013</fpage><pub-id pub-id-type="doi">10.1016/j.soh.2023.100013</pub-id><pub-id pub-id-type="pmid">39076609</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Nwaji AR, Arieri O, Anyang AS, Nguedia K, Abiade EB, Forcados GE, et al. Natural toxins and One Health: a review. Sci One Health. 2022;1: 100013. 10.1016/j.soh.2023.100013.<pub-id pub-id-type="pmid">39076609</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Guerrant</surname><given-names>RL</given-names></name></person-group><article-title>Microbial toxins and diarrhoeal diseases: introduction and overview</article-title><source>Ciba Found Symp</source><year>1985</year><volume>112</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1002/9780470720936.ch1</pub-id><pub-id pub-id-type="pmid">3891253</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Guerrant RL. Microbial toxins and diarrhoeal diseases: introduction and overview. Ciba Found Symp. 1985;112:1&#x02013;13. 10.1002/9780470720936.ch1.<pub-id pub-id-type="pmid">3891253</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Popoff</surname><given-names>MR</given-names></name></person-group><article-title>Overview of bacterial protein toxins from pathogenic bacteria: mode of action and insights into evolution</article-title><source>Toxins (Basel)</source><year>2024</year><pub-id pub-id-type="doi">10.3390/toxins16040182</pub-id><pub-id pub-id-type="pmid">39591240</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Popoff MR. Overview of bacterial protein toxins from pathogenic bacteria: mode of action and insights into evolution. Toxins (Basel). 2024. 10.3390/toxins16040182.<pub-id pub-id-type="pmid">39591240</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>C</given-names></name><name><surname>Azevedo</surname><given-names>J</given-names></name><name><surname>Antunes</surname><given-names>A</given-names></name><name><surname>Vasconcelos</surname><given-names>V</given-names></name></person-group><article-title>Cylindrospermopsin: occurrence, methods of detection and toxicology</article-title><source>J Appl Microbiol</source><year>2013</year><volume>114</volume><fpage>605</fpage><lpage>620</lpage><pub-id pub-id-type="doi">10.1111/jam.12048</pub-id><pub-id pub-id-type="pmid">23082903</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Moreira C, Azevedo J, Antunes A, Vasconcelos V. Cylindrospermopsin: occurrence, methods of detection and toxicology. J Appl Microbiol. 2013;114:605&#x02013;20. 10.1111/jam.12048.<pub-id pub-id-type="pmid">23082903</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Tan</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>D</given-names></name><etal/></person-group><article-title>Occurrence and quantitative risk assessment of twelve mycotoxins in eggs and chicken tissues in China</article-title><source>Toxins (Basel)</source><year>2018</year><pub-id pub-id-type="doi">10.3390/toxins10110477</pub-id><pub-id pub-id-type="pmid">30587774</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Wang L, Zhang Q, Yan Z, Tan Y, Zhu R, Yu D, et al. Occurrence and quantitative risk assessment of twelve mycotoxins in eggs and chicken tissues in China. Toxins (Basel). 2018. 10.3390/toxins10110477.<pub-id pub-id-type="pmid">30587774</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>PC</given-names></name><name><surname>Sharma</surname><given-names>D</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><name><surname>Bhagat</surname><given-names>M</given-names></name><name><surname>Ola</surname><given-names>M</given-names></name><name><surname>Thakur</surname><given-names>VK</given-names></name><etal/></person-group><article-title>Recent advances in microbial toxin-related strategies to combat cancer</article-title><source>Semin Cancer Biol</source><year>2022</year><volume>86</volume><fpage>753</fpage><lpage>768</lpage><pub-id pub-id-type="doi">10.1016/j.semcancer.2021.07.007</pub-id><pub-id pub-id-type="pmid">34271147</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Sharma PC, Sharma D, Sharma A, Bhagat M, Ola M, Thakur VK, et al. Recent advances in microbial toxin-related strategies to combat cancer. Semin Cancer Biol. 2022;86:753&#x02013;68. 10.1016/j.semcancer.2021.07.007.<pub-id pub-id-type="pmid">34271147</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Pulingam</surname><given-names>T</given-names></name><name><surname>Parumasivam</surname><given-names>T</given-names></name><name><surname>Gazzali</surname><given-names>AM</given-names></name><name><surname>Sulaiman</surname><given-names>AM</given-names></name><name><surname>Chee</surname><given-names>JY</given-names></name><name><surname>Lakshmanan</surname><given-names>M</given-names></name><etal/></person-group><article-title>Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome</article-title><source>Eur J Pharm Sci</source><year>2022</year><volume>170</volume><fpage>106103</fpage><pub-id pub-id-type="doi">10.1016/j.ejps.2021.106103</pub-id><pub-id pub-id-type="pmid">34936936</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Pulingam T, Parumasivam T, Gazzali AM, Sulaiman AM, Chee JY, Lakshmanan M, et al. Antimicrobial resistance: prevalence, economic burden, mechanisms of resistance and strategies to overcome. Eur J Pharm Sci. 2022;170: 106103. 10.1016/j.ejps.2021.106103.<pub-id pub-id-type="pmid">34936936</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Sulaiman</surname><given-names>SK</given-names></name><name><surname>Musa</surname><given-names>MS</given-names></name><name><surname>Tsiga-Ahmed</surname><given-names>FI</given-names></name><name><surname>Dayyab</surname><given-names>FM</given-names></name><name><surname>Sulaiman</surname><given-names>AK</given-names></name><name><surname>Bako</surname><given-names>AT</given-names></name></person-group><article-title>A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs)</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><fpage>e0278224</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0278224</pub-id><pub-id pub-id-type="pmid">36455209</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Sulaiman SK, Musa MS, Tsiga-Ahmed FI, Dayyab FM, Sulaiman AK, Bako AT. A systematic review and meta-analysis of the prevalence of caregiver acceptance of malaria vaccine for under-five children in low-income and middle-income countries (LMICs). PLoS ONE. 2022;17: e0278224. 10.1371/journal.pone.0278224.<pub-id pub-id-type="pmid">36455209</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Tsakou</surname><given-names>F</given-names></name><name><surname>Jersie-Christensen</surname><given-names>R</given-names></name><name><surname>Jenssen</surname><given-names>H</given-names></name><name><surname>Mojsoska</surname><given-names>B</given-names></name></person-group><article-title>The role of proteomics in bacterial response to antibiotics</article-title><source>Pharmaceuticals (Basel)</source><year>2020</year><pub-id pub-id-type="doi">10.3390/ph13090214</pub-id><pub-id pub-id-type="pmid">32867221</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Tsakou F, Jersie-Christensen R, Jenssen H, Mojsoska B. The role of proteomics in bacterial response to antibiotics. Pharmaceuticals (Basel). 2020. 10.3390/ph13090214.<pub-id pub-id-type="pmid">32867221</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q-Y</given-names></name><name><surname>Yan</surname><given-names>Z-B</given-names></name><name><surname>Meng</surname><given-names>Y-M</given-names></name><name><surname>Hong</surname><given-names>X-Y</given-names></name><name><surname>Shao</surname><given-names>G</given-names></name><name><surname>Ma</surname><given-names>J-J</given-names></name><etal/></person-group><article-title>Antimicrobial peptides: mechanism of action, activity and clinical potential</article-title><source>Mil Med Res</source><year>2021</year><volume>8</volume><fpage>48</fpage><pub-id pub-id-type="doi">10.1186/s40779-021-00343-2</pub-id><pub-id pub-id-type="pmid">34496967</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Zhang Q-Y, Yan Z-B, Meng Y-M, Hong X-Y, Shao G, Ma J-J, et al. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021;8:48. 10.1186/s40779-021-00343-2.<pub-id pub-id-type="pmid">34496967</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Mohr</surname><given-names>KI</given-names></name><name><surname>Volz</surname><given-names>C</given-names></name><name><surname>Jansen</surname><given-names>R</given-names></name><name><surname>Wray</surname><given-names>V</given-names></name><name><surname>Hoffmann</surname><given-names>J</given-names></name><name><surname>Bernecker</surname><given-names>S</given-names></name><etal/></person-group><article-title>Pinensins: the first antifungal lantibiotics</article-title><source>Angew Chem Int Ed Engl</source><year>2015</year><volume>54</volume><fpage>11254</fpage><lpage>11258</lpage><pub-id pub-id-type="doi">10.1002/anie.201500927</pub-id><pub-id pub-id-type="pmid">26211520</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Mohr KI, Volz C, Jansen R, Wray V, Hoffmann J, Bernecker S, et al. Pinensins: the first antifungal lantibiotics. Angew Chem Int Ed Engl. 2015;54:11254&#x02013;8. 10.1002/anie.201500927.<pub-id pub-id-type="pmid">26211520</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Arnison</surname><given-names>PG</given-names></name><name><surname>Bibb</surname><given-names>MJ</given-names></name><name><surname>Bierbaum</surname><given-names>G</given-names></name><name><surname>Bowers</surname><given-names>AA</given-names></name><name><surname>Bugni</surname><given-names>TS</given-names></name><name><surname>Bulaj</surname><given-names>G</given-names></name><etal/></person-group><article-title>Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature</article-title><source>Nat Prod Rep</source><year>2013</year><volume>30</volume><fpage>108</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1039/c2np20085f</pub-id><pub-id pub-id-type="pmid">23165928</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, et al. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep. 2013;30:108&#x02013;60. 10.1039/c2np20085f.<pub-id pub-id-type="pmid">23165928</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Montalb&#x000e1;n-L&#x000f3;pez</surname><given-names>M</given-names></name><name><surname>Scott</surname><given-names>TA</given-names></name><name><surname>Ramesh</surname><given-names>S</given-names></name><name><surname>Rahman</surname><given-names>IR</given-names></name><name><surname>van Heel</surname><given-names>AJ</given-names></name><name><surname>Viel</surname><given-names>JH</given-names></name><etal/></person-group><article-title>New developments in RiPP discovery, enzymology and engineering</article-title><source>Nat Prod Rep</source><year>2021</year><volume>38</volume><fpage>130</fpage><lpage>239</lpage><pub-id pub-id-type="doi">10.1039/d0np00027b</pub-id><pub-id pub-id-type="pmid">32935693</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Montalb&#x000e1;n-L&#x000f3;pez M, Scott TA, Ramesh S, Rahman IR, van Heel AJ, Viel JH, et al. New developments in RiPP discovery, enzymology and engineering. Nat Prod Rep. 2021;38:130&#x02013;239. 10.1039/d0np00027b.<pub-id pub-id-type="pmid">32935693</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>S&#x000fc;ssmuth</surname><given-names>RD</given-names></name><name><surname>Mainz</surname><given-names>A</given-names></name></person-group><article-title>Nonribosomal peptide synthesis-principles and prospects</article-title><source>Angew Chem Int Ed Engl</source><year>2017</year><volume>56</volume><fpage>3770</fpage><lpage>3821</lpage><pub-id pub-id-type="doi">10.1002/anie.201609079</pub-id><pub-id pub-id-type="pmid">28323366</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">S&#x000fc;ssmuth RD, Mainz A. Nonribosomal peptide synthesis-principles and prospects. Angew Chem Int Ed Engl. 2017;56:3770&#x02013;821. 10.1002/anie.201609079.<pub-id pub-id-type="pmid">28323366</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Chevallereau</surname><given-names>A</given-names></name><name><surname>Pons</surname><given-names>BJ</given-names></name><name><surname>van Houte</surname><given-names>S</given-names></name><name><surname>Westra</surname><given-names>ER</given-names></name></person-group><article-title>Interactions between bacterial and phage communities in natural environments</article-title><source>Nat Rev Microbiol</source><year>2022</year><volume>20</volume><fpage>49</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1038/s41579-021-00602-y</pub-id><pub-id pub-id-type="pmid">34373631</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Chevallereau A, Pons BJ, van Houte S, Westra ER. Interactions between bacterial and phage communities in natural environments. Nat Rev Microbiol. 2022;20:49&#x02013;62. 10.1038/s41579-021-00602-y.<pub-id pub-id-type="pmid">34373631</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Cahill</surname><given-names>J</given-names></name><name><surname>Young</surname><given-names>R</given-names></name></person-group><article-title>Phage lysis: multiple genes for multiple barriers</article-title><source>Adv Virus Res</source><year>2019</year><volume>103</volume><fpage>33</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1016/bs.aivir.2018.09.003</pub-id><pub-id pub-id-type="pmid">30635077</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Cahill J, Young R. Phage lysis: multiple genes for multiple barriers. Adv Virus Res. 2019;103:33&#x02013;70. 10.1016/bs.aivir.2018.09.003.<pub-id pub-id-type="pmid">30635077</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Tkhilaishvili</surname><given-names>T</given-names></name><name><surname>Lombardi</surname><given-names>L</given-names></name><name><surname>Klatt</surname><given-names>A-B</given-names></name><name><surname>Trampuz</surname><given-names>A</given-names></name><name><surname>Di Luca</surname><given-names>M</given-names></name></person-group><article-title>Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus</article-title><source>Int J Antimicrob Agents</source><year>2018</year><volume>52</volume><fpage>842</fpage><lpage>853</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2018.09.006</pub-id><pub-id pub-id-type="pmid">30236955</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Tkhilaishvili T, Lombardi L, Klatt A-B, Trampuz A, Di Luca M. Bacteriophage Sb-1 enhances antibiotic activity against biofilm, degrades exopolysaccharide matrix and targets persisters of Staphylococcus aureus. Int J Antimicrob Agents. 2018;52:842&#x02013;53. 10.1016/j.ijantimicag.2018.09.006.<pub-id pub-id-type="pmid">30236955</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Clokie</surname><given-names>MR</given-names></name><name><surname>Millard</surname><given-names>AD</given-names></name><name><surname>Letarov</surname><given-names>AV</given-names></name><name><surname>Heaphy</surname><given-names>S</given-names></name></person-group><article-title>Phages in nature</article-title><source>Bacteriophage</source><year>2011</year><volume>1</volume><fpage>31</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.4161/bact.1.1.14942</pub-id><pub-id pub-id-type="pmid">21687533</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Clokie MR, Millard AD, Letarov AV, Heaphy S. Phages in nature. Bacteriophage. 2011;1:31&#x02013;45. 10.4161/bact.1.1.14942.<pub-id pub-id-type="pmid">21687533</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Hofstaedter</surname><given-names>CE</given-names></name><name><surname>Zhao</surname><given-names>C</given-names></name><name><surname>Mattei</surname><given-names>L</given-names></name><name><surname>Tanes</surname><given-names>C</given-names></name><name><surname>Clarke</surname><given-names>E</given-names></name><etal/></person-group><article-title>Optimizing methods and dodging pitfalls in microbiome research</article-title><source>Microbiome</source><year>2017</year><volume>5</volume><fpage>52</fpage><pub-id pub-id-type="doi">10.1186/s40168-017-0267-5</pub-id><pub-id pub-id-type="pmid">28476139</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Kim D, Hofstaedter CE, Zhao C, Mattei L, Tanes C, Clarke E, et al. Optimizing methods and dodging pitfalls in microbiome research. Microbiome. 2017;5:52. 10.1186/s40168-017-0267-5.<pub-id pub-id-type="pmid">28476139</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Mirzayi</surname><given-names>C</given-names></name><name><surname>Renson</surname><given-names>A</given-names></name><name><surname>Furlanello</surname><given-names>C</given-names></name><name><surname>Sansone</surname><given-names>S-A</given-names></name><name><surname>Zohra</surname><given-names>F</given-names></name><name><surname>Elsafoury</surname><given-names>S</given-names></name><etal/></person-group><article-title>Reporting guidelines for human microbiome research: the STORMS checklist</article-title><source>Nat Med</source><year>2021</year><volume>27</volume><fpage>1885</fpage><lpage>1892</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01552-x</pub-id><pub-id pub-id-type="pmid">34789871</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Mirzayi C, Renson A, Furlanello C, Sansone S-A, Zohra F, Elsafoury S, et al. Reporting guidelines for human microbiome research: the STORMS checklist. Nat Med. 2021;27:1885&#x02013;92. 10.1038/s41591-021-01552-x.<pub-id pub-id-type="pmid">34789871</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Roume</surname><given-names>H</given-names></name><name><surname>Heintz-Buschart</surname><given-names>A</given-names></name><name><surname>Muller</surname><given-names>EEL</given-names></name><name><surname>Wilmes</surname><given-names>P</given-names></name></person-group><article-title>Sequential isolation of metabolites, RNA, DNA, and proteins from the same unique sample</article-title><source>Methods Enzymol</source><year>2013</year><volume>531</volume><fpage>219</fpage><lpage>236</lpage><pub-id pub-id-type="doi">10.1016/B978-0-12-407863-5.00011-3</pub-id><pub-id pub-id-type="pmid">24060123</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Roume H, Heintz-Buschart A, Muller EEL, Wilmes P. Sequential isolation of metabolites, RNA, DNA, and proteins from the same unique sample. Methods Enzymol. 2013;531:219&#x02013;36. 10.1016/B978-0-12-407863-5.00011-3.<pub-id pub-id-type="pmid">24060123</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Deusch</surname><given-names>S</given-names></name><name><surname>Seifert</surname><given-names>J</given-names></name></person-group><article-title>Catching the tip of the iceberg - evaluation of sample preparation protocols for metaproteomic studies of the rumen microbiota</article-title><source>Proteomics</source><year>2015</year><volume>15</volume><fpage>3590</fpage><lpage>3595</lpage><pub-id pub-id-type="doi">10.1002/pmic.201400556</pub-id><pub-id pub-id-type="pmid">25765363</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Deusch S, Seifert J. Catching the tip of the iceberg - evaluation of sample preparation protocols for metaproteomic studies of the rumen microbiota. Proteomics. 2015;15:3590&#x02013;5. 10.1002/pmic.201400556.<pub-id pub-id-type="pmid">25765363</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Kohrs</surname><given-names>F</given-names></name><name><surname>Reichl</surname><given-names>U</given-names></name><name><surname>Benndorf</surname><given-names>D</given-names></name></person-group><article-title>Metaproteomics of complex microbial communities in biogas plants</article-title><source>Microb Biotechnol</source><year>2015</year><volume>8</volume><fpage>749</fpage><lpage>763</lpage><pub-id pub-id-type="doi">10.1111/1751-7915.12276</pub-id><pub-id pub-id-type="pmid">25874383</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Heyer R, Kohrs F, Reichl U, Benndorf D. Metaproteomics of complex microbial communities in biogas plants. Microb Biotechnol. 2015;8:749&#x02013;63. 10.1111/1751-7915.12276.<pub-id pub-id-type="pmid">25874383</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Keiblinger</surname><given-names>KM</given-names></name><name><surname>Fuchs</surname><given-names>S</given-names></name><name><surname>Zechmeister-Boltenstern</surname><given-names>S</given-names></name><name><surname>Riedel</surname><given-names>K</given-names></name></person-group><article-title>Soil and leaf litter metaproteomics-a brief guideline from sampling to understanding</article-title><source>FEMS Microbiol Ecol</source><year>2016</year><pub-id pub-id-type="doi">10.1093/femsec/fiw180</pub-id><pub-id pub-id-type="pmid">27549116</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Keiblinger KM, Fuchs S, Zechmeister-Boltenstern S, Riedel K. Soil and leaf litter metaproteomics-a brief guideline from sampling to understanding. FEMS Microbiol Ecol. 2016. 10.1093/femsec/fiw180.<pub-id pub-id-type="pmid">27549116</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Kleikamp</surname><given-names>HBC</given-names></name><name><surname>Grouzdev</surname><given-names>D</given-names></name><name><surname>Schaasberg</surname><given-names>P</given-names></name><name><surname>van Valderen</surname><given-names>R</given-names></name><name><surname>van der Zwaan</surname><given-names>R</given-names></name><name><surname>van Wijgaart</surname><given-names>R</given-names></name><name><surname>de, </surname></name><etal/></person-group><article-title>Metaproteomics, metagenomics and 16S rRNA sequencing provide different perspectives on the aerobic granular sludge microbiome</article-title><source>Water Res</source><year>2023</year><volume>246</volume><fpage>120700</fpage><pub-id pub-id-type="doi">10.1016/j.watres.2023.120700</pub-id><pub-id pub-id-type="pmid">37866247</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Kleikamp HBC, Grouzdev D, Schaasberg P, van Valderen R, van der Zwaan R, van Wijgaart R, de, et al. Metaproteomics, metagenomics and 16S rRNA sequencing provide different perspectives on the aerobic granular sludge microbiome. Water Res. 2023;246: 120700. 10.1016/j.watres.2023.120700.<pub-id pub-id-type="pmid">37866247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Kunath</surname><given-names>BJ</given-names></name><name><surname>Minniti</surname><given-names>G</given-names></name><name><surname>Skaugen</surname><given-names>M</given-names></name><name><surname>Hagen</surname><given-names>LH</given-names></name><name><surname>Vaaje-Kolstad</surname><given-names>G</given-names></name><name><surname>Eijsink</surname><given-names>VGH</given-names></name><etal/></person-group><article-title>Metaproteomics: sample preparation and methodological considerations</article-title><source>Adv Exp Med Biol</source><year>2019</year><volume>1073</volume><fpage>187</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1007/978-3-030-12298-0_8</pub-id><pub-id pub-id-type="pmid">31236844</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Kunath BJ, Minniti G, Skaugen M, Hagen LH, Vaaje-Kolstad G, Eijsink VGH, et al. Metaproteomics: sample preparation and methodological considerations. Adv Exp Med Biol. 2019;1073:187&#x02013;215. 10.1007/978-3-030-12298-0_8.<pub-id pub-id-type="pmid">31236844</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Speda</surname><given-names>J</given-names></name><name><surname>Johansson</surname><given-names>MA</given-names></name><name><surname>Carlsson</surname><given-names>U</given-names></name><name><surname>Karlsson</surname><given-names>M</given-names></name></person-group><article-title>Assessment of sample preparation methods for metaproteomics of extracellular proteins</article-title><source>Anal Biochem</source><year>2017</year><volume>516</volume><fpage>23</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2016.10.008</pub-id><pub-id pub-id-type="pmid">27742212</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Speda J, Johansson MA, Carlsson U, Karlsson M. Assessment of sample preparation methods for metaproteomics of extracellular proteins. Anal Biochem. 2017;516:23&#x02013;36. 10.1016/j.ab.2016.10.008.<pub-id pub-id-type="pmid">27742212</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Mayne</surname><given-names>J</given-names></name><name><surname>Ning</surname><given-names>Z</given-names></name><name><surname>Stintzi</surname><given-names>A</given-names></name><name><surname>Figeys</surname><given-names>D</given-names></name></person-group><article-title>Assessing the impact of protein extraction methods for human gut metaproteomics</article-title><source>J Proteomics</source><year>2018</year><volume>180</volume><fpage>120</fpage><lpage>127</lpage><pub-id pub-id-type="doi">10.1016/j.jprot.2017.07.001</pub-id><pub-id pub-id-type="pmid">28705725</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Zhang X, Li L, Mayne J, Ning Z, Stintzi A, Figeys D. Assessing the impact of protein extraction methods for human gut metaproteomics. J Proteomics. 2018;180:120&#x02013;7. 10.1016/j.jprot.2017.07.001.<pub-id pub-id-type="pmid">28705725</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Kohrs</surname><given-names>F</given-names></name><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Magnussen</surname><given-names>A</given-names></name><name><surname>Benndorf</surname><given-names>D</given-names></name><name><surname>Muth</surname><given-names>T</given-names></name><name><surname>Behne</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sample prefractionation with liquid isoelectric focusing enables in depth microbial metaproteome analysis of mesophilic and thermophilic biogas plants</article-title><source>Anaerobe</source><year>2014</year><volume>29</volume><fpage>59</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.anaerobe.2013.11.009</pub-id><pub-id pub-id-type="pmid">24309213</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Kohrs F, Heyer R, Magnussen A, Benndorf D, Muth T, Behne A, et al. Sample prefractionation with liquid isoelectric focusing enables in depth microbial metaproteome analysis of mesophilic and thermophilic biogas plants. Anaerobe. 2014;29:59&#x02013;67. 10.1016/j.anaerobe.2013.11.009.<pub-id pub-id-type="pmid">24309213</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name><surname>Bumpus</surname><given-names>SB</given-names></name><name><surname>Evans</surname><given-names>BS</given-names></name><name><surname>Thomas</surname><given-names>PM</given-names></name><name><surname>Ntai</surname><given-names>I</given-names></name><name><surname>Kelleher</surname><given-names>NL</given-names></name></person-group><article-title>A proteomics approach to discovering natural products and their biosynthetic pathways</article-title><source>Nat Biotechnol</source><year>2009</year><volume>27</volume><fpage>951</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1038/nbt.1565</pub-id><pub-id pub-id-type="pmid">19767731</pub-id>
</element-citation><mixed-citation id="mc-CR93" publication-type="journal">Bumpus SB, Evans BS, Thomas PM, Ntai I, Kelleher NL. A proteomics approach to discovering natural products and their biosynthetic pathways. Nat Biotechnol. 2009;27:951&#x02013;6. 10.1038/nbt.1565.<pub-id pub-id-type="pmid">19767731</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Ntai</surname><given-names>I</given-names></name><name><surname>Ju</surname><given-names>K-S</given-names></name><name><surname>Unger</surname><given-names>M</given-names></name><name><surname>Zamdborg</surname><given-names>L</given-names></name><name><surname>Robinson</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>A proteomic survey of nonribosomal peptide and polyketide biosynthesis in actinobacteria</article-title><source>J Proteome Res</source><year>2012</year><volume>11</volume><fpage>85</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1021/pr2009115</pub-id><pub-id pub-id-type="pmid">21978092</pub-id>
</element-citation><mixed-citation id="mc-CR94" publication-type="journal">Chen Y, Ntai I, Ju K-S, Unger M, Zamdborg L, Robinson SJ, et al. A proteomic survey of nonribosomal peptide and polyketide biosynthesis in actinobacteria. J Proteome Res. 2012;11:85&#x02013;94. 10.1021/pr2009115.<pub-id pub-id-type="pmid">21978092</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name><surname>Meier</surname><given-names>JL</given-names></name><name><surname>Burkart</surname><given-names>MD</given-names></name></person-group><article-title>Proteomic analysis of polyketide and nonribosomal peptide biosynthesis</article-title><source>Curr Opin Chem Biol</source><year>2011</year><volume>15</volume><fpage>48</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.cbpa.2010.10.021</pub-id><pub-id pub-id-type="pmid">21087894</pub-id>
</element-citation><mixed-citation id="mc-CR95" publication-type="journal">Meier JL, Burkart MD. Proteomic analysis of polyketide and nonribosomal peptide biosynthesis. Curr Opin Chem Biol. 2011;15:48&#x02013;56. 10.1016/j.cbpa.2010.10.021.<pub-id pub-id-type="pmid">21087894</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><citation-alternatives><element-citation id="ec-CR96" publication-type="journal"><person-group person-group-type="author"><name><surname>Dumas</surname><given-names>T</given-names></name><name><surname>Martinez Pinna</surname><given-names>R</given-names></name><name><surname>Lozano</surname><given-names>C</given-names></name><name><surname>Radau</surname><given-names>S</given-names></name><name><surname>Pible</surname><given-names>O</given-names></name><name><surname>Grenga</surname><given-names>L</given-names></name><name><surname>Armengaud</surname><given-names>J</given-names></name></person-group><article-title>The astounding exhaustiveness and speed of the Astral mass analyzer for highly complex samples is a quantum leap in the functional analysis of microbiomes</article-title><source>Microbiome</source><year>2024</year><volume>12</volume><fpage>46</fpage><pub-id pub-id-type="doi">10.1186/s40168-024-01766-4</pub-id><pub-id pub-id-type="pmid">38454512</pub-id>
</element-citation><mixed-citation id="mc-CR96" publication-type="journal">Dumas T, Martinez Pinna R, Lozano C, Radau S, Pible O, Grenga L, Armengaud J. The astounding exhaustiveness and speed of the Astral mass analyzer for highly complex samples is a quantum leap in the functional analysis of microbiomes. Microbiome. 2024;12:46. 10.1186/s40168-024-01766-4.<pub-id pub-id-type="pmid">38454512</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR97"><label>97.</label><citation-alternatives><element-citation id="ec-CR97" publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000f3;mez-Varela</surname><given-names>D</given-names></name><name><surname>Xian</surname><given-names>F</given-names></name><name><surname>Grundtner</surname><given-names>S</given-names></name><name><surname>Sondermann</surname><given-names>JR</given-names></name><name><surname>Carta</surname><given-names>G</given-names></name><name><surname>Schmidt</surname><given-names>M</given-names></name></person-group><article-title>Increasing taxonomic and functional characterization of host-microbiome interactions by DIA-PASEF metaproteomics</article-title><source>Front Microbiol</source><year>2023</year><volume>14</volume><fpage>1258703</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2023.1258703</pub-id><pub-id pub-id-type="pmid">37908546</pub-id>
</element-citation><mixed-citation id="mc-CR97" publication-type="journal">G&#x000f3;mez-Varela D, Xian F, Grundtner S, Sondermann JR, Carta G, Schmidt M. Increasing taxonomic and functional characterization of host-microbiome interactions by DIA-PASEF metaproteomics. Front Microbiol. 2023;14: 1258703. 10.3389/fmicb.2023.1258703.<pub-id pub-id-type="pmid">37908546</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR98"><label>98.</label><mixed-citation publication-type="other">Onigbinde S, Gutierrez Reyes CD, Sandilya V, Chukwubueze F, Oluokun O, Sahioun S, et al. Optimization of glycopeptide enrichment techniques for the identification of clinical biomarkers. Expert Rev Proteomics. 2024:1&#x02013;32. 10.1080/14789450/2024.2418491.</mixed-citation></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name><surname>Armengaud</surname><given-names>J</given-names></name></person-group><article-title>Metaproteomics to understand how microbiota function: the crystal ball predicts a promising future</article-title><source>Environ Microbiol</source><year>2023</year><volume>25</volume><fpage>115</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.16238</pub-id><pub-id pub-id-type="pmid">36209500</pub-id>
</element-citation><mixed-citation id="mc-CR99" publication-type="journal">Armengaud J. Metaproteomics to understand how microbiota function: the crystal ball predicts a promising future. Environ Microbiol. 2023;25:115&#x02013;25. 10.1111/1462-2920.16238.<pub-id pub-id-type="pmid">36209500</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name><surname>von Bergen</surname><given-names>M</given-names></name><name><surname>Jehmlich</surname><given-names>N</given-names></name><name><surname>Taubert</surname><given-names>M</given-names></name><name><surname>Vogt</surname><given-names>C</given-names></name><name><surname>Bastida</surname><given-names>F</given-names></name><name><surname>Herbst</surname><given-names>F-A</given-names></name><etal/></person-group><article-title>Insights from quantitative metaproteomics and protein-stable isotope probing into microbial ecology</article-title><source>ISME J</source><year>2013</year><volume>7</volume><fpage>1877</fpage><lpage>1885</lpage><pub-id pub-id-type="doi">10.1038/ismej.2013.78</pub-id><pub-id pub-id-type="pmid">23677009</pub-id>
</element-citation><mixed-citation id="mc-CR100" publication-type="journal">von Bergen M, Jehmlich N, Taubert M, Vogt C, Bastida F, Herbst F-A, et al. Insights from quantitative metaproteomics and protein-stable isotope probing into microbial ecology. ISME J. 2013;7:1877&#x02013;85. 10.1038/ismej.2013.78.<pub-id pub-id-type="pmid">23677009</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><citation-alternatives><element-citation id="ec-CR101" publication-type="journal"><person-group person-group-type="author"><name><surname>Kleiner</surname><given-names>M</given-names></name><name><surname>Kouris</surname><given-names>A</given-names></name><name><surname>Violette</surname><given-names>M</given-names></name><name><surname>D'Angelo</surname><given-names>G</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Korenek</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ultra-sensitive isotope probing to quantify activity and substrate assimilation in microbiomes</article-title><source>Microbiome</source><year>2023</year><volume>11</volume><fpage>24</fpage><pub-id pub-id-type="doi">10.1186/s40168-022-01454-1</pub-id><pub-id pub-id-type="pmid">36755313</pub-id>
</element-citation><mixed-citation id="mc-CR101" publication-type="journal">Kleiner M, Kouris A, Violette M, D&#x02019;Angelo G, Liu Y, Korenek A, et al. Ultra-sensitive isotope probing to quantify activity and substrate assimilation in microbiomes. Microbiome. 2023;11:24. 10.1186/s40168-022-01454-1.<pub-id pub-id-type="pmid">36755313</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name><surname>Starke</surname><given-names>R</given-names></name><name><surname>Oliphant</surname><given-names>K</given-names></name><name><surname>Jehmlich</surname><given-names>N</given-names></name><name><surname>Sch&#x000e4;pe</surname><given-names>SS</given-names></name><name><surname>Sachsenberg</surname><given-names>T</given-names></name><name><surname>Kohlbacher</surname><given-names>O</given-names></name><etal/></person-group><article-title>Tracing incorporation of heavy water into proteins for species-specific metabolic activity in complex communities</article-title><source>J Proteomics</source><year>2020</year><volume>222</volume><fpage>103791</fpage><pub-id pub-id-type="doi">10.1016/j.jprot.2020.103791</pub-id><pub-id pub-id-type="pmid">32335296</pub-id>
</element-citation><mixed-citation id="mc-CR102" publication-type="journal">Starke R, Oliphant K, Jehmlich N, Sch&#x000e4;pe SS, Sachsenberg T, Kohlbacher O, et al. Tracing incorporation of heavy water into proteins for species-specific metabolic activity in complex communities. J Proteomics. 2020;222: 103791. 10.1016/j.jprot.2020.103791.<pub-id pub-id-type="pmid">32335296</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name><surname>van Kasteren</surname><given-names>S</given-names></name><name><surname>Rozen</surname><given-names>DE</given-names></name></person-group><article-title>Using click chemistry to study microbial ecology and evolution</article-title><source>ISME Commun</source><year>2023</year><volume>3</volume><fpage>9</fpage><pub-id pub-id-type="doi">10.1038/s43705-022-00205-5</pub-id><pub-id pub-id-type="pmid">36721064</pub-id>
</element-citation><mixed-citation id="mc-CR103" publication-type="journal">van Kasteren S, Rozen DE. Using click chemistry to study microbial ecology and evolution. ISME Commun. 2023;3:9. 10.1038/s43705-022-00205-5.<pub-id pub-id-type="pmid">36721064</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name><surname>Schaible</surname><given-names>GA</given-names></name><name><surname>Jay</surname><given-names>ZJ</given-names></name><name><surname>Cliff</surname><given-names>J</given-names></name><name><surname>Schulz</surname><given-names>F</given-names></name><name><surname>Gauvin</surname><given-names>C</given-names></name><name><surname>Goudeau</surname><given-names>D</given-names></name><etal/></person-group><article-title>Multicellular magnetotactic bacteria are genetically heterogeneous consortia with metabolically differentiated cells</article-title><source>PLoS Biol</source><year>2024</year><volume>22</volume><fpage>e3002638</fpage><pub-id pub-id-type="doi">10.1371/journal.pbio.3002638</pub-id><pub-id pub-id-type="pmid">38990824</pub-id>
</element-citation><mixed-citation id="mc-CR104" publication-type="journal">Schaible GA, Jay ZJ, Cliff J, Schulz F, Gauvin C, Goudeau D, et al. Multicellular magnetotactic bacteria are genetically heterogeneous consortia with metabolically differentiated cells. PLoS Biol. 2024;22: e3002638. 10.1371/journal.pbio.3002638.<pub-id pub-id-type="pmid">38990824</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name><surname>Hellwig</surname><given-names>P</given-names></name><name><surname>Dittrich</surname><given-names>A</given-names></name><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Reichl</surname><given-names>U</given-names></name><name><surname>Benndorf</surname><given-names>D</given-names></name></person-group><article-title>Detection, isolation and characterization of phage-host complexes using BONCAT and click chemistry</article-title><source>Front Microbiol</source><year>2024</year><volume>15</volume><fpage>1434301</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2024.1434301</pub-id><pub-id pub-id-type="pmid">39296306</pub-id>
</element-citation><mixed-citation id="mc-CR105" publication-type="journal">Hellwig P, Dittrich A, Heyer R, Reichl U, Benndorf D. Detection, isolation and characterization of phage-host complexes using BONCAT and click chemistry. Front Microbiol. 2024;15: 1434301. 10.3389/fmicb.2024.1434301.<pub-id pub-id-type="pmid">39296306</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name><surname>Hellwig</surname><given-names>P</given-names></name><name><surname>Kautzner</surname><given-names>D</given-names></name><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Dittrich</surname><given-names>A</given-names></name><name><surname>Wibberg</surname><given-names>D</given-names></name><name><surname>Busche</surname><given-names>T</given-names></name><etal/></person-group><article-title>Tracing active members in microbial communities by BONCAT and click chemistry-based enrichment of newly synthesized proteins</article-title><source>ISME Commun.</source><year>2024</year><volume>4</volume><fpage>ycae153</fpage><pub-id pub-id-type="doi">10.1093/ismeco/ycae153</pub-id><pub-id pub-id-type="pmid">39736848</pub-id>
</element-citation><mixed-citation id="mc-CR106" publication-type="journal">Hellwig P, Kautzner D, Heyer R, Dittrich A, Wibberg D, Busche T, et al. Tracing active members in microbial communities by BONCAT and click chemistry-based enrichment of newly synthesized proteins. ISME Commun. 2024;4:ycae153. 10.1093/ismeco/ycae153.<pub-id pub-id-type="pmid">39736848</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderlin</surname><given-names>AG</given-names></name><name><surname>Kurka Margolis</surname><given-names>H</given-names></name><name><surname>Meyer</surname><given-names>AF</given-names></name><name><surname>Lamason</surname><given-names>RL</given-names></name></person-group><article-title>Cell-selective proteomics reveal novel effectors secreted by an obligate intracellular bacterial pathogen</article-title><source>Nat Commun</source><year>2024</year><volume>15</volume><fpage>6073</fpage><pub-id pub-id-type="doi">10.1038/s41467-024-50493-9</pub-id><pub-id pub-id-type="pmid">39025857</pub-id>
</element-citation><mixed-citation id="mc-CR107" publication-type="journal">Sanderlin AG, Kurka Margolis H, Meyer AF, Lamason RL. Cell-selective proteomics reveal novel effectors secreted by an obligate intracellular bacterial pathogen. Nat Commun. 2024;15:6073. 10.1038/s41467-024-50493-9.<pub-id pub-id-type="pmid">39025857</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name><surname>Schiebenhoefer</surname><given-names>H</given-names></name><name><surname>Schallert</surname><given-names>K</given-names></name><name><surname>Renard</surname><given-names>BY</given-names></name><name><surname>Trappe</surname><given-names>K</given-names></name><name><surname>Schmid</surname><given-names>E</given-names></name><name><surname>Benndorf</surname><given-names>D</given-names></name><etal/></person-group><article-title>A complete and flexible workflow for metaproteomics data analysis based on MetaProteomeAnalyzer and Prophane</article-title><source>Nat Protoc</source><year>2020</year><volume>15</volume><fpage>3212</fpage><lpage>3239</lpage><pub-id pub-id-type="doi">10.1038/s41596-020-0368-7</pub-id><pub-id pub-id-type="pmid">32859984</pub-id>
</element-citation><mixed-citation id="mc-CR108" publication-type="journal">Schiebenhoefer H, Schallert K, Renard BY, Trappe K, Schmid E, Benndorf D, et al. A complete and flexible workflow for metaproteomics data analysis based on MetaProteomeAnalyzer and Prophane. Nat Protoc. 2020;15:3212&#x02013;39. 10.1038/s41596-020-0368-7.<pub-id pub-id-type="pmid">32859984</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Schallert</surname><given-names>K</given-names></name><name><surname>Zoun</surname><given-names>R</given-names></name><name><surname>Becher</surname><given-names>B</given-names></name><name><surname>Saake</surname><given-names>G</given-names></name><name><surname>Benndorf</surname><given-names>D</given-names></name></person-group><article-title>Challenges and perspectives of metaproteomic data analysis</article-title><source>J Biotechnol</source><year>2017</year><volume>261</volume><fpage>24</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/j.jbiotec.2017.06.1201</pub-id><pub-id pub-id-type="pmid">28663049</pub-id>
</element-citation><mixed-citation id="mc-CR109" publication-type="journal">Heyer R, Schallert K, Zoun R, Becher B, Saake G, Benndorf D. Challenges and perspectives of metaproteomic data analysis. J Biotechnol. 2017;261:24&#x02013;36. 10.1016/j.jbiotec.2017.06.1201.<pub-id pub-id-type="pmid">28663049</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="other">Vande Moortele T, Devlaminck B, van de Vyver S, van den Bossche T, Martens L, Dawyndt P, et al. Unipept 6.0: Expanding metaproteomics analysis with support for missed cleavages, Semi-Tryptic and Non-Tryptic Peptides; 2024.</mixed-citation></ref><ref id="CR111"><label>111.</label><citation-alternatives><element-citation id="ec-CR111" publication-type="journal"><person-group person-group-type="author"><name><surname>Muth</surname><given-names>T</given-names></name><name><surname>Behne</surname><given-names>A</given-names></name><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Kohrs</surname><given-names>F</given-names></name><name><surname>Benndorf</surname><given-names>D</given-names></name><name><surname>Hoffmann</surname><given-names>M</given-names></name><etal/></person-group><article-title>The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation</article-title><source>J Proteome Res</source><year>2015</year><volume>14</volume><fpage>1557</fpage><lpage>1565</lpage><pub-id pub-id-type="doi">10.1021/pr501246w</pub-id><pub-id pub-id-type="pmid">25660940</pub-id>
</element-citation><mixed-citation id="mc-CR111" publication-type="journal">Muth T, Behne A, Heyer R, Kohrs F, Benndorf D, Hoffmann M, et al. The MetaProteomeAnalyzer: a powerful open-source software suite for metaproteomics data analysis and interpretation. J Proteome Res. 2015;14:1557&#x02013;65. 10.1021/pr501246w.<pub-id pub-id-type="pmid">25660940</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>K</given-names></name><name><surname>Ning</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Liao</surname><given-names>B</given-names></name><name><surname>Mayne</surname><given-names>J</given-names></name><name><surname>Figeys</surname><given-names>D</given-names></name></person-group><article-title>MetaLab 2.0 enables accurate post-translational modifications profiling in metaproteomics</article-title><source>J Am Soc Mass Spectrom.</source><year>2020</year><volume>31</volume><fpage>1473</fpage><lpage>1482</lpage><pub-id pub-id-type="doi">10.1021/jasms.0c00083</pub-id><pub-id pub-id-type="pmid">32396346</pub-id>
</element-citation><mixed-citation id="mc-CR112" publication-type="journal">Cheng K, Ning Z, Zhang X, Li L, Liao B, Mayne J, Figeys D. MetaLab 2.0 enables accurate post-translational modifications profiling in metaproteomics. J Am Soc Mass Spectrom. 2020;31:1473&#x02013;82. 10.1021/jasms.0c00083.<pub-id pub-id-type="pmid">32396346</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name><surname>Medema</surname><given-names>MH</given-names></name><name><surname>Blin</surname><given-names>K</given-names></name><name><surname>Cimermancic</surname><given-names>P</given-names></name><name><surname>de Jager</surname><given-names>V</given-names></name><name><surname>Zakrzewski</surname><given-names>P</given-names></name><name><surname>Fischbach</surname><given-names>MA</given-names></name><etal/></person-group><article-title>antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences</article-title><source>Nucleic Acids Res</source><year>2011</year><volume>39</volume><fpage>W339</fpage><lpage>W346</lpage><pub-id pub-id-type="doi">10.1093/nar/gkr466</pub-id><pub-id pub-id-type="pmid">21672958</pub-id>
</element-citation><mixed-citation id="mc-CR113" publication-type="journal">Medema MH, Blin K, Cimermancic P, de Jager V, Zakrzewski P, Fischbach MA, et al. antiSMASH: rapid identification, annotation and analysis of secondary metabolite biosynthesis gene clusters in bacterial and fungal genome sequences. Nucleic Acids Res. 2011;39:W339&#x02013;46. 10.1093/nar/gkr466.<pub-id pub-id-type="pmid">21672958</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name><surname>Nesvizhskii</surname><given-names>AI</given-names></name></person-group><article-title>Proteogenomics: concepts, applications and computational strategies</article-title><source>Nat Methods</source><year>2014</year><volume>11</volume><fpage>1114</fpage><lpage>1125</lpage><pub-id pub-id-type="doi">10.1038/nmeth.3144</pub-id><pub-id pub-id-type="pmid">25357241</pub-id>
</element-citation><mixed-citation id="mc-CR114" publication-type="journal">Nesvizhskii AI. Proteogenomics: concepts, applications and computational strategies. Nat Methods. 2014;11:1114&#x02013;25. 10.1038/nmeth.3144.<pub-id pub-id-type="pmid">25357241</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="other">van den Bossche T, Beslic D, van Puyenbroeck S, Suomi T, Holstein T, Martens L, et al. Metaproteomics beyond databases: addressing the challenges and potentials of de novo sequencing. Proteomics. 2025:e202400321. 10.1002/pmic.202400321.</mixed-citation></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name><surname>Bouwmeester</surname><given-names>R</given-names></name><name><surname>Gabriels</surname><given-names>R</given-names></name><name><surname>van den Bossche</surname><given-names>T</given-names></name><name><surname>Martens</surname><given-names>L</given-names></name><name><surname>Degroeve</surname><given-names>S</given-names></name></person-group><article-title>The age of data-driven proteomics: how machine learning enables novel workflows</article-title><source>Proteomics</source><year>2020</year><volume>20</volume><fpage>e1900351</fpage><pub-id pub-id-type="doi">10.1002/pmic.201900351</pub-id><pub-id pub-id-type="pmid">32267083</pub-id>
</element-citation><mixed-citation id="mc-CR116" publication-type="journal">Bouwmeester R, Gabriels R, van den Bossche T, Martens L, Degroeve S. The age of data-driven proteomics: how machine learning enables novel workflows. Proteomics. 2020;20: e1900351. 10.1002/pmic.201900351.<pub-id pub-id-type="pmid">32267083</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><citation-alternatives><element-citation id="ec-CR117" publication-type="journal"><person-group person-group-type="author"><name><surname>Lange</surname><given-names>E</given-names></name><name><surname>Kranert</surname><given-names>L</given-names></name><name><surname>Kr&#x000fc;ger</surname><given-names>J</given-names></name><name><surname>Benndorf</surname><given-names>D</given-names></name><name><surname>Heyer</surname><given-names>R</given-names></name></person-group><article-title>Microbiome modeling: a beginner's guide</article-title><source>Front Microbiol</source><year>2024</year><volume>15</volume><fpage>1368377</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2024.1368377</pub-id><pub-id pub-id-type="pmid">38962127</pub-id>
</element-citation><mixed-citation id="mc-CR117" publication-type="journal">Lange E, Kranert L, Kr&#x000fc;ger J, Benndorf D, Heyer R. Microbiome modeling: a beginner&#x02019;s guide. Front Microbiol. 2024;15: 1368377. 10.3389/fmicb.2024.1368377.<pub-id pub-id-type="pmid">38962127</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR118"><label>118.</label><citation-alternatives><element-citation id="ec-CR118" publication-type="journal"><person-group person-group-type="author"><name><surname>Priyadarsini</surname><given-names>M</given-names></name><name><surname>Kushwaha</surname><given-names>J</given-names></name><name><surname>Pandey</surname><given-names>KP</given-names></name><name><surname>Rani</surname><given-names>J</given-names></name><name><surname>Dhoble</surname><given-names>AS</given-names></name></person-group><article-title>Application of flow cytometry for rapid, high-throughput, multiparametric analysis of environmental microbiomes</article-title><source>J Microbiol Methods</source><year>2023</year><volume>214</volume><fpage>106841</fpage><pub-id pub-id-type="doi">10.1016/j.mimet.2023.106841</pub-id><pub-id pub-id-type="pmid">37832922</pub-id>
</element-citation><mixed-citation id="mc-CR118" publication-type="journal">Priyadarsini M, Kushwaha J, Pandey KP, Rani J, Dhoble AS. Application of flow cytometry for rapid, high-throughput, multiparametric analysis of environmental microbiomes. J Microbiol Methods. 2023;214: 106841. 10.1016/j.mimet.2023.106841.<pub-id pub-id-type="pmid">37832922</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR119"><label>119.</label><citation-alternatives><element-citation id="ec-CR119" publication-type="journal"><person-group person-group-type="author"><name><surname>Midani</surname><given-names>FS</given-names></name><name><surname>David</surname><given-names>LA</given-names></name></person-group><article-title>Tracking defined microbial communities by multicolor flow cytometry reveals tradeoffs between productivity and diversity</article-title><source>Front Microbiol</source><year>2022</year><volume>13</volume><fpage>910390</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2022.910390</pub-id><pub-id pub-id-type="pmid">36687598</pub-id>
</element-citation><mixed-citation id="mc-CR119" publication-type="journal">Midani FS, David LA. Tracking defined microbial communities by multicolor flow cytometry reveals tradeoffs between productivity and diversity. Front Microbiol. 2022;13: 910390. 10.3389/fmicb.2022.910390.<pub-id pub-id-type="pmid">36687598</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR120"><label>120.</label><citation-alternatives><element-citation id="ec-CR120" publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>BG</given-names></name><name><surname>Raskind</surname><given-names>A</given-names></name><name><surname>Hissong</surname><given-names>R</given-names></name><name><surname>Dougherty</surname><given-names>MK</given-names></name><name><surname>McGill</surname><given-names>SK</given-names></name><name><surname>Gulati</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Offline two-dimensional liquid chromatography-mass spectrometry for deep annotation of the fecal metabolome following fecal microbiota transplantation</article-title><source>J Proteome Res</source><year>2024</year><volume>23</volume><fpage>2000</fpage><lpage>2012</lpage><pub-id pub-id-type="doi">10.1021/acs.jproteome.4c00022</pub-id><pub-id pub-id-type="pmid">38752739</pub-id>
</element-citation><mixed-citation id="mc-CR120" publication-type="journal">Anderson BG, Raskind A, Hissong R, Dougherty MK, McGill SK, Gulati AS, et al. Offline two-dimensional liquid chromatography-mass spectrometry for deep annotation of the fecal metabolome following fecal microbiota transplantation. J Proteome Res. 2024;23:2000&#x02013;12. 10.1021/acs.jproteome.4c00022.<pub-id pub-id-type="pmid">38752739</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR121"><label>121.</label><citation-alternatives><element-citation id="ec-CR121" publication-type="journal"><person-group person-group-type="author"><name><surname>Phillips</surname><given-names>M</given-names></name><name><surname>Cataneo</surname><given-names>RN</given-names></name><name><surname>Chaturvedi</surname><given-names>A</given-names></name><name><surname>Kaplan</surname><given-names>PD</given-names></name><name><surname>Libardoni</surname><given-names>M</given-names></name><name><surname>Mundada</surname><given-names>M</given-names></name><etal/></person-group><article-title>Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry</article-title><source>PLoS ONE</source><year>2013</year><volume>8</volume><fpage>e75274</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0075274</pub-id><pub-id pub-id-type="pmid">24086492</pub-id>
</element-citation><mixed-citation id="mc-CR121" publication-type="journal">Phillips M, Cataneo RN, Chaturvedi A, Kaplan PD, Libardoni M, Mundada M, et al. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry. PLoS ONE. 2013;8: e75274. 10.1371/journal.pone.0075274.<pub-id pub-id-type="pmid">24086492</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR122"><label>122.</label><mixed-citation publication-type="other">UniProt: the Universal Protein Knowledgebase in 2023. Nucleic Acids Res. 2023;51:D523-D531. 10.1093/nar/gkac1052.</mixed-citation></ref><ref id="CR123"><label>123.</label><citation-alternatives><element-citation id="ec-CR123" publication-type="journal"><person-group person-group-type="author"><name><surname>Kanehisa</surname><given-names>M</given-names></name><name><surname>Furumichi</surname><given-names>M</given-names></name><name><surname>Sato</surname><given-names>Y</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><name><surname>Ishiguro-Watanabe</surname><given-names>M</given-names></name></person-group><article-title>KEGG for taxonomy-based analysis of pathways and genomes</article-title><source>Nucleic Acids Res</source><year>2023</year><volume>51</volume><fpage>D587</fpage><lpage>D592</lpage><pub-id pub-id-type="doi">10.1093/nar/gkac963</pub-id><pub-id pub-id-type="pmid">36300620</pub-id>
</element-citation><mixed-citation id="mc-CR123" publication-type="journal">Kanehisa M, Furumichi M, Sato Y, Kawashima M, Ishiguro-Watanabe M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 2023;51:D587&#x02013;92. 10.1093/nar/gkac963.<pub-id pub-id-type="pmid">36300620</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR124"><label>124.</label><citation-alternatives><element-citation id="ec-CR124" publication-type="journal"><person-group person-group-type="author"><name><surname>Walke</surname><given-names>D</given-names></name><name><surname>Micheel</surname><given-names>D</given-names></name><name><surname>Schallert</surname><given-names>K</given-names></name><name><surname>Muth</surname><given-names>T</given-names></name><name><surname>Broneske</surname><given-names>D</given-names></name><name><surname>Saake</surname><given-names>G</given-names></name><name><surname>Heyer</surname><given-names>R</given-names></name></person-group><article-title>The importance of graph databases and graph learning for clinical applications</article-title><source>Database (Oxford)</source><year>2023</year><pub-id pub-id-type="doi">10.1093/database/baad045</pub-id><pub-id pub-id-type="pmid">37428679</pub-id>
</element-citation><mixed-citation id="mc-CR124" publication-type="journal">Walke D, Micheel D, Schallert K, Muth T, Broneske D, Saake G, Heyer R. The importance of graph databases and graph learning for clinical applications. Database (Oxford). 2023. 10.1093/database/baad045.<pub-id pub-id-type="pmid">37428679</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR125"><label>125.</label><citation-alternatives><element-citation id="ec-CR125" publication-type="journal"><person-group person-group-type="author"><name><surname>Berry</surname><given-names>D</given-names></name><name><surname>Widder</surname><given-names>S</given-names></name></person-group><article-title>Deciphering microbial interactions and detecting keystone species with co-occurrence networks</article-title><source>Front Microbiol</source><year>2014</year><volume>5</volume><fpage>219</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2014.00219</pub-id><pub-id pub-id-type="pmid">24904535</pub-id>
</element-citation><mixed-citation id="mc-CR125" publication-type="journal">Berry D, Widder S. Deciphering microbial interactions and detecting keystone species with co-occurrence networks. Front Microbiol. 2014;5: 219. 10.3389/fmicb.2014.00219.<pub-id pub-id-type="pmid">24904535</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR126"><label>126.</label><citation-alternatives><element-citation id="ec-CR126" publication-type="journal"><person-group person-group-type="author"><name><surname>van den Bossche</surname><given-names>T</given-names></name><name><surname>Kunath</surname><given-names>BJ</given-names></name><name><surname>Schallert</surname><given-names>K</given-names></name><name><surname>Sch&#x000e4;pe</surname><given-names>SS</given-names></name><name><surname>Abraham</surname><given-names>PE</given-names></name><name><surname>Armengaud</surname><given-names>J</given-names></name><etal/></person-group><article-title>Critical Assessment of MetaProteome Investigation (CAMPI): a multi-laboratory comparison of established workflows</article-title><source>Nat Commun</source><year>2021</year><volume>12</volume><fpage>7305</fpage><pub-id pub-id-type="doi">10.1038/s41467-021-27542-8</pub-id><pub-id pub-id-type="pmid">34911965</pub-id>
</element-citation><mixed-citation id="mc-CR126" publication-type="journal">van den Bossche T, Kunath BJ, Schallert K, Sch&#x000e4;pe SS, Abraham PE, Armengaud J, et al. Critical Assessment of MetaProteome Investigation (CAMPI): a multi-laboratory comparison of established workflows. Nat Commun. 2021;12:7305. 10.1038/s41467-021-27542-8.<pub-id pub-id-type="pmid">34911965</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR127"><label>127.</label><citation-alternatives><element-citation id="ec-CR127" publication-type="journal"><person-group person-group-type="author"><name><surname>van Leeuwen</surname><given-names>PT</given-names></name><name><surname>Brul</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wortel</surname><given-names>MT</given-names></name></person-group><article-title>Synthetic microbial communities (SynComs) of the human gut: design, assembly, and applications</article-title><source>FEMS Microbiol Rev</source><year>2023</year><pub-id pub-id-type="doi">10.1093/femsre/fuad012</pub-id><pub-id pub-id-type="pmid">36931888</pub-id>
</element-citation><mixed-citation id="mc-CR127" publication-type="journal">van Leeuwen PT, Brul S, Zhang J, Wortel MT. Synthetic microbial communities (SynComs) of the human gut: design, assembly, and applications. FEMS Microbiol Rev. 2023. 10.1093/femsre/fuad012.<pub-id pub-id-type="pmid">36931888</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR128"><label>128.</label><citation-alternatives><element-citation id="ec-CR128" publication-type="journal"><person-group person-group-type="author"><name><surname>Banerjee</surname><given-names>S</given-names></name><name><surname>Schlaeppi</surname><given-names>K</given-names></name><name><surname>van der Heijden</surname><given-names>MGA</given-names></name></person-group><article-title>Keystone taxa as drivers of microbiome structure and functioning</article-title><source>Nat Rev Microbiol</source><year>2018</year><volume>16</volume><fpage>567</fpage><lpage>576</lpage><pub-id pub-id-type="doi">10.1038/s41579-018-0024-1</pub-id><pub-id pub-id-type="pmid">29789680</pub-id>
</element-citation><mixed-citation id="mc-CR128" publication-type="journal">Banerjee S, Schlaeppi K, van der Heijden MGA. Keystone taxa as drivers of microbiome structure and functioning. Nat Rev Microbiol. 2018;16:567&#x02013;76. 10.1038/s41579-018-0024-1.<pub-id pub-id-type="pmid">29789680</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR129"><label>129.</label><citation-alternatives><element-citation id="ec-CR129" publication-type="journal"><person-group person-group-type="author"><name><surname>Herren</surname><given-names>CM</given-names></name><name><surname>McMahon</surname><given-names>KD</given-names></name></person-group><article-title>Keystone taxa predict compositional change in microbial communities</article-title><source>Environ Microbiol</source><year>2018</year><volume>20</volume><fpage>2207</fpage><lpage>2217</lpage><pub-id pub-id-type="doi">10.1111/1462-2920.14257</pub-id><pub-id pub-id-type="pmid">29708645</pub-id>
</element-citation><mixed-citation id="mc-CR129" publication-type="journal">Herren CM, McMahon KD. Keystone taxa predict compositional change in microbial communities. Environ Microbiol. 2018;20:2207&#x02013;17. 10.1111/1462-2920.14257.<pub-id pub-id-type="pmid">29708645</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR130"><label>130.</label><citation-alternatives><element-citation id="ec-CR130" publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X-G</given-names></name><name><surname>Chen</surname><given-names>M-X</given-names></name><name><surname>Zhao</surname><given-names>S-Q</given-names></name><name><surname>Wang</surname><given-names>X-Q</given-names></name></person-group><article-title>Intestinal models for personalized medicine: from conventional models to microfluidic primary intestine-on-a-chip</article-title><source>Stem Cell Rev Rep</source><year>2022</year><volume>18</volume><fpage>2137</fpage><lpage>2151</lpage><pub-id pub-id-type="doi">10.1007/s12015-021-10205-y</pub-id><pub-id pub-id-type="pmid">34181185</pub-id>
</element-citation><mixed-citation id="mc-CR130" publication-type="journal">Li X-G, Chen M-X, Zhao S-Q, Wang X-Q. Intestinal models for personalized medicine: from conventional models to microfluidic primary intestine-on-a-chip. Stem Cell Rev Rep. 2022;18:2137&#x02013;51. 10.1007/s12015-021-10205-y.<pub-id pub-id-type="pmid">34181185</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR131"><label>131.</label><citation-alternatives><element-citation id="ec-CR131" publication-type="journal"><person-group person-group-type="author"><name><surname>Molly</surname><given-names>K</given-names></name><name><surname>Vande Woestyne</surname><given-names>M</given-names></name><name><surname>Verstraete</surname><given-names>W</given-names></name></person-group><article-title>Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem</article-title><source>Appl Microbiol Biotechnol</source><year>1993</year><volume>39</volume><fpage>254</fpage><lpage>258</lpage><pub-id pub-id-type="doi">10.1007/BF00228615</pub-id><pub-id pub-id-type="pmid">7763732</pub-id>
</element-citation><mixed-citation id="mc-CR131" publication-type="journal">Molly K, Vande Woestyne M, Verstraete W. Development of a 5-step multi-chamber reactor as a simulation of the human intestinal microbial ecosystem. Appl Microbiol Biotechnol. 1993;39:254&#x02013;8. 10.1007/BF00228615.<pub-id pub-id-type="pmid">7763732</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR132"><label>132.</label><citation-alternatives><element-citation id="ec-CR132" publication-type="journal"><person-group person-group-type="author"><name><surname>Vorl&#x000e4;nder</surname><given-names>D</given-names></name><name><surname>Schultz</surname><given-names>G</given-names></name><name><surname>Hoffmann</surname><given-names>K</given-names></name><name><surname>Rasch</surname><given-names>D</given-names></name><name><surname>Dohnt</surname><given-names>K</given-names></name></person-group><article-title>PETR: a novel peristaltic mixed tubular bioreactor simulating human colonic conditions</article-title><source>Biotechnol Bioeng</source><year>2024</year><volume>121</volume><fpage>1118</fpage><lpage>1143</lpage><pub-id pub-id-type="doi">10.1002/bit.28636</pub-id><pub-id pub-id-type="pmid">38151924</pub-id>
</element-citation><mixed-citation id="mc-CR132" publication-type="journal">Vorl&#x000e4;nder D, Schultz G, Hoffmann K, Rasch D, Dohnt K. PETR: a novel peristaltic mixed tubular bioreactor simulating human colonic conditions. Biotechnol Bioeng. 2024;121:1118&#x02013;43. 10.1002/bit.28636.<pub-id pub-id-type="pmid">38151924</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR133"><label>133.</label><citation-alternatives><element-citation id="ec-CR133" publication-type="journal"><person-group person-group-type="author"><name><surname>Shah</surname><given-names>P</given-names></name><name><surname>Fritz</surname><given-names>JV</given-names></name><name><surname>Glaab</surname><given-names>E</given-names></name><name><surname>Desai</surname><given-names>MS</given-names></name><name><surname>Greenhalgh</surname><given-names>K</given-names></name><name><surname>Frachet</surname><given-names>A</given-names></name><etal/></person-group><article-title>A microfluidics-based in vitro model of the gastrointestinal human&#x02013;microbe interface</article-title><source>Nat Commun</source><year>2016</year><volume>7</volume><fpage>11535</fpage><pub-id pub-id-type="doi">10.1038/ncomms11535</pub-id><pub-id pub-id-type="pmid">27168102</pub-id>
</element-citation><mixed-citation id="mc-CR133" publication-type="journal">Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, et al. A microfluidics-based in vitro model of the gastrointestinal human&#x02013;microbe interface. Nat Commun. 2016;7: 11535. 10.1038/ncomms11535.<pub-id pub-id-type="pmid">27168102</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR134"><label>134.</label><citation-alternatives><element-citation id="ec-CR134" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HJ</given-names></name><name><surname>Huh</surname><given-names>D</given-names></name><name><surname>Hamilton</surname><given-names>G</given-names></name><name><surname>Ingber</surname><given-names>DE</given-names></name></person-group><article-title>Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow</article-title><source>Lab Chip</source><year>2012</year><volume>12</volume><fpage>2165</fpage><lpage>2174</lpage><pub-id pub-id-type="doi">10.1039/C2LC40074J</pub-id><pub-id pub-id-type="pmid">22434367</pub-id>
</element-citation><mixed-citation id="mc-CR134" publication-type="journal">Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012;12:2165&#x02013;74. 10.1039/C2LC40074J.<pub-id pub-id-type="pmid">22434367</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR135"><label>135.</label><citation-alternatives><element-citation id="ec-CR135" publication-type="book"><person-group person-group-type="author"><name><surname>Kunath</surname><given-names>BJ</given-names></name><name><surname>Minniti</surname><given-names>G</given-names></name><name><surname>Skaugen</surname><given-names>M</given-names></name><name><surname>Hagen</surname><given-names>LH</given-names></name><name><surname>Vaaje-Kolstad</surname><given-names>G</given-names></name><name><surname>Eijsink</surname><given-names>VGH</given-names></name><etal/></person-group><person-group person-group-type="editor"><name><surname>Capelo-Mart&#x000ed;nez</surname><given-names>J-L</given-names></name><etal/></person-group><article-title>Metaproteomics: sample preparation and methodological considerations</article-title><source>Emerging Sample Treatments in Proteomics</source><year>2019</year><publisher-loc>Cham</publisher-loc><publisher-name>Springer International Publishing</publisher-name><fpage>187</fpage><lpage>215</lpage></element-citation><mixed-citation id="mc-CR135" publication-type="book">Kunath BJ, Minniti G, Skaugen M, Hagen LH, Vaaje-Kolstad G, Eijsink VGH, et al. Metaproteomics: sample preparation and methodological considerations. In: Capelo-Mart&#x000ed;nez J-L, editor., et al., Emerging Sample Treatments in Proteomics. Cham: Springer International Publishing; 2019. p. 187&#x02013;215. 10.1007/978-3-030-12298-0_8.</mixed-citation></citation-alternatives></ref><ref id="CR136"><label>136.</label><citation-alternatives><element-citation id="ec-CR136" publication-type="journal"><person-group person-group-type="author"><name><surname>Schiebenhoefer</surname><given-names>H</given-names></name><name><surname>van den Bossche</surname><given-names>T</given-names></name><name><surname>Fuchs</surname><given-names>S</given-names></name><name><surname>Renard</surname><given-names>BY</given-names></name><name><surname>Muth</surname><given-names>T</given-names></name><name><surname>Martens</surname><given-names>L</given-names></name></person-group><article-title>Challenges and promise at the interface of metaproteomics and genomics: an overview of recent progress in metaproteogenomic data analysis</article-title><source>Expert Rev Proteomics</source><year>2019</year><volume>16</volume><fpage>375</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1080/14789450.2019.1609944</pub-id><pub-id pub-id-type="pmid">31002542</pub-id>
</element-citation><mixed-citation id="mc-CR136" publication-type="journal">Schiebenhoefer H, van den Bossche T, Fuchs S, Renard BY, Muth T, Martens L. Challenges and promise at the interface of metaproteomics and genomics: an overview of recent progress in metaproteogenomic data analysis. Expert Rev Proteomics. 2019;16:375&#x02013;90. 10.1080/14789450.2019.1609944.<pub-id pub-id-type="pmid">31002542</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR137"><label>137.</label><citation-alternatives><element-citation id="ec-CR137" publication-type="journal"><person-group person-group-type="author"><name><surname>Roume</surname><given-names>H</given-names></name><name><surname>Muller</surname><given-names>EEL</given-names></name><name><surname>Cordes</surname><given-names>T</given-names></name><name><surname>Renaut</surname><given-names>J</given-names></name><name><surname>Hiller</surname><given-names>K</given-names></name><name><surname>Wilmes</surname><given-names>P</given-names></name></person-group><article-title>A biomolecular isolation framework for eco-systems biology</article-title><source>ISME J</source><year>2013</year><volume>7</volume><fpage>110</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1038/ismej.2012.72</pub-id><pub-id pub-id-type="pmid">22763648</pub-id>
</element-citation><mixed-citation id="mc-CR137" publication-type="journal">Roume H, Muller EEL, Cordes T, Renaut J, Hiller K, Wilmes P. A biomolecular isolation framework for eco-systems biology. ISME J. 2013;7:110&#x02013;21. 10.1038/ismej.2012.72.<pub-id pub-id-type="pmid">22763648</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR138"><label>138.</label><citation-alternatives><element-citation id="ec-CR138" publication-type="journal"><person-group person-group-type="author"><name><surname>Heyer</surname><given-names>R</given-names></name><name><surname>Schallert</surname><given-names>K</given-names></name><name><surname>B&#x000fc;del</surname><given-names>A</given-names></name><name><surname>Zoun</surname><given-names>R</given-names></name><name><surname>Dorl</surname><given-names>S</given-names></name><name><surname>Behne</surname><given-names>A</given-names></name><etal/></person-group><article-title>A robust and universal metaproteomics workflow for research studies and routine diagnostics within 24 h using phenol extraction, FASP digest, and the MetaProteomeAnalyzer</article-title><source>Front Microbiol</source><year>2019</year><volume>10</volume><fpage>1883</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2019.01883</pub-id><pub-id pub-id-type="pmid">31474963</pub-id>
</element-citation><mixed-citation id="mc-CR138" publication-type="journal">Heyer R, Schallert K, B&#x000fc;del A, Zoun R, Dorl S, Behne A, et al. A robust and universal metaproteomics workflow for research studies and routine diagnostics within 24 h using phenol extraction, FASP digest, and the MetaProteomeAnalyzer. Front Microbiol. 2019;10: 1883. 10.3389/fmicb.2019.01883.<pub-id pub-id-type="pmid">31474963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR139"><label>139.</label><citation-alternatives><element-citation id="ec-CR139" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Fekete</surname><given-names>EEF</given-names></name><name><surname>Creskey</surname><given-names>M</given-names></name><name><surname>Cheng</surname><given-names>K</given-names></name><name><surname>Ning</surname><given-names>Z</given-names></name><name><surname>Pfeifle</surname><given-names>A</given-names></name><etal/></person-group><article-title>Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry</article-title><source>Microbiome Res Rep</source><year>2024</year><volume>3</volume><fpage>39</fpage><pub-id pub-id-type="doi">10.20517/mrr.2024.21</pub-id><pub-id pub-id-type="pmid">39421247</pub-id>
</element-citation><mixed-citation id="mc-CR139" publication-type="journal">Wang A, Fekete EEF, Creskey M, Cheng K, Ning Z, Pfeifle A, et al. Assessing fecal metaproteomics workflow and small protein recovery using DDA and DIA PASEF mass spectrometry. Microbiome Res Rep. 2024;3:39. 10.20517/mrr.2024.21.<pub-id pub-id-type="pmid">39421247</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR140"><label>140.</label><mixed-citation publication-type="other">Tanca A, Schallert K, Grenga L, Peters SL, Abbondio M, Diego L de, et al. Critical Assessment of MetaProteome Investigation 2 (CAMPI-2): multi-laboratory assessment of sample processing methods to stabilize fecal microbiome for functional analysis; 2025.</mixed-citation></ref><ref id="CR141"><label>141.</label><citation-alternatives><element-citation id="ec-CR141" publication-type="journal"><person-group person-group-type="author"><name><surname>Llor&#x000e9;ns-Rico</surname><given-names>V</given-names></name><name><surname>Simcock</surname><given-names>JA</given-names></name><name><surname>Huys</surname><given-names>GRB</given-names></name><name><surname>Raes</surname><given-names>J</given-names></name></person-group><article-title>Single-cell approaches in human microbiome research</article-title><source>Cell.</source><year>2022</year><volume>185</volume><fpage>2725</fpage><lpage>2738</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2022.06.040</pub-id><pub-id pub-id-type="pmid">35868276</pub-id>
</element-citation><mixed-citation id="mc-CR141" publication-type="journal">Llor&#x000e9;ns-Rico V, Simcock JA, Huys GRB, Raes J. Single-cell approaches in human microbiome research. Cell. 2022;185:2725&#x02013;38. 10.1016/j.cell.2022.06.040.<pub-id pub-id-type="pmid">35868276</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR142"><label>142.</label><citation-alternatives><element-citation id="ec-CR142" publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano-Villar</surname><given-names>S</given-names></name><name><surname>Tincati</surname><given-names>C</given-names></name><name><surname>Raju</surname><given-names>SC</given-names></name><name><surname>S&#x000e1;enz</surname><given-names>JS</given-names></name><name><surname>Moreno</surname><given-names>E</given-names></name><name><surname>Bargiela</surname><given-names>R</given-names></name><etal/></person-group><article-title>Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer</article-title><source>Nat Med</source><year>2023</year><volume>29</volume><fpage>1738</fpage><lpage>1749</lpage><pub-id pub-id-type="doi">10.1038/s41591-023-02407-3</pub-id><pub-id pub-id-type="pmid">37464040</pub-id>
</element-citation><mixed-citation id="mc-CR142" publication-type="journal">Serrano-Villar S, Tincati C, Raju SC, S&#x000e1;enz JS, Moreno E, Bargiela R, et al. Microbiome-derived cobalamin and succinyl-CoA as biomarkers for improved screening of anal cancer. Nat Med. 2023;29:1738&#x02013;49. 10.1038/s41591-023-02407-3.<pub-id pub-id-type="pmid">37464040</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR143"><label>143.</label><citation-alternatives><element-citation id="ec-CR143" publication-type="journal"><person-group person-group-type="author"><name><surname>Kunath</surname><given-names>BJ</given-names></name><name><surname>de Rudder</surname><given-names>C</given-names></name><name><surname>Laczny</surname><given-names>CC</given-names></name><name><surname>Letellier</surname><given-names>E</given-names></name><name><surname>Wilmes</surname><given-names>P</given-names></name></person-group><article-title>The oral-gut microbiome axis in health and disease</article-title><source>Nat Rev Microbiol</source><year>2024</year><volume>22</volume><fpage>791</fpage><lpage>805</lpage><pub-id pub-id-type="doi">10.1038/s41579-024-01075-5</pub-id><pub-id pub-id-type="pmid">39039286</pub-id>
</element-citation><mixed-citation id="mc-CR143" publication-type="journal">Kunath BJ, de Rudder C, Laczny CC, Letellier E, Wilmes P. The oral-gut microbiome axis in health and disease. Nat Rev Microbiol. 2024;22:791&#x02013;805. 10.1038/s41579-024-01075-5.<pub-id pub-id-type="pmid">39039286</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR144"><label>144.</label><citation-alternatives><element-citation id="ec-CR144" publication-type="journal"><person-group person-group-type="author"><name><surname>Jumper</surname><given-names>J</given-names></name><name><surname>Evans</surname><given-names>R</given-names></name><name><surname>Pritzel</surname><given-names>A</given-names></name><name><surname>Green</surname><given-names>T</given-names></name><name><surname>Figurnov</surname><given-names>M</given-names></name><name><surname>Ronneberger</surname><given-names>O</given-names></name><etal/></person-group><article-title>Highly accurate protein structure prediction with AlphaFold</article-title><source>Nature</source><year>2021</year><volume>596</volume><fpage>583</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03819-2</pub-id><pub-id pub-id-type="pmid">34265844</pub-id>
</element-citation><mixed-citation id="mc-CR144" publication-type="journal">Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021;596:583&#x02013;9. 10.1038/s41586-021-03819-2.<pub-id pub-id-type="pmid">34265844</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR145"><label>145.</label><citation-alternatives><element-citation id="ec-CR145" publication-type="journal"><person-group person-group-type="author"><name><surname>Taneishi</surname><given-names>K</given-names></name><name><surname>Tsuchiya</surname><given-names>Y</given-names></name></person-group><article-title>Structure-based analyses of gut microbiome-related proteins by neural networks and molecular dynamics simulations</article-title><source>Curr Opin Struct Biol</source><year>2022</year><volume>73</volume><fpage>102336</fpage><pub-id pub-id-type="doi">10.1016/j.sbi.2022.102336</pub-id><pub-id pub-id-type="pmid">35183821</pub-id>
</element-citation><mixed-citation id="mc-CR145" publication-type="journal">Taneishi K, Tsuchiya Y. Structure-based analyses of gut microbiome-related proteins by neural networks and molecular dynamics simulations. Curr Opin Struct Biol. 2022;73: 102336. 10.1016/j.sbi.2022.102336.<pub-id pub-id-type="pmid">35183821</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR146"><label>146.</label><citation-alternatives><element-citation id="ec-CR146" publication-type="journal"><person-group person-group-type="author"><name><surname>Pu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name><name><surname>Heymann</surname><given-names>D</given-names></name><name><surname>Robert</surname><given-names>C</given-names></name><etal/></person-group><article-title>Drug-tolerant persister cells in cancer: the cutting edges and future directions</article-title><source>Nat Rev Clin Oncol</source><year>2023</year><volume>20</volume><fpage>799</fpage><lpage>813</lpage><pub-id pub-id-type="doi">10.1038/s41571-023-00815-5</pub-id><pub-id pub-id-type="pmid">37749382</pub-id>
</element-citation><mixed-citation id="mc-CR146" publication-type="journal">Pu Y, Li L, Peng H, Liu L, Heymann D, Robert C, et al. Drug-tolerant persister cells in cancer: the cutting edges and future directions. Nat Rev Clin Oncol. 2023;20:799&#x02013;813. 10.1038/s41571-023-00815-5.<pub-id pub-id-type="pmid">37749382</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR147"><label>147.</label><citation-alternatives><element-citation id="ec-CR147" publication-type="journal"><person-group person-group-type="author"><name><surname>Fossmark</surname><given-names>R</given-names></name><name><surname>Olaisen</surname><given-names>M</given-names></name></person-group><article-title>Changes in the gastrointestinal microbiota induced by proton pump inhibitors-a review of findings from experimental trials</article-title><source>Microorganisms</source><year>2024</year><pub-id pub-id-type="doi">10.3390/microorganisms12061110</pub-id><pub-id pub-id-type="pmid">38930492</pub-id>
</element-citation><mixed-citation id="mc-CR147" publication-type="journal">Fossmark R, Olaisen M. Changes in the gastrointestinal microbiota induced by proton pump inhibitors-a review of findings from experimental trials. Microorganisms. 2024. 10.3390/microorganisms12061110.<pub-id pub-id-type="pmid">38930492</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR148"><label>148.</label><citation-alternatives><element-citation id="ec-CR148" publication-type="journal"><person-group person-group-type="author"><name><surname>Sawaid</surname><given-names>IO</given-names></name><name><surname>Samson</surname><given-names>AO</given-names></name></person-group><article-title>Proton pump inhibitors and cancer risk: a comprehensive review of epidemiological and mechanistic evidence</article-title><source>J Clin Med</source><year>2024</year><pub-id pub-id-type="doi">10.3390/jcm13071970</pub-id><pub-id pub-id-type="pmid">38673557</pub-id>
</element-citation><mixed-citation id="mc-CR148" publication-type="journal">Sawaid IO, Samson AO. Proton pump inhibitors and cancer risk: a comprehensive review of epidemiological and mechanistic evidence. J Clin Med. 2024. 10.3390/jcm13071970.<pub-id pub-id-type="pmid">38673557</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR149"><label>149.</label><citation-alternatives><element-citation id="ec-CR149" publication-type="journal"><person-group person-group-type="author"><name><surname>Aarnoutse</surname><given-names>R</given-names></name><name><surname>Ziemons</surname><given-names>J</given-names></name><name><surname>Penders</surname><given-names>J</given-names></name><name><surname>Rensen</surname><given-names>SS</given-names></name><name><surname>de Vos-Geelen</surname><given-names>J</given-names></name><name><surname>Smidt</surname><given-names>ML</given-names></name></person-group><article-title>The clinical link between human intestinal microbiota and systemic cancer therapy</article-title><source>Int J Mol Sci</source><year>2019</year><pub-id pub-id-type="doi">10.3390/ijms20174145</pub-id><pub-id pub-id-type="pmid">31450659</pub-id>
</element-citation><mixed-citation id="mc-CR149" publication-type="journal">Aarnoutse R, Ziemons J, Penders J, Rensen SS, de Vos-Geelen J, Smidt ML. The clinical link between human intestinal microbiota and systemic cancer therapy. Int J Mol Sci. 2019. 10.3390/ijms20174145.<pub-id pub-id-type="pmid">31450659</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR150"><label>150.</label><citation-alternatives><element-citation id="ec-CR150" publication-type="journal"><person-group person-group-type="author"><name><surname>Gopalakrishnan</surname><given-names>V</given-names></name><name><surname>Spencer</surname><given-names>CN</given-names></name><name><surname>Nezi</surname><given-names>L</given-names></name><name><surname>Reuben</surname><given-names>A</given-names></name><name><surname>Andrews</surname><given-names>MC</given-names></name><name><surname>Karpinets</surname><given-names>TV</given-names></name><etal/></person-group><article-title>Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients</article-title><source>Science</source><year>2018</year><volume>359</volume><fpage>97</fpage><lpage>103</lpage><pub-id pub-id-type="doi">10.1126/science.aan4236</pub-id><pub-id pub-id-type="pmid">29097493</pub-id>
</element-citation><mixed-citation id="mc-CR150" publication-type="journal">Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 2018;359:97&#x02013;103. 10.1126/science.aan4236.<pub-id pub-id-type="pmid">29097493</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR151"><label>151.</label><citation-alternatives><element-citation id="ec-CR151" publication-type="journal"><person-group person-group-type="author"><name><surname>Vill&#x000e9;ger</surname><given-names>R</given-names></name><name><surname>Lop&#x000e8;s</surname><given-names>A</given-names></name><name><surname>Carrier</surname><given-names>G</given-names></name><name><surname>Veziant</surname><given-names>J</given-names></name><name><surname>Billard</surname><given-names>E</given-names></name><name><surname>Barnich</surname><given-names>N</given-names></name><etal/></person-group><article-title>Intestinal microbiota: a novel target to improve anti-tumor treatment?</article-title><source>Int J Mol Sci</source><year>2019</year><pub-id pub-id-type="doi">10.3390/ijms20184584</pub-id><pub-id pub-id-type="pmid">31533218</pub-id>
</element-citation><mixed-citation id="mc-CR151" publication-type="journal">Vill&#x000e9;ger R, Lop&#x000e8;s A, Carrier G, Veziant J, Billard E, Barnich N, et al. Intestinal microbiota: a novel target to improve anti-tumor treatment? Int J Mol Sci. 2019. 10.3390/ijms20184584.<pub-id pub-id-type="pmid">31533218</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR152"><label>152.</label><citation-alternatives><element-citation id="ec-CR152" publication-type="journal"><person-group person-group-type="author"><name><surname>Ervin</surname><given-names>SM</given-names></name><name><surname>Ramanan</surname><given-names>SV</given-names></name><name><surname>Bhatt</surname><given-names>AP</given-names></name></person-group><article-title>Relationship between the gut microbiome and systemic chemotherapy</article-title><source>Dig Dis Sci</source><year>2020</year><volume>65</volume><fpage>874</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1007/s10620-020-06119-3</pub-id><pub-id pub-id-type="pmid">32026181</pub-id>
</element-citation><mixed-citation id="mc-CR152" publication-type="journal">Ervin SM, Ramanan SV, Bhatt AP. Relationship between the gut microbiome and systemic chemotherapy. Dig Dis Sci. 2020;65:874&#x02013;84. 10.1007/s10620-020-06119-3.<pub-id pub-id-type="pmid">32026181</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR153"><label>153.</label><citation-alternatives><element-citation id="ec-CR153" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Lyu</surname><given-names>M</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><etal/></person-group><article-title>In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study</article-title><source>Microbiome</source><year>2024</year><volume>12</volume><fpage>6</fpage><pub-id pub-id-type="doi">10.1186/s40168-023-01730-8</pub-id><pub-id pub-id-type="pmid">38191439</pub-id>
</element-citation><mixed-citation id="mc-CR153" publication-type="journal">Chen J, Sun Y, Li J, Lyu M, Yuan L, Sun J, et al. In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study. Microbiome. 2024;12:6. 10.1186/s40168-023-01730-8.<pub-id pub-id-type="pmid">38191439</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR154"><label>154.</label><citation-alternatives><element-citation id="ec-CR154" publication-type="journal"><person-group person-group-type="author"><name><surname>Cristobal-Cueto</surname><given-names>P</given-names></name><name><surname>Garc&#x000ed;a-Quintanilla</surname><given-names>A</given-names></name><name><surname>Esteban</surname><given-names>J</given-names></name><name><surname>Garc&#x000ed;a-Quintanilla</surname><given-names>M</given-names></name></person-group><article-title>Phages in food industry biocontrol and bioremediation</article-title><source>Antibiotics (Basel)</source><year>2021</year><pub-id pub-id-type="doi">10.3390/antibiotics10070786</pub-id><pub-id pub-id-type="pmid">34203362</pub-id>
</element-citation><mixed-citation id="mc-CR154" publication-type="journal">Cristobal-Cueto P, Garc&#x000ed;a-Quintanilla A, Esteban J, Garc&#x000ed;a-Quintanilla M. Phages in food industry biocontrol and bioremediation. Antibiotics (Basel). 2021. 10.3390/antibiotics10070786.<pub-id pub-id-type="pmid">34203362</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR155"><label>155.</label><citation-alternatives><element-citation id="ec-CR155" publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>I</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Souza-Alonso</surname><given-names>P</given-names></name><name><surname>Vos&#x000e1;tka</surname><given-names>M</given-names></name><name><surname>Freitas</surname><given-names>H</given-names></name><name><surname>Oliveira</surname><given-names>RS</given-names></name></person-group><article-title>Seed coating: a tool for delivering beneficial microbes to agricultural crops</article-title><source>Front Plant Sci</source><year>2019</year><volume>10</volume><fpage>1357</fpage><pub-id pub-id-type="doi">10.3389/fpls.2019.01357</pub-id><pub-id pub-id-type="pmid">31781135</pub-id>
</element-citation><mixed-citation id="mc-CR155" publication-type="journal">Rocha I, Ma Y, Souza-Alonso P, Vos&#x000e1;tka M, Freitas H, Oliveira RS. Seed coating: a tool for delivering beneficial microbes to agricultural crops. Front Plant Sci. 2019;10: 1357. 10.3389/fpls.2019.01357.<pub-id pub-id-type="pmid">31781135</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR156"><label>156.</label><mixed-citation publication-type="other">Quinto EJ, Caro I, Villalobos-Delgado LH, Mateo J, De-Mateo-Silleras B, Redondo-Del-R&#x000ed;o MP. Food safety through natural antimicrobials. Antibiotics (Basel) 2019. 10.3390/antibiotics8040208.</mixed-citation></ref><ref id="CR157"><label>157.</label><citation-alternatives><element-citation id="ec-CR157" publication-type="journal"><person-group person-group-type="author"><name><surname>Bhatt</surname><given-names>P</given-names></name><name><surname>Engel</surname><given-names>BA</given-names></name><name><surname>Reuhs</surname><given-names>M</given-names></name><name><surname>Simsek</surname><given-names>H</given-names></name></person-group><article-title>Cyanophage technology in removal of cyanobacteria mediated harmful algal blooms: a novel and eco-friendly method</article-title><source>Chemosphere</source><year>2023</year><volume>315</volume><fpage>137769</fpage><pub-id pub-id-type="doi">10.1016/j.chemosphere.2023.137769</pub-id><pub-id pub-id-type="pmid">36623591</pub-id>
</element-citation><mixed-citation id="mc-CR157" publication-type="journal">Bhatt P, Engel BA, Reuhs M, Simsek H. Cyanophage technology in removal of cyanobacteria mediated harmful algal blooms: a novel and eco-friendly method. Chemosphere. 2023;315: 137769. 10.1016/j.chemosphere.2023.137769.<pub-id pub-id-type="pmid">36623591</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR158"><label>158.</label><citation-alternatives><element-citation id="ec-CR158" publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M</given-names></name><name><surname>Jaiswal</surname><given-names>S</given-names></name><name><surname>Sodhi</surname><given-names>KK</given-names></name><name><surname>Shree</surname><given-names>P</given-names></name><name><surname>Singh</surname><given-names>DK</given-names></name><name><surname>Agrawal</surname><given-names>PK</given-names></name><name><surname>Shukla</surname><given-names>P</given-names></name></person-group><article-title>Antibiotics bioremediation: perspectives on its ecotoxicity and resistance</article-title><source>Environ Int</source><year>2019</year><volume>124</volume><fpage>448</fpage><lpage>461</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2018.12.065</pub-id><pub-id pub-id-type="pmid">30684803</pub-id>
</element-citation><mixed-citation id="mc-CR158" publication-type="journal">Kumar M, Jaiswal S, Sodhi KK, Shree P, Singh DK, Agrawal PK, Shukla P. Antibiotics bioremediation: perspectives on its ecotoxicity and resistance. Environ Int. 2019;124:448&#x02013;61. 10.1016/j.envint.2018.12.065.<pub-id pub-id-type="pmid">30684803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR159"><label>159.</label><citation-alternatives><element-citation id="ec-CR159" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Gill</surname><given-names>JJ</given-names></name><name><surname>Young</surname><given-names>R</given-names></name><name><surname>Summer</surname><given-names>EJ</given-names></name></person-group><article-title>Bacteriophages of wastewater foaming-associated filamentous Gordonia reduce host levels in raw activated sludge</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>13754</fpage><pub-id pub-id-type="doi">10.1038/srep13754</pub-id><pub-id pub-id-type="pmid">26349678</pub-id>
</element-citation><mixed-citation id="mc-CR159" publication-type="journal">Liu M, Gill JJ, Young R, Summer EJ. Bacteriophages of wastewater foaming-associated filamentous Gordonia reduce host levels in raw activated sludge. Sci Rep. 2015;5: 13754. 10.1038/srep13754.<pub-id pub-id-type="pmid">26349678</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR160"><label>160.</label><citation-alternatives><element-citation id="ec-CR160" publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>S-M</given-names></name><name><surname>Heo</surname><given-names>HR</given-names></name><name><surname>Kim</surname><given-names>CS</given-names></name><name><surname>Shin</surname><given-names>HH</given-names></name></person-group><article-title>Genetically engineered bacteriophages as novel nanomaterials: applications beyond antimicrobial agents</article-title><source>Front Bioeng Biotechnol</source><year>2024</year><volume>12</volume><fpage>1319830</fpage><pub-id pub-id-type="doi">10.3389/fbioe.2024.1319830</pub-id><pub-id pub-id-type="pmid">38725991</pub-id>
</element-citation><mixed-citation id="mc-CR160" publication-type="journal">Kim S-M, Heo HR, Kim CS, Shin HH. Genetically engineered bacteriophages as novel nanomaterials: applications beyond antimicrobial agents. Front Bioeng Biotechnol. 2024;12: 1319830. 10.3389/fbioe.2024.1319830.<pub-id pub-id-type="pmid">38725991</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR161"><label>161.</label><citation-alternatives><element-citation id="ec-CR161" publication-type="journal"><person-group person-group-type="author"><name><surname>Qiu</surname><given-names>D</given-names></name><name><surname>Ke</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Qian</surname><given-names>H</given-names></name></person-group><article-title>Response of microbial antibiotic resistance to pesticides: an emerging health threat</article-title><source>Sci Total Environ</source><year>2022</year><volume>850</volume><fpage>158057</fpage><pub-id pub-id-type="doi">10.1016/j.scitotenv.2022.158057</pub-id><pub-id pub-id-type="pmid">35977623</pub-id>
</element-citation><mixed-citation id="mc-CR161" publication-type="journal">Qiu D, Ke M, Zhang Q, Zhang F, Lu T, Sun L, Qian H. Response of microbial antibiotic resistance to pesticides: an emerging health threat. Sci Total Environ. 2022;850: 158057. 10.1016/j.scitotenv.2022.158057.<pub-id pub-id-type="pmid">35977623</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR162"><label>162.</label><citation-alternatives><element-citation id="ec-CR162" publication-type="journal"><person-group person-group-type="author"><name><surname>van Puyvelde</surname><given-names>B</given-names></name><name><surname>Dhaenens</surname><given-names>M</given-names></name></person-group><article-title>Add mass spectrometry to the pandemic toolbox</article-title><source>Elife</source><year>2021</year><pub-id pub-id-type="doi">10.7554/eLife.75471</pub-id><pub-id pub-id-type="pmid">34889738</pub-id>
</element-citation><mixed-citation id="mc-CR162" publication-type="journal">van Puyvelde B, Dhaenens M. Add mass spectrometry to the pandemic toolbox. Elife. 2021. 10.7554/eLife.75471.<pub-id pub-id-type="pmid">34889738</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>